data_2npb_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2npb _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 121.728 0.775 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.442 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 25' ' ' LYS . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' CD ' HH12 ' A' ' 74' ' ' ARG . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.435 HH12 ' CD ' ' A' ' 70' ' ' GLU . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.87 0.367 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 35' ' ' ASP . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.401 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 6' ' ' ARG . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.44 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.44 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 33' ' ' CYS . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.087 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CB ' ' HH ' ' A' ' 19' ' ' TYR . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' A' ' 9' ' ' TYR . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 25' ' ' LYS . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.428 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.291 0.091 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 120.217 0.056 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 68' ' ' ASP . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.44 ' CD1' ' H ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.44 ' H ' ' CD1' ' A' ' 3' ' ' LEU . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.096 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.768 -1.11 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CB ' ' HH ' ' A' ' 19' ' ' TYR . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.45 ' HH ' ' CB ' ' A' ' 9' ' ' TYR . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 119.424 -0.322 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.538 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.538 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 120.91 0.385 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.741 0.305 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.452 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.452 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.439 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 33' ' ' CYS . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' HG ' ' A' ' 59' ' ' SER . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.407 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.978 0.418 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.55 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . 0.55 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.453 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 111.288 0.107 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ARG . . . . . 0.444 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.407 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.48 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.21 178.54 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 155.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -135.11 47.47 2.34 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -68.24 82.14 0.19 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.929 2.204 . . . . 0.0 115.785 -165.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -56.01 142.43 65.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.229 1.012 . . . . 0.0 113.275 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.18 -173.21 1.5 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.755 2.97 . . . . 0.0 110.874 164.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 66.48 -48.03 0.44 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.407 2.683 . . . . 0.0 113.725 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.21 149.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 109.413 165.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.6 t -148.63 166.54 28.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.046 1.339 . . . . 0.0 112.318 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.88 26.49 67.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.088 1.328 . . . . 0.0 115.751 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -125.59 -179.64 4.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.852 1.326 . . . . 0.0 114.225 -165.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.439 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.439 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 -177.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.758 1.617 . . . . 0.0 111.474 162.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.64 95.94 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.12 95.47 1.64 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.141 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -118.22 132.38 23.78 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.38 1.072 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.05 142.3 27.55 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.101 2.534 . . . . 0.0 112.054 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -136.57 -73.58 0.44 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.135 0.974 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -154.36 -35.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.7 t -139.49 -72.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.19 1.396 . . . . 0.0 110.045 166.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 149.13 175.37 21.48 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.24 1.4 . . . . 0.0 113.739 171.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.5 126.13 11.01 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 107.8 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.442 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.501 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.442 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.501 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 162.28 16.62 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.152 1.342 . . . . 0.0 110.393 157.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.479 ' CD ' ' HZ2' ' A' ' 25' ' ' LYS . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.479 ' HZ2' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.408 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.408 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -133.56 79.92 1.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.97 35.82 1.68 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.088 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.7 p -71.44 149.68 93.78 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.463 1.505 . . . . 0.0 112.619 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.51 3.92 4.39 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.92 2.414 . . . . 0.0 115.521 -169.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.31 86.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -158.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -143.07 102.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.728 1.603 . . . . 0.0 110.212 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.8 m -48.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.868 2.067 . . . . 0.0 113.03 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.27 -7.25 34.73 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.962 1.744 . . . . 0.0 115.923 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.44 119.81 16.13 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.822 1.311 . . . . 0.0 107.53 168.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' CD ' HH12 ' A' ' 74' ' ' ARG . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.435 HH12 ' CD ' ' A' ' 70' ' ' GLU . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptm . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 172.4 18.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.64 2.376 . . . . 0.0 107.591 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.471 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.03 47.54 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.17 82.3 0.35 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 127.051 2.262 . . . . 0.0 111.979 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -113.4 158.9 37.14 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.058 1.343 . . . . 0.0 113.785 -159.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.41 79.42 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.277 2.651 . . . . 0.0 111.809 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -137.25 154.43 50.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.612 1.165 . . . . 0.0 110.501 171.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.26 -29.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.201 1.0 . . . . 0.0 111.985 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.65 87.88 2.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.521 1.528 . . . . 0.0 111.124 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.56 50.31 2.47 Favored Glycine 0 CA--C 1.537 1.417 0 O-C-N 120.973 -1.079 . . . . 0.0 115.575 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.23 95.53 2.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.754 1.777 . . . . 0.0 111.124 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.412 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.89 175.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.818 0.735 . . . . 0.0 111.59 149.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.401 HH12 ' CG ' ' A' ' 35' ' ' ASP . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.401 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.401 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.401 ' CG ' HH12 ' A' ' 6' ' ' ARG . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -139.76 61.88 1.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.65 79.7 0.34 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.166 1.841 . . . . 0.0 111.03 170.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -101.63 164.4 15.98 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 128.512 2.725 . . . . 0.0 113.233 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.04 176.75 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.006 2.471 . . . . 0.0 111.508 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 64.6 -36.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 128.922 2.889 . . . . 0.0 116.75 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.8 145.3 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.75 1.159 . . . . 0.0 111.406 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.932 -1.105 . . . . 0.0 112.212 -165.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 79.27 0.9 84.8 Favored Glycine 0 CA--C 1.543 1.786 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 170.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.38 82.44 0.56 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.915 1.686 . . . . 0.0 111.498 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.44 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.44 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 116.888 -1.53 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 161.96 6.96 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.077 1.308 . . . . 0.0 112.551 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.48 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.499 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.401 ' C ' ' H ' ' A' ' 33' ' ' CYS . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' H ' ' C ' ' A' ' 31' ' ' PRO . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -145.0 107.03 4.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.36 68.25 3.55 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.081 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -49.82 132.16 21.23 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.005 1.722 . . . . 0.0 108.534 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.5 138.76 43.04 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 121.394 1.396 . . . . 0.0 113.321 -154.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 61.04 13.93 5.0 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.316 1.847 . . . . 0.0 115.984 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.64 153.52 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.8 48.44 0.47 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.657 2.783 . . . . 0.0 115.328 -166.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.16 12.8 Favored Glycine 0 CA--C 1.541 1.667 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -66.38 154.88 38.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.847 1.323 . . . . 0.0 112.83 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.18 164.95 0.15 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.619 1.554 . . . . 0.0 112.242 142.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.438 ' CB ' ' HH ' ' A' ' 19' ' ' TYR . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.438 ' HH ' ' CB ' ' A' ' 9' ' ' TYR . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.417 ' CD ' ' HZ2' ' A' ' 25' ' ' LYS . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.417 ' HZ2' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -130.97 75.24 1.65 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.31 106.52 2.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.077 -1.419 . . . . 0.0 113.042 -167.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -67.51 151.34 97.26 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.93 69.67 5.44 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.665 2.91 . . . . 0.0 110.402 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 61.36 -29.6 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.882 3.273 . . . . 0.0 116.472 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.62 145.08 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.265 2.226 . . . . 0.0 112.403 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p 37.77 52.43 1.42 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.527 1.931 . . . . 0.0 114.144 172.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.47 24.16 0.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.521 2.486 . . . . 0.0 117.93 -167.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.89 139.47 54.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.246 2.218 . . . . 0.0 111.195 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.428 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.428 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.491 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.33 173.55 4.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.646 0.657 . . . . 0.0 110.989 158.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.516 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.99 151.13 24.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.86 64.54 0.44 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.449 1.976 . . . . 0.0 112.239 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 133.3 73.94 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 127.249 2.22 . . . . 0.0 113.052 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.72 173.12 8.56 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.856 3.038 . . . . 0.0 113.54 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 65.51 -27.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.89 2.876 . . . . 0.0 116.537 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.24 149.83 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 111.501 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -67.64 -39.06 84.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 112.863 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.85 165.76 14.9 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.979 0.766 . . . . 0.0 114.955 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.69 163.4 5.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.354 3.062 . . . . 0.0 108.906 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.436 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.39 148.67 45.02 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.012 0.824 . . . . 0.0 110.886 163.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -154.94 139.84 17.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.98 61.22 0.38 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.641 2.067 . . . . 0.0 114.387 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -52.54 120.83 19.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.149 1.38 . . . . 0.0 113.418 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.14 55.2 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.697 3.598 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -136.67 -55.42 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.597 2.359 . . . . 0.0 110.182 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.8 t -142.65 -72.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.296 1.038 . . . . 0.0 111.527 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.7 p 49.76 -104.56 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.105 1.762 . . . . 0.0 113.107 -161.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.68 -55.0 0.72 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 127.83 2.633 . . . . 0.0 113.868 -177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -57.56 152.74 14.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.166 1.786 . . . . 0.0 111.706 166.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.485 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.412 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.501 ' C ' ' H ' ' A' ' 68' ' ' ASP . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.501 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.39 172.37 7.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.278 1.031 . . . . 0.0 111.281 167.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' CD1' ' H ' ' A' ' 4' ' ' ALA . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.44 ' H ' ' CD1' ' A' ' 3' ' ' LEU . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -141.17 91.75 2.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.55 3.84 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.932 -1.486 . . . . 0.0 115.893 -149.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -118.65 58.42 3.56 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.744 1.218 . . . . 0.0 113.284 -168.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.8 93.12 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.772 2.981 . . . . 0.0 109.961 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.14 32.2 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 128.134 2.574 . . . . 0.0 116.026 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.75 -69.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.864 2.065 . . . . 0.0 108.84 168.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -149.41 -65.96 0.22 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.2 1.4 . . . . 0.0 112.81 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.25 60.02 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.419 1.009 . . . . 0.0 114.409 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -61.97 149.3 41.14 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 156.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.474 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.516 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.99 179.2 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.084 0.954 . . . . 0.0 113.061 -149.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.402 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.402 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -138.82 96.25 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.76 62.38 2.28 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.517 1.056 . . . . 0.0 113.504 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -48.54 147.1 4.42 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 128.493 2.717 . . . . 0.0 113.541 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.39 -156.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.553 1.443 0 C-N-CA 124.474 3.449 . . . . 0.0 113.828 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -48.65 168.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.277 2.231 . . . . 0.0 114.909 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t 67.5 -43.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 127.627 2.371 . . . . 0.0 112.931 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.1 p -73.74 151.64 40.6 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.06 -1.025 . . . . 0.0 111.876 166.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.25 54.76 0.19 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 123.604 0.621 . . . . 0.0 112.682 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -150.41 162.98 39.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.919 1.688 . . . . 0.0 110.578 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.83 164.46 22.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.256 1.823 . . . . 0.0 109.898 158.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.45 ' CB ' ' HH ' ' A' ' 19' ' ' TYR . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.45 ' HH ' ' CB ' ' A' ' 9' ' ' TYR . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.462 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.463 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.463 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.462 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.414 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HG2' ' H ' ' A' ' 40' ' ' GLY . 4.0 tt0 -151.71 173.83 14.24 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.416 ' H ' ' HG2' ' A' ' 39' ' ' GLU . . . -170.81 38.14 0.18 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.79 2.138 . . . . 0.0 114.803 -175.273 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -64.58 147.76 97.33 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 118.708 1.254 . . . . 0.0 114.082 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.71 63.97 8.08 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.932 3.088 . . . . 0.0 112.882 -171.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -135.4 -83.91 0.4 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.904 1.682 . . . . 0.0 111.284 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.98 7.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 124.642 1.177 . . . . 0.0 112.376 -168.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.7 0.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 119.063 2.986 . . . . 0.0 119.063 -154.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.56 -20.02 67.51 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 119.272 -2.143 . . . . 0.0 114.001 172.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -62.96 104.7 0.58 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.443 1.497 . . . . 0.0 111.132 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.538 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.538 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.414 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.62 154.38 42.08 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.883 0.765 . . . . 0.0 110.354 156.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.469 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.504 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -150.0 95.01 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.68 66.02 2.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.457 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -81.95 153.33 69.68 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 112.038 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.8 1.36 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.424 2.75 . . . . 0.0 114.181 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -68.78 -10.84 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.374 1.07 . . . . 0.0 112.753 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.79 133.2 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 112.006 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -123.98 -5.13 7.96 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.9 30.03 0.19 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.761 1.172 . . . . 0.0 112.345 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -130.77 137.25 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.294 1.438 . . . . 0.0 108.869 -164.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.471 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.504 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.27 159.27 20.1 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.412 0.551 . . . . 0.0 110.862 157.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -119.37 48.27 1.54 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.85 93.7 0.27 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.914 2.197 . . . . 0.0 110.522 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -128.98 151.09 77.0 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 125.474 1.509 . . . . 0.0 112.085 -164.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.52 166.5 25.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.126 1.884 . . . . 0.0 112.159 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 58.51 -120.8 1.19 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.215 1.406 . . . . 0.0 111.384 -169.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . 0.285 25.8 m 50.86 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 1 C-N-CA 132.474 4.309 . . . . 0.0 119.628 -176.102 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m 101.49 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 1 C-N-CA 132.148 4.179 . . . . 0.0 109.922 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 33.35 0.13 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 127.655 2.55 . . . . 0.0 117.311 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.477 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 -67.94 164.08 20.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.199 1.8 . . . . 0.0 110.551 163.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.477 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.452 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.452 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 159.26 34.79 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.151 0.432 . . . . 0.0 111.801 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.439 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 33' ' ' CYS . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.408 ' H ' ' C ' ' A' ' 31' ' ' PRO . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 93.11 2.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.32 32.53 0.96 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -158.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -130.07 73.19 81.59 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.422 1.611 . . . . 0.0 115.159 -167.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 7.73 2.58 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.974 3.783 . . . . 0.0 114.876 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 64.37 -39.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 129.133 2.973 . . . . 0.0 114.88 -172.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 t -139.2 147.5 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.276 1.43 . . . . 0.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.1 m 52.51 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 128.356 2.663 . . . . 0.0 116.432 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 54.29 0.01 OUTLIER Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.498 1.045 . . . . 0.0 115.482 -168.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -77.05 108.83 10.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.05 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 HD12 ' HG ' ' A' ' 59' ' ' SER . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.407 ' HG ' HD12 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.406 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.406 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.57 175.06 3.68 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.023 1.283 . . . . 0.0 111.008 150.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.459 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.459 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -128.84 82.77 2.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.24 70.22 2.99 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.228 0.918 . . . . 0.0 113.17 -166.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 m -123.17 61.78 19.16 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.524 1.53 . . . . 0.0 111.681 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.8 173.66 12.61 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 124.245 3.297 . . . . 0.0 111.554 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -131.05 -108.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.349 1.06 . . . . 0.0 109.53 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.82 -1.57 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 165.07 34.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.427 1.091 . . . . 0.0 112.289 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.39 66.19 0.87 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.77 2.128 . . . . 0.0 114.222 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -57.38 93.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.032 0.933 . . . . 0.0 110.174 163.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.44 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.456 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -179.81 7.22 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.13 2.172 . . . . 0.0 108.091 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.451 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -129.05 91.6 3.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 73.73 1.81 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.849 2.166 . . . . 0.0 111.68 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -59.49 149.86 68.13 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.849 1.66 . . . . 0.0 112.667 -176.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.93 -7.38 19.51 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.466 2.111 . . . . 0.0 113.571 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -58.25 117.09 4.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.919 -1.113 . . . . 0.0 110.475 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -58.17 -6.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -62.01 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.193 1.797 . . . . 0.0 111.565 166.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.8 50.26 0.86 Allowed Glycine 0 N--CA 1.476 1.355 0 C-N-CA 126.748 2.118 . . . . 0.0 114.88 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -92.62 89.61 6.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.069 2.147 . . . . 0.0 109.518 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.47 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.451 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 119.291 -0.385 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.47 142.39 46.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.072 0.549 . . . . 0.0 109.699 158.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.55 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' N ' ' HE2' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . 0.55 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.37 59.26 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.35 60.42 1.51 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.341 1.924 . . . . 0.0 113.738 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.7 t -53.83 128.03 53.78 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.302 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.74 65.68 7.54 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.834 3.689 . . . . 0.0 112.651 -170.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -138.49 -171.89 3.16 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.105 2.562 . . . . 0.0 108.991 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.27 111.8 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.094 . . . . 0.0 110.64 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -141.45 -25.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.557 1.143 . . . . 0.0 113.957 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.93 -5.08 55.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.649 1.119 . . . . 0.0 114.844 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.72 141.04 58.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.107 1.763 . . . . 0.0 109.424 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.453 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.406 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.406 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.453 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.75 -178.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.73 1.612 . . . . 0.0 114.465 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.431 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.05 82.55 1.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.42 35.69 1.35 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.712 2.101 . . . . 0.0 115.667 -168.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -53.79 103.96 0.4 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 126.639 1.976 . . . . 0.0 112.579 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -87.17 75.18 2.5 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.723 2.949 . . . . 0.0 111.859 -161.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -22.19 3.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -172.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.62 100.89 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 121.13 1.787 . . . . 0.0 112.062 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.2 m 57.39 -70.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 157.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.04 24.14 0.02 OUTLIER Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -159.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -67.75 157.34 34.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.376 1.088 . . . . 0.0 111.288 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.462 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.462 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptm . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.201 0.048 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.83 154.1 39.03 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 0.0 111.601 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.444 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HZ3' ' CD ' ' A' ' 27' ' ' GLU . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.464 ' CD ' ' HZ1' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.464 ' HZ1' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.407 ' CD ' ' HZ3' ' A' ' 23' ' ' LYS . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.77 79.02 1.79 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.36 82.94 0.53 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.646 -1.284 . . . . 0.0 113.85 -169.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -74.76 145.73 82.06 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 0.0 112.738 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.53 -0.35 8.66 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.394 2.729 . . . . 0.0 113.95 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.09 84.19 0.23 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.699 1.2 . . . . 0.0 111.863 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.7 95.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.401 2.281 . . . . 0.0 112.461 171.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 p -142.81 -15.86 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.472 1.509 . . . . 0.0 114.12 -171.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.09 1.96 66.71 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.48 141.74 55.51 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.765 1.282 . . . . 0.0 110.806 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.48 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.621 ' CB ' HD21 ' A' ' 84' ' ' LEU . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' CD1' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 121.728 0.775 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.506 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' TYR . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.516 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.646 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' HH11 ' A' ' 6' ' ' ARG . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 57' ' ' VAL . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 52' ' ' VAL . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.87 0.367 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.631 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.478 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 36' ' ' ILE . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.087 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.462 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' HH11 ' A' ' 6' ' ' ARG . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.291 0.091 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.556 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.556 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 120.217 0.056 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.467 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 36' ' ' ILE . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' HD21 ' A' ' 84' ' ' LEU . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB2' HH11 ' A' ' 6' ' ' ARG . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CG ' ' HE3' ' A' ' 60' ' ' LYS . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.587 ' CB ' HD21 ' A' ' 84' ' ' LEU . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' H ' ' HB2' ' A' ' 60' ' ' LYS . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 48' ' ' PHE . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.096 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 36' ' ' ILE . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.768 -1.11 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 52' ' ' VAL . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HD21 ' A' ' 84' ' ' LEU . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 119.424 -0.322 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 5' ' ' VAL . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB2' HH11 ' A' ' 6' ' ' ARG . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 120.91 0.385 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 52' ' ' VAL . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.585 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' A' ' 84' ' ' LEU . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 26' ' ' LEU . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.741 0.305 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 5' ' ' VAL . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.448 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.448 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 26' ' ' LEU . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' H ' ' HD2' ' A' ' 72' ' ' LYS . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 68' ' ' ASP . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.978 0.418 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 36' ' ' ILE . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.594 ' HB3' HD21 ' A' ' 84' ' ' LEU . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 26' ' ' LEU . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 52' ' ' VAL . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 50' ' ' VAL . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HD23 ' A' ' 84' ' ' LEU . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 52' ' ' VAL . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' CYS . . . . . 0.651 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.657 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 111.288 0.107 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.627 ' HB3' HD21 ' A' ' 84' ' ' LEU . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 5' ' ' VAL . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' HIS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.21 178.54 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 155.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.621 ' CB ' HD21 ' A' ' 84' ' ' LEU . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' CD1' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -135.11 47.47 2.34 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 9' ' ' TYR . . . -68.24 82.14 0.19 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.929 2.204 . . . . 0.0 115.785 -165.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -56.01 142.43 65.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.229 1.012 . . . . 0.0 113.275 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.18 -173.21 1.5 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.755 2.97 . . . . 0.0 110.874 164.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 66.48 -48.03 0.44 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.407 2.683 . . . . 0.0 113.725 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.21 149.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 109.413 165.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.6 t -148.63 166.54 28.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.046 1.339 . . . . 0.0 112.318 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.88 26.49 67.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.088 1.328 . . . . 0.0 115.751 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -125.59 -179.64 4.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.852 1.326 . . . . 0.0 114.225 -165.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 -177.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.758 1.617 . . . . 0.0 111.474 162.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.64 95.94 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.12 95.47 1.64 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.141 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -118.22 132.38 23.78 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.38 1.072 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.05 142.3 27.55 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.101 2.534 . . . . 0.0 112.054 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -136.57 -73.58 0.44 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.135 0.974 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -154.36 -35.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 46' ' ' GLY . 7.7 t -139.49 -72.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.19 1.396 . . . . 0.0 110.045 166.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 45' ' ' THR . . . 149.13 175.37 21.48 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.24 1.4 . . . . 0.0 113.739 171.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.5 126.13 11.01 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 107.8 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.506 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' TYR . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 162.28 16.62 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.152 1.342 . . . . 0.0 110.393 157.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.516 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.646 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' HH11 ' A' ' 6' ' ' ARG . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -133.56 79.92 1.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.97 35.82 1.68 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.088 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.7 p -71.44 149.68 93.78 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.463 1.505 . . . . 0.0 112.619 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.51 3.92 4.39 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.92 2.414 . . . . 0.0 115.521 -169.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.31 86.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -158.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -143.07 102.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.728 1.603 . . . . 0.0 110.212 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.8 m -48.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.868 2.067 . . . . 0.0 113.03 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.27 -7.25 34.73 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.962 1.744 . . . . 0.0 115.923 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.44 119.81 16.13 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.822 1.311 . . . . 0.0 107.53 168.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 57' ' ' VAL . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 52' ' ' VAL . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptm . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 172.4 18.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.64 2.376 . . . . 0.0 107.591 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.03 47.54 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.17 82.3 0.35 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 127.051 2.262 . . . . 0.0 111.979 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -113.4 158.9 37.14 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.058 1.343 . . . . 0.0 113.785 -159.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.41 79.42 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.277 2.651 . . . . 0.0 111.809 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -137.25 154.43 50.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.612 1.165 . . . . 0.0 110.501 171.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.26 -29.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.201 1.0 . . . . 0.0 111.985 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.65 87.88 2.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.521 1.528 . . . . 0.0 111.124 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.56 50.31 2.47 Favored Glycine 0 CA--C 1.537 1.417 0 O-C-N 120.973 -1.079 . . . . 0.0 115.575 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.23 95.53 2.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.754 1.777 . . . . 0.0 111.124 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.89 175.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.818 0.735 . . . . 0.0 111.59 149.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.539 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.631 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -139.76 61.88 1.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.65 79.7 0.34 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.166 1.841 . . . . 0.0 111.03 170.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -101.63 164.4 15.98 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 128.512 2.725 . . . . 0.0 113.233 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.04 176.75 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.006 2.471 . . . . 0.0 111.508 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 64.6 -36.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 128.922 2.889 . . . . 0.0 116.75 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.8 145.3 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.75 1.159 . . . . 0.0 111.406 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.932 -1.105 . . . . 0.0 112.212 -165.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . 79.27 0.9 84.8 Favored Glycine 0 CA--C 1.543 1.786 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.38 82.44 0.56 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.915 1.686 . . . . 0.0 111.498 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.478 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 116.888 -1.53 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 161.96 6.96 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.077 1.308 . . . . 0.0 112.551 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 36' ' ' ILE . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -145.0 107.03 4.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.36 68.25 3.55 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.081 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -49.82 132.16 21.23 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.005 1.722 . . . . 0.0 108.534 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.5 138.76 43.04 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 121.394 1.396 . . . . 0.0 113.321 -154.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 61.04 13.93 5.0 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.316 1.847 . . . . 0.0 115.984 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.64 153.52 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.8 48.44 0.47 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.657 2.783 . . . . 0.0 115.328 -166.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.16 12.8 Favored Glycine 0 CA--C 1.541 1.667 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -66.38 154.88 38.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.847 1.323 . . . . 0.0 112.83 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.18 164.95 0.15 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.619 1.554 . . . . 0.0 112.242 142.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.462 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' HH11 ' A' ' 6' ' ' ARG . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -130.97 75.24 1.65 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.31 106.52 2.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.077 -1.419 . . . . 0.0 113.042 -167.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -67.51 151.34 97.26 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.93 69.67 5.44 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.665 2.91 . . . . 0.0 110.402 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 61.36 -29.6 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.882 3.273 . . . . 0.0 116.472 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.62 145.08 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.265 2.226 . . . . 0.0 112.403 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p 37.77 52.43 1.42 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.527 1.931 . . . . 0.0 114.144 172.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.47 24.16 0.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.521 2.486 . . . . 0.0 117.93 -167.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.89 139.47 54.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.246 2.218 . . . . 0.0 111.195 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.33 173.55 4.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.646 0.657 . . . . 0.0 110.989 158.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.99 151.13 24.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.86 64.54 0.44 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.449 1.976 . . . . 0.0 112.239 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 133.3 73.94 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 127.249 2.22 . . . . 0.0 113.052 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.72 173.12 8.56 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.856 3.038 . . . . 0.0 113.54 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 65.51 -27.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.89 2.876 . . . . 0.0 116.537 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.24 149.83 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 111.501 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -67.64 -39.06 84.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 112.863 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.85 165.76 14.9 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.979 0.766 . . . . 0.0 114.955 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.69 163.4 5.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.354 3.062 . . . . 0.0 108.906 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.556 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.556 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.39 148.67 45.02 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.012 0.824 . . . . 0.0 110.886 163.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.467 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' GLY . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 36' ' ' ILE . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' HD21 ' A' ' 84' ' ' LEU . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB2' HH11 ' A' ' 6' ' ' ARG . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -154.94 139.84 17.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.98 61.22 0.38 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.641 2.067 . . . . 0.0 114.387 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -52.54 120.83 19.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.149 1.38 . . . . 0.0 113.418 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.14 55.2 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.697 3.598 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -136.67 -55.42 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.597 2.359 . . . . 0.0 110.182 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.8 t -142.65 -72.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.296 1.038 . . . . 0.0 111.527 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.7 p 49.76 -104.56 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.105 1.762 . . . . 0.0 113.107 -161.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 10' ' ' SER . . . 69.68 -55.0 0.72 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 127.83 2.633 . . . . 0.0 113.868 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -57.56 152.74 14.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.166 1.786 . . . . 0.0 111.706 166.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CG ' ' HE3' ' A' ' 60' ' ' LYS . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.39 172.37 7.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.278 1.031 . . . . 0.0 111.281 167.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.587 ' CB ' HD21 ' A' ' 84' ' ' LEU . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -141.17 91.75 2.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.55 3.84 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.932 -1.486 . . . . 0.0 115.893 -149.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -118.65 58.42 3.56 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.744 1.218 . . . . 0.0 113.284 -168.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.8 93.12 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.772 2.981 . . . . 0.0 109.961 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.14 32.2 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 128.134 2.574 . . . . 0.0 116.026 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.75 -69.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.864 2.065 . . . . 0.0 108.84 168.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -149.41 -65.96 0.22 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.2 1.4 . . . . 0.0 112.81 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.25 60.02 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.419 1.009 . . . . 0.0 114.409 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -61.97 149.3 41.14 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 156.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' H ' ' HB2' ' A' ' 60' ' ' LYS . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 48' ' ' PHE . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.99 179.2 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.084 0.954 . . . . 0.0 113.061 -149.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 36' ' ' ILE . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -138.82 96.25 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.76 62.38 2.28 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.517 1.056 . . . . 0.0 113.504 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -48.54 147.1 4.42 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 128.493 2.717 . . . . 0.0 113.541 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.39 -156.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.553 1.443 0 C-N-CA 124.474 3.449 . . . . 0.0 113.828 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -48.65 168.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.277 2.231 . . . . 0.0 114.909 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t 67.5 -43.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 127.627 2.371 . . . . 0.0 112.931 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.1 p -73.74 151.64 40.6 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.06 -1.025 . . . . 0.0 111.876 166.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.25 54.76 0.19 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 123.604 0.621 . . . . 0.0 112.682 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -150.41 162.98 39.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.919 1.688 . . . . 0.0 110.578 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.83 164.46 22.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.256 1.823 . . . . 0.0 109.898 158.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 52' ' ' VAL . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HD21 ' A' ' 84' ' ' LEU . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -151.71 173.83 14.24 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.81 38.14 0.18 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.79 2.138 . . . . 0.0 114.803 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -64.58 147.76 97.33 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 118.708 1.254 . . . . 0.0 114.082 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.71 63.97 8.08 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.932 3.088 . . . . 0.0 112.882 -171.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -135.4 -83.91 0.4 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.904 1.682 . . . . 0.0 111.284 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.98 7.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 124.642 1.177 . . . . 0.0 112.376 -168.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.7 0.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 119.063 2.986 . . . . 0.0 119.063 -154.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.56 -20.02 67.51 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 119.272 -2.143 . . . . 0.0 114.001 172.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -62.96 104.7 0.58 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.443 1.497 . . . . 0.0 111.132 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 5' ' ' VAL . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.62 154.38 42.08 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.883 0.765 . . . . 0.0 110.354 156.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB2' HH11 ' A' ' 6' ' ' ARG . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -150.0 95.01 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.68 66.02 2.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.457 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -81.95 153.33 69.68 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 112.038 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.8 1.36 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.424 2.75 . . . . 0.0 114.181 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -68.78 -10.84 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.374 1.07 . . . . 0.0 112.753 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.79 133.2 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 112.006 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -123.98 -5.13 7.96 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.9 30.03 0.19 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.761 1.172 . . . . 0.0 112.345 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -130.77 137.25 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.294 1.438 . . . . 0.0 108.869 -164.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.27 159.27 20.1 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.412 0.551 . . . . 0.0 110.862 157.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 52' ' ' VAL . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.585 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' A' ' 84' ' ' LEU . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 26' ' ' LEU . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -119.37 48.27 1.54 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.85 93.7 0.27 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.914 2.197 . . . . 0.0 110.522 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -128.98 151.09 77.0 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 125.474 1.509 . . . . 0.0 112.085 -164.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.52 166.5 25.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.126 1.884 . . . . 0.0 112.159 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 58.51 -120.8 1.19 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.215 1.406 . . . . 0.0 111.384 -169.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . 0.285 25.8 m 50.86 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 1 C-N-CA 132.474 4.309 . . . . 0.0 119.628 -176.102 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m 101.49 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 1 C-N-CA 132.148 4.179 . . . . 0.0 109.922 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 33.35 0.13 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 127.655 2.55 . . . . 0.0 117.311 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 -67.94 164.08 20.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.199 1.8 . . . . 0.0 110.551 163.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 5' ' ' VAL . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 159.26 34.79 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.151 0.432 . . . . 0.0 111.801 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.448 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.448 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 26' ' ' LEU . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 93.11 2.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.32 32.53 0.96 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -158.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -130.07 73.19 81.59 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.422 1.611 . . . . 0.0 115.159 -167.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 7.73 2.58 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.974 3.783 . . . . 0.0 114.876 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 64.37 -39.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 129.133 2.973 . . . . 0.0 114.88 -172.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 t -139.2 147.5 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.276 1.43 . . . . 0.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.1 m 52.51 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 128.356 2.663 . . . . 0.0 116.432 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 54.29 0.01 OUTLIER Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.498 1.045 . . . . 0.0 115.482 -168.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -77.05 108.83 10.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.05 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' H ' ' HD2' ' A' ' 72' ' ' LYS . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 68' ' ' ASP . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.57 175.06 3.68 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.023 1.283 . . . . 0.0 111.008 150.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 36' ' ' ILE . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.594 ' HB3' HD21 ' A' ' 84' ' ' LEU . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 26' ' ' LEU . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -128.84 82.77 2.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.24 70.22 2.99 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.228 0.918 . . . . 0.0 113.17 -166.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 m -123.17 61.78 19.16 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.524 1.53 . . . . 0.0 111.681 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.8 173.66 12.61 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 124.245 3.297 . . . . 0.0 111.554 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -131.05 -108.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.349 1.06 . . . . 0.0 109.53 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.82 -1.57 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 165.07 34.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.427 1.091 . . . . 0.0 112.289 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.39 66.19 0.87 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.77 2.128 . . . . 0.0 114.222 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -57.38 93.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.032 0.933 . . . . 0.0 110.174 163.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -179.81 7.22 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.13 2.172 . . . . 0.0 108.091 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 52' ' ' VAL . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 50' ' ' VAL . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HD23 ' A' ' 84' ' ' LEU . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -129.05 91.6 3.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 73.73 1.81 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.849 2.166 . . . . 0.0 111.68 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -59.49 149.86 68.13 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.849 1.66 . . . . 0.0 112.667 -176.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.93 -7.38 19.51 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.466 2.111 . . . . 0.0 113.571 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -58.25 117.09 4.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.919 -1.113 . . . . 0.0 110.475 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -58.17 -6.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -62.01 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.193 1.797 . . . . 0.0 111.565 166.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.8 50.26 0.86 Allowed Glycine 0 N--CA 1.476 1.355 0 C-N-CA 126.748 2.118 . . . . 0.0 114.88 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -92.62 89.61 6.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.069 2.147 . . . . 0.0 109.518 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 119.291 -0.385 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.47 142.39 46.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.072 0.549 . . . . 0.0 109.699 158.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 52' ' ' VAL . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' CYS . . . . . 0.651 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.37 59.26 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.35 60.42 1.51 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.341 1.924 . . . . 0.0 113.738 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.7 t -53.83 128.03 53.78 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.302 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.74 65.68 7.54 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.834 3.689 . . . . 0.0 112.651 -170.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -138.49 -171.89 3.16 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.105 2.562 . . . . 0.0 108.991 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.27 111.8 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.094 . . . . 0.0 110.64 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -141.45 -25.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.557 1.143 . . . . 0.0 113.957 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.93 -5.08 55.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.649 1.119 . . . . 0.0 114.844 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.72 141.04 58.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.107 1.763 . . . . 0.0 109.424 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.657 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.75 -178.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.73 1.612 . . . . 0.0 114.465 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.05 82.55 1.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.42 35.69 1.35 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.712 2.101 . . . . 0.0 115.667 -168.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -53.79 103.96 0.4 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 126.639 1.976 . . . . 0.0 112.579 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -87.17 75.18 2.5 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.723 2.949 . . . . 0.0 111.859 -161.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -22.19 3.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -172.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.62 100.89 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 121.13 1.787 . . . . 0.0 112.062 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.2 m 57.39 -70.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 157.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.04 24.14 0.02 OUTLIER Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -159.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -67.75 157.34 34.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.376 1.088 . . . . 0.0 111.288 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptm . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.201 0.048 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.83 154.1 39.03 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 0.0 111.601 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.627 ' HB3' HD21 ' A' ' 84' ' ' LEU . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.77 79.02 1.79 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.36 82.94 0.53 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.646 -1.284 . . . . 0.0 113.85 -169.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -74.76 145.73 82.06 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 0.0 112.738 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.53 -0.35 8.66 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.394 2.729 . . . . 0.0 113.95 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.09 84.19 0.23 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.699 1.2 . . . . 0.0 111.863 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.7 95.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.401 2.281 . . . . 0.0 112.461 171.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 p -142.81 -15.86 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.472 1.509 . . . . 0.0 114.12 -171.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.09 1.96 66.71 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.48 141.74 55.51 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.765 1.282 . . . . 0.0 110.806 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 5' ' ' VAL . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' HIS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.621 ' CB ' HD21 ' A' ' 84' ' ' LEU . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.483 ' CD1' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 114.225 1.194 . . . . 0.0 114.225 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.719 0 CA-C-O 121.728 0.775 . . . . 0.0 111.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 . . . . . 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 . . . . . 0 N--CA 1.469 0.476 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.506 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.525 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' TYR . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.88 0 CA-C-O 119.547 -0.263 . . . . 0.0 110.393 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.516 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.646 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' HH11 ' A' ' 6' ' ' ARG . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 . . . . . 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.547 0.839 0 N-CA-C 107.53 -1.285 . . . . 0.0 107.53 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 57' ' ' VAL . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 52' ' ' VAL . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.533 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 . . . . . 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 . . . . . 0 N--CA 1.471 0.6 0 CA-C-O 120.87 0.367 . . . . 0.0 111.124 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.883 0 CA-C-O 121.145 0.498 . . . . 0.0 111.59 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.631 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 . . . . . 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 . . . . . 0 CA--C 1.543 0.693 0 N-CA-C 111.498 0.184 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.486 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.478 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.816 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 36' ' ' ILE . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.412 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.414 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 . . . . . 0 CA--C 1.543 0.701 0 N-CA-C 112.83 0.678 . . . . 0.0 112.83 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.553 1.087 0 N-CA-C 112.242 0.46 . . . . 0.0 112.242 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.462 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' HH11 ' A' ' 6' ' ' ARG . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 . . . . . 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 . . . . . 0 CA--C 1.544 0.713 0 CA-C-O 119.499 -0.286 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.638 0 CA-C-O 120.291 0.091 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.547 0.838 0 CA-C-O 117.88 -1.057 . . . . 0.0 108.906 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.556 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.556 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.722 0 CA-C-O 120.217 0.056 . . . . 0.0 110.886 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.467 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 36' ' ' ILE . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' HD21 ' A' ' 84' ' ' LEU . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB2' HH11 ' A' ' 6' ' ' ARG . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 . . . . . 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 . . . . . 0 CA--C 1.541 0.626 0 N-CA-C 111.706 0.262 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CG ' ' HE3' ' A' ' 60' ' ' LYS . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.587 ' CB ' HD21 ' A' ' 84' ' ' LEU . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 . . . . . 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.516 ' H ' ' HB2' ' A' ' 60' ' ' LYS . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 48' ' ' PHE . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.096 0 N-CA-C 113.061 0.763 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 36' ' ' ILE . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 . . . . . 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 . . . . . 0 CA--C 1.542 0.666 0 CA-C-O 117.768 -1.11 . . . . 0.0 110.578 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.78 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 52' ' ' VAL . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.552 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HD21 ' A' ' 84' ' ' LEU . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 . . . . . 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 . . . . . 0 CA--C 1.542 0.65 0 CA-C-O 119.424 -0.322 . . . . 0.0 111.132 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 5' ' ' VAL . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.564 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.739 0 N-CA-C 110.354 -0.239 . . . . 0.0 110.354 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB2' HH11 ' A' ' 6' ' ' ARG . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 . . . . . 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 . . . . . 0 CA--C 1.53 0.175 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.797 0 CA-C-O 120.91 0.385 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 52' ' ' VAL . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.585 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' A' ' 84' ' ' LEU . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 26' ' ' LEU . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 . . . . . 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 . . . . . 0 CA--C 1.541 0.602 0 CA-C-O 120.741 0.305 . . . . 0.0 110.551 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 5' ' ' VAL . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.79 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.448 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.448 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 26' ' ' LEU . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 . . . . . 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 . . . . . 0 CA--C 1.544 0.745 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.421 ' H ' ' HD2' ' A' ' 72' ' ' LYS . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 68' ' ' ASP . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.818 0 CA-C-O 120.978 0.418 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 36' ' ' ILE . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.594 ' HB3' HD21 ' A' ' 84' ' ' LEU . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 26' ' ' LEU . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 . . . . . 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.174 -0.306 . . . . 0.0 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.495 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 52' ' ' VAL . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 50' ' ' VAL . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HD23 ' A' ' 84' ' ' LEU . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 . . . . . 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 . . . . . 0 CA--C 1.536 0.416 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.737 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 52' ' ' VAL . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . 0.651 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 . . . . . 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 . . . . . 0 CA--C 1.539 0.524 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.657 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.924 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.474 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 . . . . . 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 111.288 0.107 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.538 0 N-CA-C 111.601 0.223 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.627 ' HB3' HD21 ' A' ' 84' ' ' LEU . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 . . . . . 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 CA--C 1.538 0.491 0 CA-C-O 119.552 -0.261 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 5' ' ' VAL . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' HIS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tpt . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -65.21 178.54 0.87 Allowed 'General case' 0 CA--C 1.549 0.922 0 CA-C-O 121.169 0.509 . . . . 0.0 111.03 155.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.0 tp -132.28 133.07 43.64 Favored 'General case' 0 C--O 1.219 -0.546 0 C-N-CA 124.592 1.157 . . . . 0.0 111.372 176.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -92.01 124.29 36.01 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.783 1.633 . . . . 0.0 111.84 176.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 37.7 t -111.66 149.69 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 125.65 1.58 . . . . 0.0 108.965 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 87.6 mmt-85 -137.58 155.29 49.37 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 125.885 1.674 . . . . 0.0 112.447 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.2 t -135.84 109.25 9.46 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 C-N-CA 126.154 1.782 . . . . 0.0 107.31 169.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.9 t -81.69 128.24 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.677 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 168.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.437 ' H ' ' HA2' ' A' ' 40' ' ' GLY . 69.7 t80 -145.59 159.69 42.76 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -172.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 23.9 p -99.52 108.31 20.71 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 127.109 2.163 . . . . 0.0 110.679 172.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -66.2 55.79 0.18 Allowed Glycine 0 CA--C 1.542 1.772 0 C-N-CA 126.085 1.802 . . . . 0.0 117.081 -174.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.32 59.4 0.57 Allowed 'General case' 0 CA--C 1.547 0.843 0 C-N-CA 127.582 2.353 . . . . 0.0 112.407 176.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.7 t 58.53 -175.45 0.08 Allowed 'General case' 0 CA--C 1.551 1.014 0 C-N-CA 125.974 1.71 . . . . 0.0 112.411 -170.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.54 -0.09 0.07 OUTLIER Glycine 0 CA--C 1.545 1.908 0 C-N-CA 128.102 2.763 . . . . 0.0 119.974 166.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -67.9 -37.86 82.27 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.563 1.681 . . . . 0.0 114.824 -159.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -46.79 -61.56 2.65 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-O 116.821 -1.562 . . . . 0.0 114.825 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -64.04 -37.17 44.44 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 CA-C-N 122.073 1.776 . . . . 0.0 113.1 177.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 65.3 tttp -58.65 -41.1 85.28 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 112.971 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -62.98 -65.12 0.73 Allowed 'General case' 0 N--CA 1.463 0.199 0 C-N-CA 125.177 1.391 . . . . 0.0 110.499 167.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.7 mp -54.18 -39.21 66.41 Favored 'General case' 0 C--O 1.219 -0.523 0 C-N-CA 124.468 1.107 . . . . 0.0 113.435 -169.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.23 -19.42 65.82 Favored 'General case' 0 CA--C 1.545 0.78 0 O-C-N 120.291 -1.506 . . . . 0.0 112.517 -177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.5 tt -89.85 -45.3 9.35 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.025 1.33 . . . . 0.0 112.042 162.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.526 ' HE2' ' OE1' ' A' ' 24' ' ' GLU . 0.1 OUTLIER -67.29 -53.07 33.16 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.442 1.497 . . . . 0.0 112.572 -171.018 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' HE2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -68.56 -0.13 4.75 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 127.898 2.479 . . . . 0.0 112.281 173.363 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.22 -59.12 2.34 Favored 'General case' 0 C--O 1.219 -0.5 0 C-N-CA 125.757 1.623 . . . . 0.0 111.246 158.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 tp -59.42 -36.49 75.98 Favored 'General case' 0 CA--C 1.544 0.731 0 O-C-N 120.937 -1.102 . . . . 0.0 113.744 -171.328 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -71.46 -32.99 68.93 Favored 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 115.853 1.797 . . . . 0.0 115.853 168.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -63.87 -41.47 97.76 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.342 1.457 . . . . 0.0 112.684 168.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -68.29 -41.03 81.56 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.439 1.895 . . . . 0.0 112.861 178.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -135.0 49.24 3.54 Favored Pre-proline 0 CA--C 1.554 1.114 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -62.4 138.08 68.97 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 123.329 2.686 . . . . 0.0 113.603 -167.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.33 -26.28 0.16 Allowed Glycine 0 N--CA 1.476 1.303 0 C-N-CA 127.044 2.259 . . . . 0.0 115.852 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.621 ' CB ' HD21 ' A' ' 84' ' ' LEU . 13.9 m -68.97 -16.86 63.84 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 120.833 -1.392 . . . . 0.0 111.706 167.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.483 ' CD1' HD23 ' A' ' 84' ' ' LEU . 0.4 OUTLIER -143.33 159.63 42.01 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.153 1.381 . . . . 0.0 112.285 -172.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -127.7 150.45 49.77 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 129.152 2.981 . . . . 0.0 109.253 170.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.9 mp -137.74 133.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 124.834 1.254 . . . . 0.0 108.63 161.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -130.87 -179.06 5.09 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 125.061 1.345 . . . . 0.0 113.335 170.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.64 135.67 5.28 Favored Glycine 0 N--CA 1.467 0.751 0 O-C-N 120.984 -1.073 . . . . 0.0 113.975 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -135.11 47.47 2.34 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-O 123.411 1.577 . . . . 0.0 109.399 -155.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.437 ' HA2' ' H ' ' A' ' 9' ' ' TYR . . . -68.24 82.14 0.19 Allowed Glycine 0 CA--C 1.527 0.804 0 C-N-CA 126.929 2.204 . . . . 0.0 115.785 -165.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.5 t -56.01 142.43 65.42 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 124.229 1.012 . . . . 0.0 113.275 173.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -75.18 -173.21 1.5 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.755 2.97 . . . . 0.0 110.874 164.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 66.48 -48.03 0.44 Allowed 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 128.407 2.683 . . . . 0.0 113.725 -173.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.1 t -66.21 149.32 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 123.818 0.847 . . . . 0.0 109.413 165.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.6 t -148.63 166.54 28.02 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 125.046 1.339 . . . . 0.0 112.318 -175.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 61.88 26.49 67.22 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.088 1.328 . . . . 0.0 115.751 171.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 4.0 p90 -125.59 -179.64 4.73 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 118.852 1.326 . . . . 0.0 114.225 -165.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.6 t80 177.76 77.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 131.219 3.808 . . . . 0.0 108.57 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.69 112.95 25.7 Favored 'General case' 0 C--O 1.238 0.466 0 O-C-N 120.257 -1.527 . . . . 0.0 110.129 -163.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.3 t -106.72 128.02 61.75 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 118.252 0.478 . . . . 0.0 110.365 -164.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.5 m -133.37 145.32 50.23 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.915 1.286 . . . . 0.0 110.18 -173.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 12.3 p -128.58 132.33 67.96 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.597 1.559 . . . . 0.0 110.235 167.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.45 39.66 1.11 Allowed 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.729 1.612 . . . . 0.0 114.163 -175.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.71 31.68 58.16 Favored Glycine 0 CA--C 1.537 1.444 0 N-CA-C 115.39 0.916 . . . . 0.0 115.39 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.6 mmtp -134.92 113.63 11.72 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.338 2.255 . . . . 0.0 109.508 -176.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.3 tt -60.62 137.29 58.19 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.325 1.05 . . . . 0.0 111.082 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 3.5 t -121.54 -23.67 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.483 1.113 . . . . 0.0 111.259 174.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 4.0 t60 -148.11 150.44 33.85 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 124.574 1.15 . . . . 0.0 111.802 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.486 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 23.2 t -146.14 93.75 2.37 Favored 'General case' 0 C--O 1.238 0.494 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -58.19 -31.05 66.93 Favored 'General case' 0 CA--C 1.538 0.506 0 O-C-N 120.204 -1.56 . . . . 0.0 111.578 171.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.0 tmtt? -73.2 -35.08 66.3 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 125.479 1.512 . . . . 0.0 114.265 178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.486 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.13 -8.37 56.85 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 120.753 1.615 . . . . 0.0 114.204 172.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.53 28.08 13.55 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 124.247 0.927 . . . . 0.0 113.577 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.31 -13.38 60.42 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.94 -173.8 49.13 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.1 -1.2 . . . . 0.0 110.1 -173.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -83.63 -168.32 2.07 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.571 0.748 . . . . 0.0 109.234 153.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 23.9 m -77.41 77.24 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.867 0 CA-C-O 124.638 2.161 . . . . 0.0 111.502 165.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.7 m-20 -77.95 -9.31 59.03 Favored 'General case' 0 C--N 1.318 -0.785 0 C-N-CA 128.845 2.858 . . . . 0.0 113.103 -172.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -151.22 161.48 42.65 Favored 'General case' 0 N--CA 1.469 0.505 0 O-C-N 120.197 -1.565 . . . . 0.0 110.994 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -47.23 -56.45 6.69 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.186 1.794 . . . . 0.0 109.517 171.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -58.76 -28.99 66.43 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.093 -1.412 . . . . 0.0 113.238 -177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 9.5 ttmt -80.39 -40.3 26.76 Favored 'General case' 0 C--N 1.342 0.248 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -62.47 -44.99 95.06 Favored 'General case' 0 CA--C 1.54 0.573 0 CA-C-N 118.478 0.581 . . . . 0.0 111.027 170.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -60.74 -24.11 65.47 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 127.386 2.274 . . . . 0.0 114.352 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 33.5 tptt -55.54 -49.48 72.54 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 127.582 2.353 . . . . 0.0 111.653 164.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 23.3 tp -69.13 -51.45 38.21 Favored 'General case' 0 CA--C 1.513 -0.452 0 C-N-CA 124.262 1.025 . . . . 0.0 110.408 177.092 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.8 t -57.11 -41.32 77.48 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.237 -179.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 61.2 m -67.28 -42.64 83.44 Favored 'General case' 0 CA--C 1.515 -0.403 0 O-C-N 121.625 -0.672 . . . . 0.0 112.597 176.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.71 -35.85 62.71 Favored 'General case' 0 CA--C 1.521 -0.173 0 C-N-CA 120.317 -0.553 . . . . 0.0 112.332 -174.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.5 mm -77.48 -30.63 17.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -175.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -64.49 -45.78 85.86 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 122.123 0.963 . . . . 0.0 111.019 173.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.1 -48.53 78.17 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.487 178.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -62.55 -30.67 71.48 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.372 1.069 . . . . 0.0 113.478 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.621 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.9 tm? -65.23 -55.78 16.51 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 122.849 0.46 . . . . 0.0 110.75 174.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.4 -11.95 18.75 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 51.9 mm-40 -79.63 -59.17 2.85 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.952 1.301 . . . . 0.0 110.442 167.384 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -65.38 -23.64 67.02 Favored 'General case' 0 CA--C 1.537 0.452 0 N-CA-C 114.401 1.26 . . . . 0.0 114.401 -177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 . . . . . 0 CA--C 1.539 0.555 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 173.893 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.4 mtt . . . . . 0 N--CA 1.478 0.959 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.14 -177.0 0.78 Allowed 'General case' 0 CA--C 1.544 0.719 0 CA-C-N 120.758 1.617 . . . . 0.0 111.474 162.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.6 tp -118.41 158.0 26.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 125.655 1.582 . . . . 0.0 108.247 162.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.11 127.62 24.88 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 124.544 1.138 . . . . 0.0 111.621 -176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.7 t -131.94 147.91 32.32 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 CA-C-O 122.661 1.219 . . . . 0.0 111.087 -171.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -124.89 158.51 33.34 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 127.753 2.421 . . . . 0.0 110.38 175.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.7 t -136.32 97.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 C-N-CA 125.305 1.442 . . . . 0.0 108.384 168.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -74.52 133.18 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.91 0.777 . . . . 0.0 109.967 172.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 20.1 t80 -153.22 -154.25 0.52 Allowed 'General case' 0 CA--C 1.549 0.909 0 CA-C-O 121.59 0.71 . . . . 0.0 111.55 173.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.411 ' N ' ' CG ' ' A' ' 9' ' ' TYR . 30.3 t -138.92 175.64 9.38 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 128.533 2.733 . . . . 0.0 111.053 -174.268 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.88 2.98 77.07 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.12 1.343 . . . . 0.0 115.468 -175.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.82 0.75 5.21 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 -166.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -157.13 -179.78 8.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 124.635 1.174 . . . . 0.0 111.991 -178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -66.22 53.98 0.18 Allowed Glycine 0 CA--C 1.541 1.669 0 C-N-CA 126.03 1.776 . . . . 0.0 114.47 169.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -56.72 -61.08 2.68 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 126.935 2.094 . . . . 0.0 112.696 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.4 mttt -46.91 -48.03 52.45 Favored Pre-proline 0 N--CA 1.477 0.902 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -168.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -72.16 -33.13 9.78 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 CA-C-N 122.244 1.837 . . . . 0.0 114.374 174.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.1 tmtt? -74.91 -32.77 61.89 Favored 'General case' 0 N--CA 1.483 1.207 0 CA-C-N 121.157 1.799 . . . . 0.0 112.515 176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 31.3 t80 -55.04 -61.06 2.56 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 127.292 2.237 . . . . 0.0 110.109 165.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.3 mp -51.45 -40.69 59.93 Favored 'General case' 0 C--O 1.209 -1.053 0 CA-C-O 117.622 -1.18 . . . . 0.0 112.353 173.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -56.61 -47.86 78.71 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 121.645 2.021 . . . . 0.0 111.56 -178.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 16.2 tp -60.87 -50.21 74.34 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 122.898 0.479 . . . . 0.0 110.957 169.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.23 -55.59 11.71 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 124.744 1.218 . . . . 0.0 113.106 -169.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -36.93 -53.04 0.96 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.316 1.846 . . . . 0.0 112.521 166.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -67.49 -38.89 85.02 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -58.32 -58.4 8.68 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.116 1.366 . . . . 0.0 111.379 172.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -55.84 -36.72 67.83 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.058 1.343 . . . . 0.0 114.377 173.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -60.0 -41.52 92.26 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.628 1.104 . . . . 0.0 111.733 170.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.56 -43.36 90.08 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.627 1.171 . . . . 0.0 112.612 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -145.21 72.95 14.54 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 125.178 1.391 . . . . 0.0 111.775 -177.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -69.44 137.39 36.28 Favored 'Trans proline' 0 C--N 1.351 0.683 0 C-N-CA 123.298 2.665 . . . . 0.0 112.096 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.32 -17.22 0.05 OUTLIER Glycine 0 N--CA 1.479 1.533 0 C-N-CA 127.664 2.554 . . . . 0.0 117.397 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.543 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -67.37 -24.59 65.71 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.885 -1.362 . . . . 0.0 110.466 159.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -113.98 148.24 37.25 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 125.435 1.494 . . . . 0.0 111.102 172.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -100.85 142.14 32.75 Favored 'General case' 0 C--N 1.319 -0.725 0 C-N-CA 127.6 2.36 . . . . 0.0 109.426 143.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -139.32 127.24 26.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 126.733 2.013 . . . . 0.0 108.05 157.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 73.0 m -118.79 174.83 6.05 Favored 'General case' 0 C--N 1.321 -0.634 0 C-N-CA 127.196 2.198 . . . . 0.0 111.337 169.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -154.4 146.58 14.82 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 124.23 0.919 . . . . 0.0 111.532 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.2 tt0 -145.64 95.94 2.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 123.093 1.425 . . . . 0.0 109.806 -152.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.12 95.47 1.64 Allowed Glycine 0 CA--C 1.528 0.844 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.141 -176.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 15.2 t -118.22 132.38 23.78 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 124.38 1.072 . . . . 0.0 112.008 -175.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -75.05 142.3 27.55 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 123.101 2.534 . . . . 0.0 112.054 -173.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 mm-40 -136.57 -73.58 0.44 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 124.135 0.974 . . . . 0.0 110.912 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 13.4 p -154.36 -35.05 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.481 1.11 0 C-N-CA 125.213 1.405 . . . . 0.0 111.756 171.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . 0.512 HG23 ' H ' ' A' ' 46' ' ' GLY . 7.7 t -139.49 -72.02 0.39 Allowed 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 125.19 1.396 . . . . 0.0 110.045 166.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.512 ' H ' HG23 ' A' ' 45' ' ' THR . . . 149.13 175.37 21.48 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.24 1.4 . . . . 0.0 113.739 171.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.9 p90 -149.5 126.13 11.01 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 126.773 2.029 . . . . 0.0 107.8 173.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -87.77 102.61 14.84 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.292 1.437 . . . . 0.0 108.044 177.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 27.1 mt-10 -129.93 139.54 51.09 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 120.182 1.355 . . . . 0.0 113.668 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.9 t -122.49 124.28 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 121.62 0.724 . . . . 0.0 111.058 -174.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 p -122.09 132.74 54.64 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 127.269 2.228 . . . . 0.0 111.719 -175.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 3.4 p -120.3 122.71 68.96 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 125.864 1.666 . . . . 0.0 108.705 176.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.1 17.67 0.04 OUTLIER 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.087 1.884 . . . . 0.0 116.087 -167.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 105.4 -12.71 47.73 Favored Glycine 0 CA--C 1.539 1.558 0 C-N-CA 126.574 2.035 . . . . 0.0 115.303 -174.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.03 108.02 8.64 Favored 'General case' 0 N--CA 1.469 0.522 0 O-C-N 120.414 -1.639 . . . . 0.0 110.394 171.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.4 tt -53.27 130.36 34.59 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 157.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.9 t -124.62 -21.29 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.953 1.301 . . . . 0.0 111.009 170.368 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 67.4 t60 -130.34 149.41 52.04 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.969 0.907 . . . . 0.0 112.275 174.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.506 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 24.8 t -157.49 135.02 10.52 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 126.532 1.933 . . . . 0.0 110.803 162.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.525 ' HE3' ' CE2' ' A' ' 66' ' ' TYR . 34.6 mmtt -65.32 -44.34 88.12 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 117.232 -1.366 . . . . 0.0 112.699 156.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.9 pttp -67.44 -24.38 65.63 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.583 1.697 . . . . 0.0 115.583 -178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.71 -12.02 59.54 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 119.981 1.264 . . . . 0.0 113.988 170.361 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.03 36.87 17.12 Favored Glycine 0 CA--C 1.521 0.409 0 C-N-CA 123.85 0.738 . . . . 0.0 113.759 -177.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -78.95 -33.74 44.98 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 168.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.15 152.04 0.22 Allowed Glycine 0 CA--C 1.537 1.468 0 C-N-CA 124.306 0.955 . . . . 0.0 112.606 -171.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.525 ' CE2' ' HE3' ' A' ' 60' ' ' LYS . 23.7 m-85 -62.04 -167.54 0.01 OUTLIER 'General case' 0 C--O 1.237 0.426 0 C-N-CA 125.444 1.497 . . . . 0.0 111.595 -176.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 11.7 m -63.58 61.53 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 CA-C-O 124.735 2.207 . . . . 0.0 113.43 143.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 66' ' ' TYR . 66.6 m-20 -67.15 -19.24 65.57 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.752 3.221 . . . . 0.0 109.821 164.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -147.5 160.38 42.67 Favored 'General case' 0 C--N 1.342 0.261 0 O-C-N 120.957 -1.089 . . . . 0.0 110.987 175.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.76 -54.1 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 129.247 3.019 . . . . 0.0 111.581 171.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -65.35 -25.67 67.7 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 113.411 -1.722 . . . . 0.0 112.851 177.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.39 -37.19 60.69 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 175.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -57.03 -47.88 79.86 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.39 1.076 . . . . 0.0 111.014 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -56.89 -37.57 71.59 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 124.645 1.178 . . . . 0.0 114.062 175.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.4 tmtt? -63.15 -26.75 68.96 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.639 1.176 . . . . 0.0 112.101 178.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -90.54 -47.67 7.56 Favored 'General case' 0 C--N 1.334 -0.077 0 C-N-CA 124.416 1.087 . . . . 0.0 111.672 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 53.9 t -61.35 -42.68 94.6 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 O-C-N 122.088 -0.383 . . . . 0.0 110.904 -178.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 47.3 m -68.15 -36.65 80.01 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 118.912 -0.566 . . . . 0.0 111.473 176.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.11 -31.59 62.85 Favored 'General case' 0 C--O 1.23 0.031 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 -177.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.1 mm -76.78 -36.32 26.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.454 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 173.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.6 ttmt -65.48 -41.85 92.85 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 119.967 1.258 . . . . 0.0 110.955 -178.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.11 -53.13 54.47 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.528 1.131 . . . . 0.0 111.446 174.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.06 -36.64 75.4 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.8 tm? -65.02 -56.31 13.84 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.463 1.105 . . . . 0.0 110.777 177.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.66 -21.43 54.23 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -89.19 -32.41 17.47 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.23 1.412 . . . . 0.0 112.272 177.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.79 -23.38 60.79 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 126.152 1.781 . . . . 0.0 113.279 169.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.545 0.757 0 N-CA-C 113.677 0.992 . . . . 0.0 113.677 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 ttt . . . . . 0 N--CA 1.477 0.884 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -64.87 162.28 16.62 Favored 'General case' 0 CA--C 1.548 0.88 0 CA-C-N 120.152 1.342 . . . . 0.0 110.393 157.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 5.3 tp -109.67 108.51 18.93 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.867 0.758 . . . . 0.0 112.115 -174.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.1 114.63 16.12 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.202 2.201 . . . . 0.0 112.87 -176.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.3 t -120.94 141.51 41.12 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-O 122.729 1.252 . . . . 0.0 111.954 175.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.516 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.1 OUTLIER -121.27 158.63 27.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 128.054 2.542 . . . . 0.0 110.684 172.876 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 11.6 t -138.62 94.64 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.248 1.819 . . . . 0.0 108.424 170.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.9 p -84.3 127.12 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 CA-C-N 119.09 0.859 . . . . 0.0 110.909 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 t80 -154.27 153.41 31.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -178.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 89.7 p -67.65 85.86 0.2 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.084 1.354 . . . . 0.0 111.998 164.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.19 46.03 0.46 Allowed Glycine 0 CA--C 1.541 1.682 0 C-N-CA 127.228 2.346 . . . . 0.0 117.786 -166.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.34 55.79 0.16 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 129.15 2.98 . . . . 0.0 114.449 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.8 t 59.23 -177.71 0.09 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 126.43 1.892 . . . . 0.0 113.538 -174.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.22 -34.52 0.2 Allowed Glycine 0 CA--C 1.541 1.673 0 C-N-CA 127.678 2.561 . . . . 0.0 115.891 -173.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -55.15 -54.23 45.93 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 127.122 2.169 . . . . 0.0 114.281 -170.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.3 mtpt -41.91 -54.74 6.78 Favored Pre-proline 0 N--CA 1.48 1.052 0 N-CA-C 115.729 1.751 . . . . 0.0 115.729 -170.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -68.5 -38.7 10.7 Favored 'Trans proline' 0 CA--C 1.538 0.694 0 C-N-CA 122.001 1.8 . . . . 0.0 114.108 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 50.3 tttp -67.88 -33.82 75.47 Favored 'General case' 0 N--CA 1.488 1.445 0 CA-C-N 122.295 2.316 . . . . 0.0 111.605 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -58.52 -55.53 33.85 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 125.875 1.67 . . . . 0.0 110.759 170.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 56.0 mt -58.93 -41.59 87.7 Favored 'General case' 0 C--O 1.211 -0.927 0 CA-C-O 117.505 -1.236 . . . . 0.0 112.702 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -59.14 -51.32 70.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 120.936 1.698 . . . . 0.0 110.367 -179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 63.1 tp -60.24 -44.82 94.9 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.091 0.956 . . . . 0.0 112.091 173.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.2 mtpp -65.21 -59.16 4.39 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.42 1.088 . . . . 0.0 111.729 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.92 -46.0 2.68 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.999 1.72 . . . . 0.0 112.516 177.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.72 -36.02 81.49 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 115.197 1.554 . . . . 0.0 115.197 179.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -75.36 -50.07 17.08 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 126.338 1.855 . . . . 0.0 112.544 176.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -60.12 -32.44 71.01 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.927 1.691 . . . . 0.0 113.9 170.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 3.9 t-80 -57.62 -47.28 82.62 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 125.571 1.548 . . . . 0.0 112.093 162.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.409 ' HB3' ' CD2' ' A' ' 30' ' ' PHE . 1.9 tp10 -68.74 -35.31 76.96 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.496 0.718 . . . . 0.0 112.532 -175.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 29' ' ' GLU . 33.1 m-85 -135.7 49.03 3.08 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.621 1.968 . . . . 0.0 114.365 -169.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.0 Cg_endo -62.27 124.36 14.18 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.931 1.754 . . . . 0.0 111.571 -168.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 61.61 -15.54 0.06 OUTLIER Glycine 0 CA--C 1.532 1.102 0 C-N-CA 126.792 2.139 . . . . 0.0 117.528 -174.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.646 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.8 m -69.65 -13.27 62.22 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.587 1.693 . . . . 0.0 111.402 164.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -125.25 157.73 35.85 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 127.987 2.515 . . . . 0.0 112.752 176.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -120.63 139.61 52.75 Favored 'General case' 0 C--N 1.322 -0.62 0 C-N-CA 130.037 3.335 . . . . 0.0 107.794 156.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 20.3 mt -139.52 115.41 8.87 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 123.28 1.514 . . . . 0.0 107.663 159.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.516 ' HB2' HH11 ' A' ' 6' ' ' ARG . 90.7 m -108.22 172.84 6.61 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-N 113.912 -1.494 . . . . 0.0 110.404 163.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -126.95 162.53 21.05 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.23 -1.148 . . . . 0.0 110.23 167.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -133.56 79.92 1.85 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 123.79 1.757 . . . . 0.0 108.924 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.97 35.82 1.68 Allowed Glycine 0 CA--C 1.541 1.708 0 CA-C-N 113.473 -1.694 . . . . 0.0 115.088 -171.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.7 p -71.44 149.68 93.78 Favored Pre-proline 0 CA--C 1.543 0.703 0 C-N-CA 125.463 1.505 . . . . 0.0 112.619 -174.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -73.51 3.92 4.39 Favored 'Trans proline' 0 CA--C 1.544 0.993 0 C-N-CA 122.92 2.414 . . . . 0.0 115.521 -169.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.22 -38.31 86.16 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 116.574 2.064 . . . . 0.0 116.574 -158.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.6 t -143.07 102.23 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 CA-C-N 120.728 1.603 . . . . 0.0 110.212 -178.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 15.8 m -48.51 97.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 126.868 2.067 . . . . 0.0 113.03 176.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.27 -7.25 34.73 Favored Glycine 0 CA--C 1.536 1.371 0 C-N-CA 125.962 1.744 . . . . 0.0 115.923 173.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.44 119.81 16.13 Favored 'General case' 0 CA--C 1.547 0.839 0 CA-C-N 118.822 1.311 . . . . 0.0 107.53 168.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -142.24 96.5 2.97 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 125.947 1.699 . . . . 0.0 109.005 -175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.8 mm-40 -128.52 128.1 43.67 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-N 119.914 1.234 . . . . 0.0 112.67 -162.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 53.9 t -101.95 128.01 54.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.206 0 O-C-N 121.643 -0.661 . . . . 0.0 109.754 -177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -127.51 128.31 45.45 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 124.234 1.014 . . . . 0.0 110.786 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG12 ' CG2' ' A' ' 57' ' ' VAL . 10.9 p -114.54 129.19 71.03 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 126.534 1.934 . . . . 0.0 109.976 173.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.25 29.91 0.26 Allowed 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 125.728 1.611 . . . . 0.0 114.869 -176.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.78 20.5 50.45 Favored Glycine 0 CA--C 1.537 1.445 0 O-C-N 120.589 -1.319 . . . . 0.0 115.637 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 72.0 mmtt -124.57 118.7 27.15 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 127.316 2.246 . . . . 0.0 110.505 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.6 tt -63.85 131.91 49.22 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 118.588 0.631 . . . . 0.0 110.877 174.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.41 ' CG2' HG12 ' A' ' 52' ' ' VAL . 2.1 t -117.42 -22.23 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.071 0 C-N-CA 125.036 1.334 . . . . 0.0 111.565 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 19.8 t60 -146.75 145.07 29.83 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.656 1.183 . . . . 0.0 109.7 -174.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 37.2 t -153.63 107.43 3.01 Favored 'General case' 0 C--O 1.241 0.652 0 C-N-CA 123.821 0.848 . . . . 0.0 111.908 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.46 -29.91 70.63 Favored 'General case' 0 N--CA 1.469 0.492 0 O-C-N 120.753 -1.217 . . . . 0.0 112.57 164.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.19 -37.73 86.41 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.907 0.883 . . . . 0.0 112.744 177.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 3.5 ptt180 -76.93 -29.38 55.64 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 119.446 1.021 . . . . 0.0 113.391 172.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.67 25.67 7.55 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 115.169 0.828 . . . . 0.0 115.169 -173.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -61.75 -31.24 71.4 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.865 0.833 . . . . 0.0 113.072 175.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 67.87 156.17 0.71 Allowed Glycine 0 C--N 1.345 1.044 0 C-N-CA 126.228 1.871 . . . . 0.0 112.294 -174.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 31.4 m-85 -62.18 -170.38 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.359 1.464 . . . . 0.0 113.894 -178.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.254 31.6 m -62.49 89.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 CA-C-O 123.312 1.529 . . . . 0.0 109.468 146.347 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -103.91 -16.82 15.24 Favored 'General case' 0 CA--C 1.541 0.613 1 C-N-CA 131.811 4.045 . . . . 0.0 109.675 173.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -148.19 157.14 43.33 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-O 122.222 1.01 . . . . 0.0 109.926 176.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -48.55 -56.65 7.8 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 129.275 3.03 . . . . 0.0 111.151 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.34 -26.62 68.56 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 113.731 -1.577 . . . . 0.0 112.782 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.49 -30.92 64.96 Favored 'General case' 0 C--N 1.347 0.464 0 N-CA-C 113.145 0.794 . . . . 0.0 113.145 176.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -68.46 -50.19 54.31 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 123.432 0.693 . . . . 0.0 111.592 168.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 17.4 ttp-105 -55.46 -31.68 62.15 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 125.559 1.544 . . . . 0.0 114.082 -176.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.5 pttt -55.98 -42.53 76.44 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.651 0.78 . . . . 0.0 110.491 176.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.0 tt -82.62 -40.55 20.64 Favored 'General case' 0 CA--C 1.515 -0.397 0 C-N-CA 123.847 0.859 . . . . 0.0 110.167 -173.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 72.8 t -54.96 -47.08 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.583 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.716 172.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 38.3 m -63.69 -41.21 98.16 Favored 'General case' 0 CA--C 1.514 -0.412 0 C-N-CA 122.985 0.514 . . . . 0.0 111.993 -178.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.71 -31.8 57.44 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -175.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.6 mm -79.5 -30.14 13.61 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.414 0 N-CA-C 109.049 -0.722 . . . . 0.0 109.049 178.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 tppt? -64.08 -46.2 85.31 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 119.606 1.093 . . . . 0.0 110.031 176.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.56 -52.56 60.56 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.649 1.18 . . . . 0.0 110.893 175.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -33.93 72.74 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.646 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.7 tm? -63.48 -56.12 18.62 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 122.956 0.502 . . . . 0.0 110.613 176.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.75 -24.46 65.75 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -74.82 -53.27 9.42 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.553 1.141 . . . . 0.0 110.572 173.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 2.1 t -65.38 -22.17 66.76 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.357 1.463 . . . . 0.0 113.627 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 15.8 tt0 . . . . . 0 CA--C 1.535 0.376 0 N-CA-C 113.542 0.942 . . . . 0.0 113.542 174.947 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.8 ptm . . . . . 0 N--CA 1.474 0.73 0 CA-C-O 121.434 0.635 . . . . 0.0 110.501 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.94 172.4 18.52 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 127.64 2.376 . . . . 0.0 107.591 170.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -117.56 161.68 19.24 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.614 1.166 . . . . 0.0 109.254 164.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.39 127.59 37.84 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.43 1.492 . . . . 0.0 111.231 178.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 17.9 t -136.35 147.17 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.459 1.104 . . . . 0.0 111.543 -169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.8 mpp_? -133.9 164.54 27.05 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 129.019 2.928 . . . . 0.0 112.063 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.533 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 48.2 t -152.51 95.11 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 128.038 2.535 . . . . 0.0 107.949 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -80.78 128.28 38.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-N 119.11 0.868 . . . . 0.0 110.231 173.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -158.89 174.46 14.95 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.681 0.753 . . . . 0.0 111.304 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 43.4 t -76.09 123.31 25.6 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 125.464 1.505 . . . . 0.0 111.24 166.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.35 -1.0 6.7 Favored Glycine 0 CA--C 1.544 1.903 0 N-CA-C 115.936 1.134 . . . . 0.0 115.936 172.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.15 -20.95 57.11 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -155.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.3 t -141.26 92.37 2.47 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.207 -0.933 . . . . 0.0 112.012 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.42 23.91 63.09 Favored Glycine 0 CA--C 1.535 1.315 0 N-CA-C 115.05 0.78 . . . . 0.0 115.05 173.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -56.99 -41.18 77.94 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 -167.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -58.39 -54.51 55.23 Favored Pre-proline 0 N--CA 1.475 0.786 0 CA-C-O 117.863 -1.065 . . . . 0.0 113.593 -173.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -65.08 -33.75 49.24 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 CA-C-N 121.91 1.718 . . . . 0.0 113.206 171.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -55.86 -48.38 75.63 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.585 1.154 . . . . 0.0 111.251 174.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -57.02 -57.44 12.55 Favored 'General case' 0 C--O 1.225 -0.195 0 C-N-CA 126.717 2.007 . . . . 0.0 110.97 171.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.0 mt -50.45 -44.03 55.42 Favored 'General case' 0 C--O 1.218 -0.574 0 C-N-CA 123.652 0.781 . . . . 0.0 112.504 -179.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -15.5 62.89 Favored 'General case' 0 CA--C 1.548 0.888 0 O-C-N 120.387 -1.446 . . . . 0.0 112.905 -174.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 6.4 tt -94.38 -49.78 5.54 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.802 1.241 . . . . 0.0 111.591 162.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -61.93 -62.71 1.6 Allowed 'General case' 0 C--O 1.219 -0.515 0 C-N-CA 126.598 1.959 . . . . 0.0 112.205 -175.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -40.97 -44.9 2.46 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 127.024 2.129 . . . . 0.0 112.455 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.26 -52.34 59.16 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 126.47 1.908 . . . . 0.0 112.437 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -58.96 -52.18 66.88 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 127.529 2.332 . . . . 0.0 112.938 174.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.7 mt-10 -61.33 -28.31 69.12 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 171.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -67.92 -43.05 80.08 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.154 1.343 . . . . 0.0 111.714 164.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -57.41 -39.53 76.37 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 125.514 1.526 . . . . 0.0 111.846 -176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -161.48 81.42 1.97 Allowed Pre-proline 0 CA--C 1.548 0.874 0 C-N-CA 125.878 1.671 . . . . 0.0 112.946 -177.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -69.02 137.93 38.87 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.265 1.976 . . . . 0.0 111.828 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.25 -23.36 0.59 Allowed Glycine 0 N--CA 1.468 0.831 0 C-N-CA 125.919 1.723 . . . . 0.0 116.557 171.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 47.8 m -66.69 -13.34 61.16 Favored 'General case' 0 CA--C 1.537 0.48 0 CA-C-N 118.601 1.201 . . . . 0.0 112.034 162.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.22 147.21 49.71 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 126.575 1.95 . . . . 0.0 111.268 168.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -94.18 139.74 30.63 Favored 'General case' 0 C--N 1.321 -0.646 0 C-N-CA 127.935 2.494 . . . . 0.0 108.559 148.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 6.7 mt -145.28 120.05 3.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 C-N-CA 126.316 1.846 . . . . 0.0 109.671 170.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 t -130.01 -166.76 1.71 Allowed 'General case' 0 C--N 1.315 -0.919 0 C-N-CA 127.279 2.232 . . . . 0.0 109.951 173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.533 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -173.22 161.19 32.08 Favored Glycine 0 CA--C 1.527 0.831 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 170.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -98.03 47.54 1.01 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 129.281 3.032 . . . . 0.0 110.225 -173.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -70.17 82.3 0.35 Allowed Glycine 0 CA--C 1.527 0.81 0 C-N-CA 127.051 2.262 . . . . 0.0 111.979 -178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.9 p -113.4 158.9 37.14 Favored Pre-proline 0 N--CA 1.472 0.645 0 C-N-CA 125.058 1.343 . . . . 0.0 113.785 -159.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -77.41 79.42 3.18 Favored 'Trans proline' 0 CA--C 1.542 0.887 0 C-N-CA 123.277 2.651 . . . . 0.0 111.809 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -137.25 154.43 50.14 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.612 1.165 . . . . 0.0 110.501 171.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.26 -29.16 34.84 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 124.201 1.0 . . . . 0.0 111.985 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -74.65 87.88 2.18 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 125.521 1.528 . . . . 0.0 111.124 -172.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -75.56 50.31 2.47 Favored Glycine 0 CA--C 1.537 1.417 0 O-C-N 120.973 -1.079 . . . . 0.0 115.575 -175.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 37.8 p90 -74.23 95.53 2.64 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.754 1.777 . . . . 0.0 111.124 169.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -80.15 95.62 6.3 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.421 1.488 . . . . 0.0 109.303 177.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -125.82 133.67 51.92 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.316 0.962 . . . . 0.0 113.065 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 38.1 t -119.49 126.8 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 C-N-CA 123.631 0.772 . . . . 0.0 110.711 -168.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 18.7 p -130.15 140.67 50.75 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.168 2.187 . . . . 0.0 113.003 -168.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.83 122.94 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 127.356 2.263 . . . . 0.0 110.329 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.16 29.23 1.76 Allowed 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.316 1.446 . . . . 0.0 114.412 -174.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.39 7.37 72.72 Favored Glycine 0 CA--C 1.538 1.506 0 O-C-N 120.68 -1.263 . . . . 0.0 115.208 -175.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -106.49 116.29 31.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 127.314 2.245 . . . . 0.0 111.155 177.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.1 tt -64.94 138.0 58.1 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 122.963 0.505 . . . . 0.0 110.723 172.149 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.6 t -121.54 -21.17 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 125.536 1.534 . . . . 0.0 112.072 176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -140.98 151.58 44.25 Favored 'General case' 0 CA--C 1.523 -0.094 0 C-N-CA 125.897 1.679 . . . . 0.0 111.812 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.463 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 34.5 t -158.77 117.34 2.97 Favored 'General case' 0 C--O 1.238 0.472 0 C-N-CA 124.366 1.067 . . . . 0.0 113.18 172.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.64 -23.62 64.45 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 119.825 -1.797 . . . . 0.0 114.694 166.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 29.4 pttt -79.26 -31.46 43.45 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 121.111 1.778 . . . . 0.0 113.23 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -80.97 -19.24 44.52 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 178.254 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 105.18 26.01 6.47 Favored Glycine 0 CA--C 1.526 0.779 0 C-N-CA 124.219 0.914 . . . . 0.0 113.769 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -71.99 -51.64 20.89 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-N 118.653 1.226 . . . . 0.0 111.15 171.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.35 154.81 0.3 Allowed Glycine 0 CA--C 1.534 1.279 0 C-N-CA 125.031 1.301 . . . . 0.0 114.868 -179.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.9 m-85 -57.52 -179.09 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 126.938 2.095 . . . . 0.0 114.533 -175.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.256 35.1 m -77.29 73.4 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-O 124.074 1.892 . . . . 0.0 113.482 -175.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 76.2 m-20 -69.82 -18.07 63.43 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 127.828 2.451 . . . . 0.0 111.108 176.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -144.88 156.9 44.25 Favored 'General case' 0 CA--C 1.52 -0.195 0 O-C-N 121.179 -0.951 . . . . 0.0 110.786 173.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 tm-20 -44.41 -56.6 4.11 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 126.354 1.861 . . . . 0.0 111.171 163.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -56.95 -31.84 65.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 112.87 -1.968 . . . . 0.0 112.208 -178.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -73.39 -39.98 64.68 Favored 'General case' 0 C--N 1.343 0.303 0 N-CA-C 112.767 0.654 . . . . 0.0 112.767 176.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 38.5 t80 -59.83 -53.93 52.11 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 122.923 0.489 . . . . 0.0 109.944 169.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.5 ttp85 -57.0 -31.38 65.03 Favored 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 126.831 2.052 . . . . 0.0 113.625 -178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -58.51 -34.45 70.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.406 1.482 . . . . 0.0 111.979 173.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.9 tt -89.07 -45.15 9.84 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.886 0.875 . . . . 0.0 111.276 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.3 t -56.6 -42.76 77.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-O 120.818 0.342 . . . . 0.0 111.307 176.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 56.1 m -64.86 -40.78 95.7 Favored 'General case' 0 CA--C 1.512 -0.485 0 O-C-N 121.928 -0.483 . . . . 0.0 111.709 178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.17 -33.1 65.25 Favored 'General case' 0 C--N 1.333 -0.123 0 C-N-CA 120.353 -0.539 . . . . 0.0 112.375 -175.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.6 mm -77.69 -32.02 17.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.294 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -71.15 -37.18 72.24 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 119.322 0.965 . . . . 0.0 110.765 176.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.34 -54.17 41.17 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 125.407 1.483 . . . . 0.0 111.144 173.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.23 -35.76 76.18 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.486 0.714 . . . . 0.0 112.57 178.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.2 tp -60.97 -58.75 7.11 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 123.984 0.914 . . . . 0.0 111.536 170.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.09 -21.25 21.0 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 84.0 mt-30 -80.89 -47.12 14.19 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 126.171 1.789 . . . . 0.0 111.828 170.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.7 t -59.05 -23.63 62.17 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 124.714 1.206 . . . . 0.0 114.04 171.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 . . . . . 0 CA--C 1.546 0.803 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 174.049 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.1 mtt . . . . . 0 N--CA 1.478 0.974 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.89 175.57 0.48 Allowed 'General case' 0 CA--C 1.548 0.883 0 CA-C-N 118.818 0.735 . . . . 0.0 111.59 149.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.77 162.26 13.03 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.263 1.025 . . . . 0.0 108.792 166.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.68 133.79 48.3 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 113.018 175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.4 t -127.77 146.16 33.88 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 125.981 1.713 . . . . 0.0 109.221 -175.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 82.4 mmt-85 -133.37 159.45 40.25 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 125.664 1.586 . . . . 0.0 110.476 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 40.1 t -145.8 114.88 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.492 0 C-N-CA 126.931 2.093 . . . . 0.0 108.251 177.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -86.75 142.41 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 CA-C-N 118.557 0.617 . . . . 0.0 110.512 161.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' CG ' ' N ' ' A' ' 10' ' ' SER . 16.7 t80 -154.26 176.0 12.82 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.7 1.136 . . . . 0.0 112.879 165.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.539 ' HB2' ' H ' ' A' ' 46' ' ' GLY . 12.0 t -87.71 108.21 19.0 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 127.544 2.338 . . . . 0.0 109.954 171.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.16 14.76 0.61 Allowed Glycine 0 CA--C 1.541 1.677 0 C-N-CA 125.416 1.484 . . . . 0.0 116.709 -172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.46 -48.89 79.05 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 115.638 1.718 . . . . 0.0 115.638 -158.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 48.9 t -156.39 149.29 24.0 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.177 0.991 . . . . 0.0 109.97 -177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.48 -1.11 0.31 Allowed Glycine 0 CA--C 1.54 1.645 0 C-N-CA 126.346 1.927 . . . . 0.0 117.911 173.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -66.27 -37.74 86.17 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 119.524 1.662 . . . . 0.0 114.868 -160.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.7 mmtt -47.76 -60.3 4.42 Favored Pre-proline 0 N--CA 1.478 0.97 0 CA-C-O 117.139 -1.41 . . . . 0.0 114.059 -175.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -66.16 -32.91 41.95 Favored 'Trans proline' 0 CA--C 1.537 0.628 0 CA-C-N 122.103 1.787 . . . . 0.0 113.33 175.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.5 tmtt? -62.44 -40.41 96.51 Favored 'General case' 0 N--CA 1.481 1.116 0 CA-C-N 120.4 1.455 . . . . 0.0 111.847 174.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -59.29 -60.65 3.51 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.911 1.684 . . . . 0.0 110.743 169.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.4 mt -54.74 -46.11 74.24 Favored 'General case' 0 C--O 1.21 -0.983 0 C-N-CA 124.293 1.037 . . . . 0.0 112.284 -178.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 75.1 mm-40 -68.58 -16.79 63.98 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 120.977 1.717 . . . . 0.0 114.13 -175.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 44.0 tp -79.89 -49.48 11.86 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.402 0.681 . . . . 0.0 111.313 158.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -63.32 -60.97 2.69 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.092 1.757 . . . . 0.0 113.019 -172.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -43.82 -42.11 5.44 Favored 'General case' 0 C--O 1.222 -0.367 0 C-N-CA 129.711 3.205 . . . . 0.0 112.884 175.138 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.85 -54.3 37.19 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 123.476 0.711 . . . . 0.0 111.178 176.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tp -56.05 -47.02 78.7 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.246 1.018 . . . . 0.0 112.134 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -63.22 -34.28 77.32 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.428 2.01 . . . . 0.0 116.428 170.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -66.6 -41.58 88.23 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.877 1.217 . . . . 0.0 111.379 169.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.05 -33.54 74.77 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.162 1.385 . . . . 0.0 112.564 -178.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -137.01 49.04 2.63 Favored Pre-proline 0 CA--C 1.557 1.231 0 C-N-CA 126.158 1.783 . . . . 0.0 114.953 -171.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -63.08 124.89 14.73 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.97 2.447 . . . . 0.0 112.607 -166.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.52 -7.2 0.09 OUTLIER Glycine 0 CA--C 1.533 1.162 0 C-N-CA 126.48 1.99 . . . . 0.0 116.973 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.631 ' HB3' HD21 ' A' ' 84' ' ' LEU . 17.3 m -75.13 -8.08 55.57 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 119.073 1.436 . . . . 0.0 111.874 163.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 HD12 HD23 ' A' ' 84' ' ' LEU . 0.2 OUTLIER -147.93 161.44 41.32 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.999 0.904 . . . . 0.0 113.009 -171.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.7 t0 -127.7 138.86 52.93 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 128.387 2.675 . . . . 0.0 108.052 170.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.6 mp -133.51 127.76 53.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 125.207 1.403 . . . . 0.0 107.741 160.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 58.8 m -124.24 174.41 7.71 Favored 'General case' 0 C--N 1.318 -0.781 0 C-N-CA 126.299 1.84 . . . . 0.0 110.726 170.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -175.83 167.73 39.67 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 116.173 1.229 . . . . 0.0 116.173 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -139.76 61.88 1.53 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 128.49 2.716 . . . . 0.0 109.733 -155.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.65 79.7 0.34 Allowed Glycine 0 CA--C 1.532 1.141 0 C-N-CA 126.166 1.841 . . . . 0.0 111.03 170.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -101.63 164.4 15.98 Favored Pre-proline 0 N--CA 1.47 0.55 0 C-N-CA 128.512 2.725 . . . . 0.0 113.233 -163.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -75.04 176.75 9.51 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.006 2.471 . . . . 0.0 111.508 168.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 4.9 mm100 64.6 -36.65 0.2 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 128.922 2.889 . . . . 0.0 116.75 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 35.1 m -72.8 145.3 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-N 119.75 1.159 . . . . 0.0 111.406 173.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 60.9 p -121.04 87.0 2.67 Favored 'General case' 0 N--CA 1.474 0.759 0 O-C-N 120.932 -1.105 . . . . 0.0 112.212 -165.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.539 ' H ' ' HB2' ' A' ' 10' ' ' SER . . . 79.27 0.9 84.8 Favored Glycine 0 CA--C 1.543 1.786 0 N-CA-C 117.382 1.713 . . . . 0.0 117.382 170.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -70.38 82.44 0.56 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.915 1.686 . . . . 0.0 111.498 176.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -85.8 94.08 9.05 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -117.54 122.39 43.56 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 118.88 0.764 . . . . 0.0 109.833 -171.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.7 t -115.1 129.18 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-O 121.768 0.794 . . . . 0.0 110.715 -173.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.53 139.04 50.48 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 125.378 1.471 . . . . 0.0 110.034 -169.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 8.7 p -128.07 128.98 69.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 C-N-CA 126.219 1.807 . . . . 0.0 109.935 172.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.12 37.55 1.24 Allowed 'General case' 0 CA--C 1.555 1.145 0 C-N-CA 125.672 1.589 . . . . 0.0 113.908 -170.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.42 31.02 68.57 Favored Glycine 0 CA--C 1.537 1.44 0 O-C-N 120.08 -1.637 . . . . 0.0 114.535 -175.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.11 109.68 13.78 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 128.208 2.603 . . . . 0.0 108.924 173.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.486 HD22 ' N ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -58.48 128.34 36.68 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.82 2.048 . . . . 0.0 110.571 170.619 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.486 ' N ' HD22 ' A' ' 56' ' ' LEU . 2.7 t -124.72 -20.68 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 C-N-CA 124.439 1.096 . . . . 0.0 112.538 179.056 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 9.5 t60 -144.23 143.07 30.88 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.258 1.023 . . . . 0.0 112.268 -175.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.478 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.5 t -156.2 109.5 2.68 Favored 'General case' 0 C--O 1.239 0.528 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 17.2 mmmt -60.2 -21.42 61.72 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 120.42 -1.425 . . . . 0.0 114.432 157.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 51.8 tptt -77.84 -43.19 31.13 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 120.243 1.383 . . . . 0.0 113.239 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.478 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -72.16 -8.55 55.31 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 177.447 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.98 30.27 20.87 Favored Glycine 0 CA--C 1.523 0.558 0 C-N-CA 124.671 1.129 . . . . 0.0 113.631 -174.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -80.21 -15.8 56.22 Favored 'General case' 0 C--O 1.225 -0.196 0 N-CA-C 113.472 0.915 . . . . 0.0 113.472 173.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.59 -174.17 54.8 Favored Glycine 0 C--N 1.338 0.684 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -168.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -77.01 -174.21 3.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 154.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -72.49 98.35 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 O-C-N 119.752 -1.843 . . . . 0.0 108.589 159.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -102.93 -10.91 18.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 113.205 -1.816 . . . . 0.0 112.179 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -145.69 160.66 41.38 Favored 'General case' 0 N--CA 1.467 0.422 0 O-C-N 121.011 -1.055 . . . . 0.0 110.6 173.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.6 tm-20 -44.44 -57.9 3.28 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.776 2.03 . . . . 0.0 109.908 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -60.01 -22.36 62.49 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 113.522 -1.672 . . . . 0.0 113.156 -175.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.9 ttmt -84.3 -45.5 12.76 Favored 'General case' 0 CA--C 1.53 0.199 0 C-N-CA 124.196 0.998 . . . . 0.0 113.161 170.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 36.3 t80 -60.24 -43.04 96.44 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 123.585 0.754 . . . . 0.0 111.84 176.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 -55.47 -30.73 61.12 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 127.676 2.391 . . . . 0.0 113.869 -179.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 6.9 pttt -59.94 -40.65 89.69 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.953 1.301 . . . . 0.0 111.441 172.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.0 tp -77.18 -44.58 29.64 Favored 'General case' 0 CA--C 1.522 -0.127 0 C-N-CA 124.406 1.082 . . . . 0.0 110.876 178.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 88.4 t -56.48 -43.16 77.26 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.45 0 CA-C-O 119.254 -0.403 . . . . 0.0 110.788 176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 33.2 m -65.64 -44.92 84.93 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 118.448 0.567 . . . . 0.0 112.174 177.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.83 -28.55 60.74 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -171.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.0 mm -84.35 -29.3 7.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -69.18 -41.13 77.6 Favored 'General case' 0 N--CA 1.484 1.23 0 O-C-N 121.165 -0.96 . . . . 0.0 110.834 174.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.41 -53.02 61.03 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.889 1.275 . . . . 0.0 111.91 170.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.8 -31.55 69.8 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.631 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.2 tm? -67.16 -56.57 9.38 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 123.427 0.691 . . . . 0.0 110.923 177.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.04 -22.61 62.88 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.718 1.007 . . . . 0.0 113.718 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 52.5 tt0 -78.15 -46.35 20.84 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.644 1.978 . . . . 0.0 111.484 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -73.75 -19.4 60.8 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.512 1.125 . . . . 0.0 113.989 175.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 22.5 mm-40 . . . . . 0 N--CA 1.476 0.872 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 174.505 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.0 tpt . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 116.888 -1.53 . . . . 0.0 109.756 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -60.53 161.96 6.96 Favored 'General case' 0 CA--C 1.546 0.816 0 CA-C-N 120.077 1.308 . . . . 0.0 112.551 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.0 tp -134.11 124.94 26.95 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.05 0.94 . . . . 0.0 112.606 -161.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -80.11 94.69 6.03 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.694 2.397 . . . . 0.0 114.697 -171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 36' ' ' ILE . 13.8 t -86.55 143.74 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 O-C-N 120.791 -1.193 . . . . 0.0 109.353 169.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -128.01 161.46 29.11 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.362 1.865 . . . . 0.0 110.324 165.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.6 t -134.72 88.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 128.248 2.619 . . . . 0.0 107.444 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.2 t -73.91 120.7 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 CA-C-O 118.257 -0.878 . . . . 0.0 108.936 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -151.82 143.89 23.87 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 119.611 1.096 . . . . 0.0 113.291 176.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.6 t -73.81 85.54 1.7 Allowed 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.665 0.786 . . . . 0.0 109.995 168.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.08 8.1 0.67 Allowed Glycine 0 CA--C 1.537 1.41 0 N-CA-C 117.634 1.813 . . . . 0.0 117.634 -165.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -58.02 -23.4 54.1 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.458 1.903 . . . . 0.0 115.08 -167.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 34.7 t -106.08 73.79 1.01 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.081 0.952 . . . . 0.0 110.835 174.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 52.76 57.77 13.33 Favored Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.241 1.401 . . . . 0.0 115.296 169.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -63.5 -45.92 88.46 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 116.106 1.891 . . . . 0.0 116.106 -174.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.7 mtpt -45.89 -54.58 15.94 Favored Pre-proline 0 N--CA 1.479 0.978 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 -164.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -69.24 -32.1 21.43 Favored 'Trans proline' 0 C--N 1.35 0.615 0 CA-C-N 121.462 1.558 . . . . 0.0 113.25 176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.3 mtmm -71.08 -28.39 64.31 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 120.252 1.387 . . . . 0.0 113.06 176.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.7 m-30 -64.18 -63.08 1.24 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.646 0.778 . . . . 0.0 110.352 161.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 73.5 mt -54.48 -40.71 68.76 Favored 'General case' 0 C--O 1.213 -0.832 0 C-N-CA 124.361 1.064 . . . . 0.0 113.372 -173.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.6 tm0? -61.83 -41.33 97.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 119.777 1.172 . . . . 0.0 111.96 -177.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 10.3 tt -67.43 -48.7 66.49 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 122.697 0.399 . . . . 0.0 110.394 168.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.07 -57.6 10.1 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.07 1.348 . . . . 0.0 112.017 -169.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -42.34 -46.86 4.75 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 126.662 1.985 . . . . 0.0 112.706 171.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.54 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -65.64 -41.61 92.41 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 179.032 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.6 mp -64.09 -52.4 59.42 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 125.726 1.61 . . . . 0.0 112.027 175.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -59.76 -38.14 80.98 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 125.809 1.644 . . . . 0.0 114.106 173.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -58.99 -44.29 91.6 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 119.673 1.124 . . . . 0.0 111.538 167.222 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.412 ' CD ' ' HZ2' ' A' ' 81' ' ' LYS . 4.8 mm-40 -67.75 -38.3 83.29 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.409 1.084 . . . . 0.0 112.206 -174.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -148.46 68.66 10.18 Favored Pre-proline 0 CA--C 1.555 1.163 0 C-N-CA 124.985 1.314 . . . . 0.0 113.717 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.03 132.56 24.79 Favored 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.844 3.03 . . . . 0.0 112.369 -173.049 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.75 -11.61 0.03 OUTLIER Glycine 0 CA--C 1.532 1.154 0 C-N-CA 125.95 1.738 . . . . 0.0 116.249 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.4 m -64.55 -16.05 61.98 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 120.499 -1.589 . . . . 0.0 111.685 160.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.414 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -153.57 160.6 42.5 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 126.097 1.759 . . . . 0.0 112.873 -173.588 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -113.99 139.48 49.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 127.773 2.429 . . . . 0.0 107.945 166.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 ' HA ' ' HB ' ' A' ' 5' ' ' VAL . 0.7 OUTLIER -131.14 115.5 29.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 123.976 1.846 . . . . 0.0 108.463 160.008 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 21.4 m -96.88 173.26 7.38 Favored 'General case' 0 C--N 1.31 -1.136 0 CA-C-N 112.675 -2.057 . . . . 0.0 110.557 164.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -140.69 155.95 25.1 Favored Glycine 0 CA--C 1.524 0.63 0 C-N-CA 126.302 1.906 . . . . 0.0 108.441 164.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -145.0 107.03 4.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 123.226 1.489 . . . . 0.0 111.128 -172.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -84.36 68.25 3.55 Favored Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.412 -1.267 . . . . 0.0 111.081 165.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 m -49.82 132.16 21.23 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 126.005 1.722 . . . . 0.0 108.534 170.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -68.5 138.76 43.04 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 121.394 1.396 . . . . 0.0 113.321 -154.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 61.04 13.93 5.0 Favored 'General case' 0 CA--C 1.554 1.098 0 C-N-CA 126.316 1.847 . . . . 0.0 115.984 172.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 29.2 m -66.64 153.52 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 115.493 1.664 . . . . 0.0 115.493 -176.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -75.8 48.44 0.47 Allowed 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 128.657 2.783 . . . . 0.0 115.328 -166.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 71.77 -5.16 12.8 Favored Glycine 0 CA--C 1.541 1.667 0 N-CA-C 117.624 1.81 . . . . 0.0 117.624 168.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.6 p90 -66.38 154.88 38.94 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 118.847 1.323 . . . . 0.0 112.83 177.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.8 t80 -136.46 94.33 3.0 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 128.145 2.578 . . . . 0.0 108.861 -170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -126.24 118.86 26.01 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.692 -1.255 . . . . 0.0 110.09 -158.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -107.13 130.18 59.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 O-C-N 121.415 -0.803 . . . . 0.0 110.286 -172.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.0 144.71 50.28 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 124.317 1.047 . . . . 0.0 109.867 -173.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 10.2 p -130.64 121.59 50.81 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 125.183 1.393 . . . . 0.0 111.106 172.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.8 36.63 0.64 Allowed 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 125.925 1.69 . . . . 0.0 114.82 -173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.55 20.89 50.03 Favored Glycine 0 CA--C 1.536 1.36 0 O-C-N 121.24 -0.913 . . . . 0.0 114.979 -178.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -122.44 105.24 9.98 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 126.163 1.785 . . . . 0.0 110.219 179.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 9.0 tt -64.0 130.88 45.8 Favored 'General case' 0 N--CA 1.467 0.42 0 C-N-CA 122.71 0.404 . . . . 0.0 110.545 174.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.8 t -111.8 -28.31 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 124.478 1.111 . . . . 0.0 110.641 178.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -140.79 151.06 44.12 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.91 1.684 . . . . 0.0 112.017 -174.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 46.4 t -156.91 111.41 2.74 Favored 'General case' 0 C--O 1.24 0.593 0 C-N-CA 124.618 1.167 . . . . 0.0 112.586 178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 16.8 mmmt -68.57 -27.24 65.89 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.612 -1.305 . . . . 0.0 113.191 163.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -61.71 -37.05 82.72 Favored 'General case' 0 N--CA 1.474 0.758 0 C-N-CA 125.24 1.416 . . . . 0.0 112.507 173.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.401 ' HB3' ' HB3' ' A' ' 59' ' ' SER . 5.5 ttp180 -70.88 -35.49 72.36 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.291 1.837 . . . . 0.0 113.478 171.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.87 29.28 8.72 Favored Glycine 0 C--O 1.223 -0.534 0 C-N-CA 123.986 0.803 . . . . 0.0 114.217 -169.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.0 -30.23 70.17 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 173.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 80.54 153.19 8.89 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 124.538 1.066 . . . . 0.0 112.462 -178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -66.76 -166.03 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.874 1.269 . . . . 0.0 112.651 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.261 23.8 m -75.91 68.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 CA-C-O 125.054 2.359 . . . . 0.0 112.124 173.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -65.58 -21.48 66.59 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 130.051 3.34 . . . . 0.0 110.81 -177.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.4 p -139.77 154.45 47.4 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.164 1.386 . . . . 0.0 109.826 165.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -48.51 -50.97 29.57 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.056 1.342 . . . . 0.0 111.519 166.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -55.01 -33.65 62.8 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 112.975 -1.921 . . . . 0.0 111.953 178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -61.9 -53.02 61.5 Favored 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 118.972 0.805 . . . . 0.0 110.883 171.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.0 -44.95 83.29 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.949 0.88 . . . . 0.0 112.013 178.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 54.0 ttm-85 -64.81 -25.75 68.04 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.59 1.556 . . . . 0.0 113.999 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.1 mptt -65.05 -34.93 79.61 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 119.94 1.245 . . . . 0.0 111.702 171.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.4 tt -79.89 -49.07 12.45 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 117.844 0.293 . . . . 0.0 110.725 176.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 t -55.53 -44.81 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.254 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.2 m -66.79 -40.12 88.03 Favored 'General case' 0 CA--C 1.513 -0.45 0 O-C-N 122.108 -0.37 . . . . 0.0 111.587 177.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -72.35 -29.92 64.25 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -175.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 41.2 mm -77.37 -36.69 24.16 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.412 ' HZ2' ' CD ' ' A' ' 29' ' ' GLU . 21.9 ttmt -69.05 -45.18 71.06 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.39 0.676 . . . . 0.0 111.295 179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.35 -48.31 78.51 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 125.172 1.389 . . . . 0.0 110.998 176.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.07 -37.08 78.83 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 174.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.41 -55.0 27.9 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 123.31 0.644 . . . . 0.0 110.694 177.124 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.29 -22.81 61.77 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 177.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 23.2 tt0 -83.99 -37.55 22.07 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.738 1.615 . . . . 0.0 111.883 176.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 24.2 t -61.05 -35.76 77.78 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.083 1.753 . . . . 0.0 112.436 169.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 . . . . . 0 N--CA 1.474 0.766 0 N-CA-C 116.44 2.015 . . . . 0.0 116.44 -174.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.8 ptt? . . . . . 0 N--CA 1.468 0.443 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -51.18 164.95 0.15 Allowed 'General case' 0 CA--C 1.553 1.087 0 CA-C-N 120.619 1.554 . . . . 0.0 112.242 142.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.15 166.21 11.69 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.087 1.355 . . . . 0.0 109.478 171.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.69 123.45 27.79 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.079 1.352 . . . . 0.0 111.541 179.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 11.5 t -130.26 147.78 33.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 124.243 1.017 . . . . 0.0 111.305 -175.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.462 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.5 OUTLIER -131.87 158.51 41.16 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 128.057 2.543 . . . . 0.0 112.054 -178.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.3 t -142.52 103.41 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 C-N-CA 126.924 2.089 . . . . 0.0 108.709 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 51.7 t -68.64 139.04 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 O-C-N 120.978 -1.076 . . . . 0.0 108.639 163.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -159.08 162.56 36.57 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.956 0.903 . . . . 0.0 110.566 162.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 13.1 p -78.64 115.75 18.55 Favored 'General case' 0 N--CA 1.472 0.671 0 O-C-N 120.726 -1.234 . . . . 0.0 111.402 166.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -69.92 45.61 0.56 Allowed Glycine 0 CA--C 1.541 1.716 0 C-N-CA 126.033 1.778 . . . . 0.0 116.289 -178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.5 42.28 0.08 Allowed 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 128.219 2.608 . . . . 0.0 115.081 -175.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.4 t 56.93 179.54 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.346 1.859 . . . . 0.0 113.133 -166.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.25 -25.85 0.1 OUTLIER Glycine 0 CA--C 1.542 1.767 0 C-N-CA 127.194 2.331 . . . . 0.0 117.019 -177.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -61.59 -38.06 86.18 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.182 1.393 . . . . 0.0 114.402 -168.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -51.28 -55.12 31.34 Favored Pre-proline 0 N--CA 1.48 1.053 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -172.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.0 -35.98 32.2 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.301 2.0 . . . . 0.0 113.775 173.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -60.99 -41.4 96.38 Favored 'General case' 0 N--CA 1.481 1.093 0 CA-C-N 120.552 1.524 . . . . 0.0 111.953 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -57.71 -55.83 29.73 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 125.68 1.592 . . . . 0.0 111.162 171.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 61.7 mt -54.16 -40.94 67.93 Favored 'General case' 0 C--O 1.212 -0.871 0 C-N-CA 123.603 0.761 . . . . 0.0 112.364 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -60.72 -37.92 83.36 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 119.893 1.224 . . . . 0.0 111.883 -175.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 13.5 tp -74.39 -48.52 27.36 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.295 0.638 . . . . 0.0 111.507 168.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.1 mtpp -63.78 -54.58 32.94 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 124.791 1.236 . . . . 0.0 112.68 -172.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -36.67 -49.79 0.78 Allowed 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.481 1.912 . . . . 0.0 112.791 173.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.01 -51.06 71.25 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 124.56 1.144 . . . . 0.0 112.752 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -64.21 -54.07 39.26 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 127.049 2.139 . . . . 0.0 112.771 -179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -60.09 -30.43 69.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.411 1.484 . . . . 0.0 114.186 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -68.82 -40.76 79.32 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.179 1.354 . . . . 0.0 112.658 166.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -66.08 -32.96 74.74 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.576 1.15 . . . . 0.0 113.433 176.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -135.73 52.4 6.73 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 127.249 2.22 . . . . 0.0 113.487 -169.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -67.38 114.8 3.39 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.015 2.476 . . . . 0.0 113.391 -165.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 57.7 -3.57 0.09 OUTLIER Glycine 0 CA--C 1.533 1.166 0 C-N-CA 126.575 2.036 . . . . 0.0 116.254 -167.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -68.18 -13.11 61.99 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 119.426 1.613 . . . . 0.0 110.865 162.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -135.96 155.25 50.54 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.755 1.622 . . . . 0.0 113.466 175.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.0 143.05 33.72 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.975 2.51 . . . . 0.0 109.12 149.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 16.2 mt -142.09 127.44 17.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 126.865 2.066 . . . . 0.0 108.471 160.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.462 ' HB2' HH11 ' A' ' 6' ' ' ARG . 62.4 m -130.83 -177.94 4.59 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 127.294 2.237 . . . . 0.0 111.893 175.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.35 165.87 22.47 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 124.943 1.258 . . . . 0.0 112.749 169.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -130.97 75.24 1.65 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 128.709 2.804 . . . . 0.0 106.775 -178.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.31 106.52 2.24 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 114.077 -1.419 . . . . 0.0 113.042 -167.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.3 p -67.51 151.34 97.26 Favored Pre-proline 0 C--O 1.241 0.627 0 C-N-CA 124.565 1.146 . . . . 0.0 113.003 -169.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.93 69.67 5.44 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.665 2.91 . . . . 0.0 110.402 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 41.6 tt0 61.36 -29.6 0.06 Allowed 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 129.882 3.273 . . . . 0.0 116.472 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.6 p -58.62 145.08 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 127.265 2.226 . . . . 0.0 112.403 174.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.5 p 37.77 52.43 1.42 Allowed 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 126.527 1.931 . . . . 0.0 114.144 172.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -68.47 24.16 0.28 Allowed Glycine 0 CA--C 1.531 1.074 0 C-N-CA 127.521 2.486 . . . . 0.0 117.93 -167.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -57.89 139.47 54.15 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.246 2.218 . . . . 0.0 111.195 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -91.37 93.08 8.86 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.731 1.213 . . . . 0.0 110.985 176.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -121.07 115.56 23.36 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.406 1.082 . . . . 0.0 111.812 -164.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.4 t -109.4 126.35 66.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 CA-C-N 119.792 1.178 . . . . 0.0 110.852 -170.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.6 p -127.33 134.55 49.97 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 126.861 2.065 . . . . 0.0 112.441 -176.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.8 p -119.97 119.85 61.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 126.903 2.081 . . . . 0.0 109.586 176.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 49.08 20.57 0.4 Allowed 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 126.106 1.763 . . . . 0.0 114.696 -170.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.06 -10.36 56.89 Favored Glycine 0 CA--C 1.54 1.629 0 C-N-CA 126.917 2.198 . . . . 0.0 115.4 -175.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.31 109.95 16.31 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.332 1.566 . . . . 0.0 110.37 173.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -63.64 134.68 55.86 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 118.899 0.772 . . . . 0.0 110.04 167.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.9 t -119.9 -27.4 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 C-N-CA 124.58 1.152 . . . . 0.0 110.975 176.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 40.5 t60 -133.96 149.24 51.24 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.546 0.738 . . . . 0.0 110.891 -175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.45 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 35.9 t -161.7 110.02 1.47 Allowed 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.297 1.039 . . . . 0.0 112.138 178.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.32 -32.11 73.44 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 117.181 -1.39 . . . . 0.0 113.315 171.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.45 -28.69 56.67 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.45 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -73.27 -18.47 61.22 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 120.201 1.364 . . . . 0.0 113.763 170.553 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 98.23 26.5 9.41 Favored Glycine 0 C--O 1.225 -0.421 0 C-N-CA 123.414 0.53 . . . . 0.0 113.872 -177.825 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -66.3 -29.53 69.77 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.402 0.89 . . . . 0.0 113.402 178.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 105.04 -158.78 15.95 Favored Glycine 0 C--N 1.341 0.841 0 C-N-CA 123.938 0.78 . . . . 0.0 111.621 -174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.83 -160.1 0.71 Allowed 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.349 1.86 . . . . 0.0 109.379 152.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.6 m -73.49 73.9 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-O 125.01 2.338 . . . . 0.0 111.125 164.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -80.39 -9.54 59.75 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 111.779 -2.464 . . . . 0.0 111.848 -173.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.79 162.61 37.07 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 125.224 1.409 . . . . 0.0 109.473 169.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.7 mm-40 -60.73 -36.47 78.94 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.477 0.656 . . . . 0.0 111.74 173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.49 -27.95 68.85 Favored 'General case' 0 N--CA 1.469 0.481 0 O-C-N 120.242 -1.536 . . . . 0.0 113.45 176.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -64.96 -54.91 23.18 Favored 'General case' 0 C--N 1.342 0.259 0 C-N-CA 123.693 0.797 . . . . 0.0 111.118 168.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -57.33 -50.53 72.64 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.517 0.675 . . . . 0.0 111.636 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 18.4 ttp180 -60.21 -26.76 66.63 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 125.925 1.69 . . . . 0.0 113.201 -177.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.3 tptm -54.78 -47.84 73.45 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.563 1.145 . . . . 0.0 111.213 170.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.8 tt -75.79 -44.38 41.66 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 124.329 1.018 . . . . 0.0 111.131 -178.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 86.8 t -53.36 -46.74 58.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.896 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 36.9 m -63.54 -39.23 93.88 Favored 'General case' 0 CA--C 1.518 -0.276 0 C-N-CA 122.859 0.464 . . . . 0.0 112.059 179.115 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.25 -30.88 54.67 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 40.1 mm -73.99 -37.61 47.77 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.256 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 173.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -63.24 -42.47 99.21 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 119.2 0.909 . . . . 0.0 111.195 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -68.78 -45.37 71.51 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.434 1.094 . . . . 0.0 112.495 177.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.03 -38.88 87.71 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-O 121.094 0.473 . . . . 0.0 112.063 174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -63.13 -56.46 16.65 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 123.642 0.777 . . . . 0.0 111.357 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.0 -22.68 62.9 Favored 'General case' 0 CA--C 1.542 0.651 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 -178.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -77.79 -53.31 7.66 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 124.27 1.028 . . . . 0.0 111.195 172.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -61.45 -22.66 65.25 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 124.309 1.044 . . . . 0.0 113.53 178.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 168.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 ptp . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 118.44 -0.79 . . . . 0.0 110.196 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.33 173.55 4.75 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 118.646 0.657 . . . . 0.0 110.989 158.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -116.29 111.68 20.46 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.366 1.066 . . . . 0.0 113.024 -175.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.43 110.05 13.15 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.781 1.633 . . . . 0.0 111.977 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 t -112.73 148.73 15.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.816 1.246 . . . . 0.0 110.409 175.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -134.31 162.73 31.36 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 126.323 1.849 . . . . 0.0 110.908 171.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 38.6 t -135.26 101.23 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 C-N-CA 127.453 2.301 . . . . 0.0 108.911 170.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.3 t -73.8 119.22 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 117.937 -1.03 . . . . 0.0 108.637 172.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.9 t80 -147.61 143.32 27.63 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 120.488 1.495 . . . . 0.0 114.666 171.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 20.8 p -76.39 77.95 3.13 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 126.976 2.11 . . . . 0.0 111.344 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -59.76 27.16 0.04 OUTLIER Glycine 0 CA--C 1.539 1.577 0 C-N-CA 129.087 3.232 . . . . 0.0 119.484 -172.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.16 -29.16 68.49 Favored 'General case' 0 CA--C 1.545 0.768 0 CA-C-N 119.915 1.857 . . . . 0.0 115.092 -171.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 23.6 t -154.5 161.73 41.51 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.469 1.108 . . . . 0.0 110.74 173.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 61.8 -15.32 0.06 OUTLIER Glycine 0 CA--C 1.54 1.649 0 C-N-CA 128.249 2.833 . . . . 0.0 118.609 168.157 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -59.19 -52.34 66.11 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.764 1.282 . . . . 0.0 114.283 -163.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -44.55 -54.15 13.13 Favored Pre-proline 0 N--CA 1.475 0.817 0 CA-C-O 116.559 -1.686 . . . . 0.0 114.558 -165.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.06 -39.15 8.26 Favored 'Trans proline' 0 CA--C 1.538 0.707 0 CA-C-N 122.088 1.781 . . . . 0.0 113.949 174.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.7 mmtt -61.81 -33.85 74.87 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 121.832 2.106 . . . . 0.0 111.65 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -68.61 -61.85 1.64 Allowed 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 125.593 1.557 . . . . 0.0 111.474 172.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 6.1 mp -57.29 -39.18 75.2 Favored 'General case' 0 C--O 1.209 -1.029 0 CA-C-O 117.616 -1.183 . . . . 0.0 112.579 -179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.98 -40.31 83.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 121.434 1.924 . . . . 0.0 110.566 -175.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 12.3 tp -59.03 -53.28 60.18 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 118.064 0.393 . . . . 0.0 110.299 166.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -60.7 -61.21 2.76 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 124.829 1.252 . . . . 0.0 112.306 -174.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -44.05 -47.31 8.76 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 125.656 1.582 . . . . 0.0 112.532 177.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.558 ' HE2' ' HA ' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -66.76 -44.44 81.41 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 179.778 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -58.69 -51.9 67.99 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 125.308 1.443 . . . . 0.0 112.13 176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 -61.94 -32.42 72.84 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 171.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.95 -42.33 99.79 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 120.229 1.377 . . . . 0.0 111.723 166.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -60.57 -42.54 96.86 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 124.93 1.292 . . . . 0.0 111.442 -174.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -160.2 85.45 2.01 Favored Pre-proline 0 CA--C 1.547 0.832 0 C-N-CA 125.704 1.602 . . . . 0.0 112.019 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_endo -72.9 137.91 27.67 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 122.287 1.991 . . . . 0.0 111.374 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.02 -3.49 2.15 Favored Glycine 0 CA--C 1.533 1.178 0 N-CA-C 116.8 1.48 . . . . 0.0 116.8 175.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.531 ' HB3' HD21 ' A' ' 84' ' ' LEU . 8.1 m -78.39 -18.07 55.56 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 120.863 -1.375 . . . . 0.0 110.775 150.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -122.56 152.27 40.56 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 128.666 2.786 . . . . 0.0 110.468 176.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -116.49 138.6 51.25 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 128.848 2.859 . . . . 0.0 107.162 154.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -131.84 115.3 27.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 123.976 1.846 . . . . 0.0 108.4 165.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 3.7 m -107.09 -175.09 2.69 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 129.46 3.104 . . . . 0.0 110.911 177.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.86 -176.11 14.29 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 125.074 1.321 . . . . 0.0 110.913 171.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -156.99 151.13 24.98 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 128.109 2.564 . . . . 0.0 104.804 170.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -145.86 64.54 0.44 Allowed Glycine 0 CA--C 1.529 0.915 0 C-N-CA 126.449 1.976 . . . . 0.0 112.239 -177.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 133.3 73.94 Favored Pre-proline 0 CA--C 1.545 0.787 0 C-N-CA 127.249 2.22 . . . . 0.0 113.052 -174.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.72 173.12 8.56 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 123.856 3.038 . . . . 0.0 113.54 -176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 65.51 -27.85 0.11 Allowed 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 128.89 2.876 . . . . 0.0 116.537 173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.24 149.83 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 124.972 1.309 . . . . 0.0 111.501 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 8.0 m -67.64 -39.06 84.63 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 112.863 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 155.85 165.76 14.9 Favored Glycine 0 CA--C 1.528 0.868 0 CA-C-O 121.979 0.766 . . . . 0.0 114.955 171.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -172.69 163.4 5.18 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 129.354 3.062 . . . . 0.0 108.906 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -136.69 94.97 3.06 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.506 1.523 . . . . 0.0 108.216 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -126.11 111.71 14.98 Favored 'General case' 0 CA--C 1.54 0.587 0 O-C-N 121.15 -0.969 . . . . 0.0 111.843 -158.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 31.5 t -105.62 123.06 59.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 O-C-N 121.408 -0.807 . . . . 0.0 110.673 -168.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -130.62 125.71 34.79 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 125.645 1.578 . . . . 0.0 111.258 -165.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 4.4 p -118.38 121.4 67.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 126.144 1.777 . . . . 0.0 109.444 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.09 33.89 2.61 Favored 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 124.616 1.167 . . . . 0.0 113.016 -161.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.18 -8.32 39.6 Favored Glycine 0 CA--C 1.538 1.484 0 C-N-CA 125.475 1.512 . . . . 0.0 115.324 -173.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -71.87 101.47 2.65 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.995 1.397 . . . . 0.0 109.598 174.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.0 tt -58.37 120.05 8.04 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 123.413 0.685 . . . . 0.0 110.713 169.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 12.8 t -100.78 -42.88 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.601 0 CA-C-N 114.637 -1.165 . . . . 0.0 108.677 172.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.414 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 84.6 t60 -118.06 148.47 42.24 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 124.468 1.107 . . . . 0.0 111.166 -174.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB3' ' HB3' ' A' ' 62' ' ' ARG . 47.7 t -153.93 120.35 5.48 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.349 1.059 . . . . 0.0 111.369 175.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 11.9 mmmt -71.2 -29.97 65.81 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 116.402 -1.761 . . . . 0.0 113.537 167.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.2 pttm -70.97 -21.67 62.29 Favored 'General case' 0 N--CA 1.479 1.023 0 CA-C-N 120.155 1.343 . . . . 0.0 113.85 173.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.556 HH21 ' CG ' ' A' ' 64' ' ' ASP . 57.1 ttp180 -73.95 -31.58 63.1 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.733 1.213 . . . . 0.0 112.986 165.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 104.86 15.04 21.54 Favored Glycine 0 C--O 1.225 -0.469 0 C-N-CA 125.277 1.418 . . . . 0.0 114.831 175.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.556 ' CG ' HH21 ' A' ' 62' ' ' ARG . 15.6 t70 -60.97 -28.16 68.79 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 -171.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.84 146.35 0.37 Allowed Glycine 0 CA--C 1.53 0.972 0 C-N-CA 125.286 1.422 . . . . 0.0 112.558 -174.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -62.28 -179.52 0.24 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.391 1.076 . . . . 0.0 112.985 -172.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.268 33.6 m -68.22 92.5 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.506 0 CA-C-O 123.66 1.695 . . . . 0.0 110.68 163.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 -120.0 2.74 11.0 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 127.921 2.488 . . . . 0.0 111.728 -173.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -150.81 161.02 43.47 Favored 'General case' 0 N--CA 1.467 0.408 0 O-C-N 120.681 -1.262 . . . . 0.0 110.158 169.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -51.61 -53.36 39.24 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.858 1.263 . . . . 0.0 109.644 175.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.4 t -58.12 -36.98 73.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.193 -0.912 . . . . 0.0 112.572 -179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -63.61 -53.51 50.36 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 122.117 0.167 . . . . 0.0 110.752 176.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -55.02 -54.89 37.29 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.424 0.69 . . . . 0.0 110.283 176.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 20.0 ttt180 -62.38 -29.33 70.4 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 127.056 2.142 . . . . 0.0 115.309 -176.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.13 -43.63 98.58 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 120.07 1.305 . . . . 0.0 110.413 168.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -75.04 -47.15 30.39 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 123.953 0.901 . . . . 0.0 111.02 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 90.8 t -59.58 -42.68 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 O-C-N 122.237 -0.289 . . . . 0.0 110.866 175.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 58.3 m -66.68 -35.75 80.89 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 118.654 0.661 . . . . 0.0 111.622 178.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.51 -35.03 65.55 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.876 0.695 . . . . 0.0 112.876 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.5 mm -76.59 -33.64 22.71 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.503 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 176.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -68.55 -44.05 75.35 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 119.785 1.175 . . . . 0.0 111.265 178.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -60.8 -56.38 21.92 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.262 174.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.37 -34.16 72.07 Favored 'General case' 0 CA--C 1.531 0.229 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.531 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.6 tm? -65.32 -55.63 17.18 Favored 'General case' 0 CA--C 1.519 -0.246 0 C-N-CA 123.473 0.709 . . . . 0.0 111.486 175.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.59 -20.43 64.72 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 114.244 1.202 . . . . 0.0 114.244 179.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -78.82 -53.05 7.5 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.43 1.492 . . . . 0.0 110.572 171.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 4.8 t -61.44 -25.7 67.39 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 126.125 1.77 . . . . 0.0 113.593 176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.472 0.629 0 O-C-N 121.323 -0.861 . . . . 0.0 113.021 -179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.4 mtp . . . . . 0 N--CA 1.479 0.991 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -72.39 148.67 45.02 Favored 'General case' 0 CA--C 1.544 0.722 0 CA-C-N 119.012 0.824 . . . . 0.0 110.886 163.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.1 tp -82.83 111.2 18.51 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 121.861 -0.524 . . . . 0.0 110.093 -176.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -85.81 113.89 22.32 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.019 1.728 . . . . 0.0 112.171 -171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.3 t -120.26 142.24 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 C-N-CA 124.975 1.31 . . . . 0.0 112.236 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.467 HH11 ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -124.69 161.21 26.83 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 127.612 2.365 . . . . 0.0 110.815 173.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 17.8 t -142.17 115.14 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 C-N-CA 126.255 1.822 . . . . 0.0 108.108 177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.5 t -83.36 124.4 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.069 0 C-N-CA 123.465 0.706 . . . . 0.0 109.453 166.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 17.3 t80 -154.43 155.76 35.54 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 119.705 1.138 . . . . 0.0 113.263 163.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.441 ' HB3' ' H ' ' A' ' 46' ' ' GLY . 69.8 p -68.82 107.17 2.94 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.763 1.225 . . . . 0.0 111.472 166.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -57.98 0.49 0.33 Allowed Glycine 0 CA--C 1.548 2.098 0 N-CA-C 117.325 1.69 . . . . 0.0 117.325 179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.84 -16.76 63.87 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.236 1.814 . . . . 0.0 115.876 -161.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.6 t -127.72 74.85 1.56 Allowed 'General case' 0 CA--C 1.537 0.446 0 O-C-N 121.111 -0.993 . . . . 0.0 111.562 -175.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 54.74 43.57 80.2 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 124.341 0.972 . . . . 0.0 113.977 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -60.48 -46.08 91.41 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 115.205 1.557 . . . . 0.0 115.205 -167.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.8 mmtm -45.61 -58.95 5.14 Favored Pre-proline 0 N--CA 1.475 0.798 0 CA-C-O 116.496 -1.716 . . . . 0.0 115.094 -173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -67.15 -29.69 39.18 Favored 'Trans proline' 0 CA--C 1.538 0.701 0 CA-C-N 122.165 1.809 . . . . 0.0 113.676 178.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.97 -44.58 76.37 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 119.316 0.962 . . . . 0.0 111.773 175.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.9 m-30 -57.86 -52.97 63.28 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.613 1.165 . . . . 0.0 111.139 169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 75.5 mt -59.01 -38.09 78.43 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 117.349 -1.31 . . . . 0.0 112.736 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -55.01 -51.74 65.31 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-N 121.511 1.959 . . . . 0.0 110.904 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 61.1 tp -61.68 -50.33 72.91 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-O 119.498 -0.287 . . . . 0.0 110.674 171.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.62 -49.05 74.82 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -170.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -43.58 -45.65 6.8 Favored 'General case' 0 C--O 1.22 -0.477 0 C-N-CA 126.818 2.047 . . . . 0.0 112.136 170.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -64.87 -52.7 55.15 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 118.939 0.79 . . . . 0.0 112.914 177.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.482 ' HB3' HD11 ' A' ' 36' ' ' ILE . 2.5 mm? -53.7 -52.38 60.24 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 125.141 1.376 . . . . 0.0 113.697 177.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 -68.96 -29.29 67.49 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.108 1.522 . . . . 0.0 115.108 173.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -64.6 -43.49 93.63 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.001 1.273 . . . . 0.0 112.165 166.566 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.77 -36.99 70.53 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.164 1.385 . . . . 0.0 112.042 -175.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -130.74 49.73 5.14 Favored Pre-proline 0 CA--C 1.554 1.13 0 C-N-CA 125.918 1.687 . . . . 0.0 113.717 -172.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.05 126.44 17.97 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 123.48 2.787 . . . . 0.0 112.697 -164.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.04 -0.39 0.05 OUTLIER Glycine 0 CA--C 1.535 1.296 0 C-N-CA 126.616 2.055 . . . . 0.0 117.328 -172.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.482 ' HB3' HD21 ' A' ' 84' ' ' LEU . 4.0 m -79.89 -13.16 59.58 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.609 1.164 . . . . 0.0 110.295 164.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.15 161.33 33.59 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 126.609 1.963 . . . . 0.0 113.121 -174.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.65 137.2 51.53 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 128.034 2.534 . . . . 0.0 109.462 162.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.482 HD11 ' HB3' ' A' ' 26' ' ' LEU . 0.8 OUTLIER -137.72 117.38 15.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-O 123.159 1.457 . . . . 0.0 108.372 161.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.467 ' HB2' HH11 ' A' ' 6' ' ' ARG . 84.4 m -113.41 176.76 4.89 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 113.762 -1.563 . . . . 0.0 110.633 166.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.62 175.52 20.19 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.682 1.134 . . . . 0.0 111.752 174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -154.94 139.84 17.26 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 130.729 3.612 . . . . 0.0 106.478 -162.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -153.98 61.22 0.38 Allowed Glycine 0 CA--C 1.536 1.355 0 C-N-CA 126.641 2.067 . . . . 0.0 114.387 -176.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.0 t -52.54 120.83 19.31 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.149 1.38 . . . . 0.0 113.418 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -77.14 55.2 4.94 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.697 3.598 . . . . 0.0 111.673 -174.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -136.67 -55.42 0.73 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 127.597 2.359 . . . . 0.0 110.182 -172.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 25.8 t -142.65 -72.92 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.48 1.03 0 C-N-CA 124.296 1.038 . . . . 0.0 111.527 174.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 75.7 p 49.76 -104.56 0.15 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 126.105 1.762 . . . . 0.0 113.107 -161.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 10' ' ' SER . . . 69.68 -55.0 0.72 Allowed Glycine 0 N--CA 1.475 1.241 0 C-N-CA 127.83 2.633 . . . . 0.0 113.868 -177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -57.56 152.74 14.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 126.166 1.786 . . . . 0.0 111.706 166.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -122.52 102.72 8.25 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 126.568 1.947 . . . . 0.0 108.304 177.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -129.36 132.26 47.03 Favored 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 124.745 1.218 . . . . 0.0 110.581 -162.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 58.7 t -121.89 127.09 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-N 120.554 1.525 . . . . 0.0 111.403 -177.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -123.37 126.2 46.4 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 125.302 1.441 . . . . 0.0 111.703 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.6 p -114.61 127.23 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 127.444 2.298 . . . . 0.0 109.51 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.12 33.01 0.73 Allowed 'General case' 0 CA--C 1.557 1.215 0 C-N-CA 125.071 1.348 . . . . 0.0 114.618 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 81.38 22.35 60.65 Favored Glycine 0 CA--C 1.537 1.433 0 O-C-N 120.753 -1.217 . . . . 0.0 114.942 -175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 65.5 mmtt -125.53 114.57 18.94 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 127.575 2.35 . . . . 0.0 110.014 -178.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 6.5 tt -70.67 128.72 37.06 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-O 121.634 0.731 . . . . 0.0 112.014 176.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 51.2 t -120.58 -19.51 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 125.415 1.486 . . . . 0.0 112.176 -178.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -135.0 147.55 49.73 Favored 'General case' 0 CA--C 1.521 -0.156 0 CA-C-O 121.609 0.718 . . . . 0.0 111.856 171.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 35.4 t -158.0 111.23 2.44 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.048 1.739 . . . . 0.0 110.638 166.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.506 ' HE3' ' CG ' ' A' ' 66' ' ' TYR . 31.8 mmtt -62.47 -26.94 68.79 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 120.706 -1.246 . . . . 0.0 112.564 162.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmmm? -65.11 -40.35 94.41 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 119.61 1.095 . . . . 0.0 113.704 174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 8.0 ptt180 -71.33 -23.07 61.86 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.03 31.66 9.65 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 123.44 0.543 . . . . 0.0 113.483 -170.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 26.7 t0 -61.04 -46.46 90.61 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-N 117.567 0.683 . . . . 0.0 112.082 172.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 79.9 147.42 4.51 Favored Glycine 0 CA--C 1.541 1.707 0 CA-C-N 116.395 -0.366 . . . . 0.0 113.024 -160.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.506 ' CG ' ' HE3' ' A' ' 60' ' ' LYS . 31.2 m-85 -63.34 -153.57 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 129.738 3.215 . . . . 0.0 112.142 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 m -62.65 43.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-O 124.454 2.074 . . . . 0.0 115.159 142.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.493 ' H ' ' C ' ' A' ' 66' ' ' TYR . 54.0 m-20 -64.7 -0.38 1.42 Allowed 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 128.249 2.62 . . . . 0.0 112.629 172.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 1.6 m -158.24 168.36 27.24 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 127.97 2.508 . . . . 0.0 108.942 166.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.01 -53.42 58.31 Favored 'General case' 0 N--CA 1.477 0.875 0 CA-C-O 122.251 1.024 . . . . 0.0 110.112 168.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 14.7 t -54.39 -37.92 65.59 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 123.369 1.557 . . . . 0.0 111.893 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.84 -29.06 62.92 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 127.064 2.145 . . . . 0.0 114.208 -176.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -71.19 -60.92 1.97 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.314 1.446 . . . . 0.0 112.375 157.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 11.9 ttm180 -53.02 -29.85 31.92 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 128.165 2.586 . . . . 0.0 113.785 -172.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.1 pptp? -59.68 -35.45 74.48 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.923 1.689 . . . . 0.0 111.541 173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.0 tt -80.03 -49.76 11.33 Favored 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 124.503 1.121 . . . . 0.0 110.677 175.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.1 t -53.88 -45.1 62.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 CA-C-O 121.869 0.842 . . . . 0.0 110.87 -179.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 28.5 m -67.19 -39.63 86.38 Favored 'General case' 0 CA--C 1.513 -0.445 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.061 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.06 -31.44 50.26 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 112.939 0.718 . . . . 0.0 112.939 -176.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.3 mm -74.09 -34.55 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 176.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 tmmm? -67.18 -43.95 80.89 Favored 'General case' 0 C--O 1.222 -0.362 0 CA-C-N 118.983 0.81 . . . . 0.0 110.239 178.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.07 -50.31 72.46 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 124.889 1.275 . . . . 0.0 111.6 179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.36 91.29 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-O 121.499 0.666 . . . . 0.0 112.169 174.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.482 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.9 tm? -62.76 -50.56 70.56 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.882 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -61.47 -19.45 62.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -177.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . 0.263 0.0 OUTLIER -95.07 -29.04 14.8 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 173.039 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 3.0 t -69.3 -25.06 64.05 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.243 1.417 . . . . 0.0 112.43 167.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 114.376 1.25 . . . . 0.0 114.376 175.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptm . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 118.268 -0.872 . . . . 0.0 109.688 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.39 172.37 7.18 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.278 1.031 . . . . 0.0 111.281 167.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.46 168.93 8.9 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.516 1.526 . . . . 0.0 108.983 169.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.33 119.91 22.38 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.804 2.042 . . . . 0.0 110.7 174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 33.9 t -112.61 151.92 14.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 125.012 1.325 . . . . 0.0 108.995 178.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 85.5 mmt-85 -134.58 152.65 51.93 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 125.402 1.481 . . . . 0.0 112.103 -177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -139.42 90.42 0.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.373 0 C-N-CA 125.854 1.661 . . . . 0.0 107.168 -177.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.6 t -78.06 113.26 17.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 173.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -142.73 -176.25 4.8 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.905 1.282 . . . . 0.0 110.597 172.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.3 t -110.74 162.54 14.66 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 125.036 1.334 . . . . 0.0 112.94 -173.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.16 27.22 2.06 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 126.694 2.093 . . . . 0.0 114.612 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.64 17.37 0.03 OUTLIER 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 127.563 2.345 . . . . 0.0 115.993 -168.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.7 t 55.44 -178.59 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 126.079 1.752 . . . . 0.0 112.279 -159.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 65.63 -30.92 0.13 Allowed Glycine 0 CA--C 1.541 1.661 0 C-N-CA 127.101 2.286 . . . . 0.0 117.06 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -57.96 -41.44 82.91 Favored 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.835 1.654 . . . . 0.0 114.422 -167.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -46.84 -54.77 17.79 Favored Pre-proline 0 N--CA 1.479 0.999 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 -167.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -67.43 -38.62 14.41 Favored 'Trans proline' 0 CA--C 1.534 0.484 0 CA-C-N 122.023 1.758 . . . . 0.0 113.73 174.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.0 tmtt? -63.34 -37.14 86.12 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 121.729 2.059 . . . . 0.0 111.254 175.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 42.3 t80 -59.46 -58.99 6.21 Favored 'General case' 0 C--O 1.223 -0.31 0 C-N-CA 126.623 1.969 . . . . 0.0 110.193 174.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 5.5 mp -54.48 -44.17 72.4 Favored 'General case' 0 C--O 1.213 -0.825 0 C-N-CA 123.303 0.641 . . . . 0.0 111.372 174.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.2 tm0? -65.95 -29.13 69.49 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 120.454 1.479 . . . . 0.0 112.513 -174.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 58.2 tp -71.35 -52.26 19.71 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.08 0.952 . . . . 0.0 112.434 160.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.97 -55.03 12.15 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 124.153 0.981 . . . . 0.0 112.377 -167.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -41.74 -47.48 4.06 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 126.102 1.761 . . . . 0.0 111.843 171.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.86 -43.44 98.79 Favored 'General case' 0 N--CA 1.467 0.391 0 N-CA-C 113.048 0.758 . . . . 0.0 113.048 -176.178 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -71.06 -44.91 64.82 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.47 1.508 . . . . 0.0 112.133 -178.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -61.26 -39.38 90.16 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 125.043 1.337 . . . . 0.0 114.028 169.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.82 -42.12 97.72 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.474 1.11 . . . . 0.0 112.026 171.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.38 -33.3 74.93 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.836 0.854 . . . . 0.0 112.88 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -135.61 65.61 61.75 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 126.448 1.899 . . . . 0.0 112.764 -173.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -65.31 134.54 39.37 Favored 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 121.33 1.353 . . . . 0.0 111.182 -175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 64.76 -23.71 0.1 Allowed Glycine 0 N--CA 1.476 1.365 0 C-N-CA 127.732 2.586 . . . . 0.0 117.595 172.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.587 ' CB ' HD21 ' A' ' 84' ' ' LEU . 17.8 m -72.76 -8.32 54.87 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 126.945 2.098 . . . . 0.0 111.563 170.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.63 157.97 43.79 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-O 123.02 1.39 . . . . 0.0 112.493 -173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -124.55 149.88 46.49 Favored 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 130.174 3.39 . . . . 0.0 108.447 166.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.4 mp -138.04 126.68 32.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 C-N-CA 125.157 1.383 . . . . 0.0 108.365 156.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 18.0 m -118.87 172.32 7.61 Favored 'General case' 0 C--N 1.318 -0.771 0 C-N-CA 126.127 1.771 . . . . 0.0 111.44 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.96 139.5 7.77 Favored Glycine 0 CA--C 1.522 0.498 0 O-C-N 120.535 -1.353 . . . . 0.0 110.698 177.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -141.17 91.75 2.42 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 -157.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -85.47 47.55 3.84 Favored Glycine 0 CA--C 1.53 0.996 0 CA-C-N 113.932 -1.486 . . . . 0.0 115.893 -149.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.1 m -118.65 58.42 3.56 Favored Pre-proline 0 CA--C 1.552 1.035 0 C-N-CA 124.744 1.218 . . . . 0.0 113.284 -168.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -79.8 93.12 1.07 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.772 2.981 . . . . 0.0 109.961 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -64.14 32.2 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.252 0 C-N-CA 128.134 2.574 . . . . 0.0 116.026 -174.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 64.8 t -134.75 -69.05 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.864 2.065 . . . . 0.0 108.84 168.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 29.4 p -149.41 -65.96 0.22 Allowed 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.2 1.4 . . . . 0.0 112.81 177.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 176.25 60.02 0.06 OUTLIER Glycine 0 CA--C 1.526 0.759 0 C-N-CA 124.419 1.009 . . . . 0.0 114.409 -173.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -61.97 149.3 41.14 Favored 'General case' 0 CA--C 1.547 0.855 0 CA-C-O 119.101 -0.476 . . . . 0.0 111.082 156.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.516 ' H ' ' HB2' ' A' ' 60' ' ' LYS . 23.6 t80 -122.4 98.32 5.87 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 126.917 2.087 . . . . 0.0 108.139 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mm-40 -125.71 112.95 16.69 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -158.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.66 131.84 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.957 0 CA-C-O 121.246 0.546 . . . . 0.0 110.157 -171.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -129.12 144.93 51.37 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.349 1.46 . . . . 0.0 110.367 -175.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.4 p -129.45 120.87 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.607 1.563 . . . . 0.0 110.203 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 46.98 31.8 1.65 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.653 1.581 . . . . 0.0 114.742 -170.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.97 9.5 80.56 Favored Glycine 0 CA--C 1.54 1.623 0 O-C-N 120.167 -1.583 . . . . 0.0 115.363 -174.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -97.19 102.57 14.38 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.61 1.564 . . . . 0.0 109.528 170.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.9 tp -60.49 126.78 28.73 Favored 'General case' 0 C--N 1.333 -0.137 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 168.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.5 t -106.92 -25.64 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 O-C-N 124.019 0.824 . . . . 0.0 110.759 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 43.6 t60 -151.65 149.29 28.95 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.33 0.652 . . . . 0.0 111.285 -155.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.508 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 8.9 t -164.07 98.98 0.85 Allowed 'General case' 0 C--O 1.239 0.54 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -168.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.516 ' HB2' ' H ' ' A' ' 48' ' ' PHE . 2.8 mmmt -49.4 -37.7 26.18 Favored 'General case' 0 N--CA 1.474 0.755 0 O-C-N 120.108 -1.62 . . . . 0.0 113.201 165.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.1 pptp? -77.93 -23.67 48.53 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.216 1.932 . . . . 0.0 116.216 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -77.04 -12.29 59.92 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 120.703 1.592 . . . . 0.0 113.17 168.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.53 12.32 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.098 1.333 . . . . 0.0 114.321 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -76.56 -20.16 57.14 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.74 -175.33 22.68 Favored Glycine 0 C--N 1.341 0.808 0 N-CA-C 110.265 -1.134 . . . . 0.0 110.265 -162.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -79.78 177.79 8.65 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 123.704 0.802 . . . . 0.0 109.684 162.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.252 23.7 m -76.02 106.13 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 O-C-N 119.707 -1.87 . . . . 0.0 110.42 163.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -125.34 -5.47 7.18 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.723 -2.035 . . . . 0.0 112.846 -166.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -142.18 156.87 45.36 Favored 'General case' 0 CA--C 1.51 -0.577 0 O-C-N 121.357 -0.839 . . . . 0.0 109.028 175.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.12 -50.7 61.16 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 122.741 1.258 . . . . 0.0 110.274 177.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.2 t -64.93 -19.14 65.79 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.782 1.401 . . . . 0.0 114.782 -178.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.6 ttmt -84.67 -47.85 10.07 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.103 0.961 . . . . 0.0 112.709 166.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -54.2 -45.38 72.19 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.443 1.497 . . . . 0.0 111.825 178.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -62.73 -24.83 67.88 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -179.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.0 mmtm -60.69 -44.15 96.87 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 125.162 1.385 . . . . 0.0 110.452 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 16.1 tp -76.97 -47.78 19.86 Favored 'General case' 0 CA--C 1.519 -0.216 0 C-N-CA 122.743 0.417 . . . . 0.0 111.882 178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 t -53.05 -46.68 54.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.332 175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.6 m -68.33 -37.33 80.44 Favored 'General case' 0 N--CA 1.465 0.279 0 O-C-N 121.281 -0.887 . . . . 0.0 112.244 178.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.08 -30.65 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 -175.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 25.1 mm -80.75 -30.05 11.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 108.459 -0.941 . . . . 0.0 108.459 178.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 15.1 ttmm -65.63 -44.17 87.27 Favored 'General case' 0 N--CA 1.476 0.869 0 O-C-N 121.057 -1.027 . . . . 0.0 111.262 174.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.73 -49.76 71.77 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.04 1.336 . . . . 0.0 110.983 175.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -55.36 -41.39 72.48 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.097 0.559 . . . . 0.0 112.425 174.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.587 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.4 tm? -66.79 -53.12 36.21 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 124.468 1.107 . . . . 0.0 111.439 -179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -64.59 -17.59 64.12 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 177.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -86.64 -46.07 10.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.044 1.337 . . . . 0.0 110.845 173.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 41.4 t -57.54 -38.48 74.79 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 127.532 2.333 . . . . 0.0 113.426 172.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.506 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -174.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.6 ttt . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 106.165 -1.791 . . . . 0.0 106.165 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.99 179.2 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.096 0 C-N-CA 124.084 0.954 . . . . 0.0 113.061 -149.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 34' ' ' LEU . 11.1 tp -141.5 124.74 16.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 127.362 2.265 . . . . 0.0 110.572 174.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -86.65 105.69 17.07 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.193 1.397 . . . . 0.0 113.272 -170.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.1 t -89.38 139.96 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 O-C-N 121.295 -0.878 . . . . 0.0 108.801 166.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 37' ' ' CYS . 1.1 mpt_? -124.8 160.89 27.68 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 125.236 1.414 . . . . 0.0 108.5 164.257 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.7 t -133.48 101.83 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 C-N-CA 126.045 1.738 . . . . 0.0 108.152 176.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 t -71.17 122.43 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.669 0 CA-C-O 117.946 -1.026 . . . . 0.0 109.195 172.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -142.08 154.55 45.02 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.537 1.062 . . . . 0.0 112.187 170.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 12.1 t -70.17 110.52 5.23 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.008 -0.432 . . . . 0.0 109.992 169.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -63.55 24.76 0.08 OUTLIER Glycine 0 CA--C 1.543 1.831 0 C-N-CA 126.739 2.114 . . . . 0.0 117.835 -169.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.97 40.42 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 129.633 3.173 . . . . 0.0 116.38 -173.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 2.4 t 57.43 -178.44 0.06 Allowed 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 127.028 2.131 . . . . 0.0 114.241 -174.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 64.23 -19.89 0.1 OUTLIER Glycine 0 CA--C 1.543 1.826 0 C-N-CA 126.302 1.906 . . . . 0.0 116.724 -173.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 55.4 p90 -62.39 -39.46 93.3 Favored 'General case' 0 C--O 1.221 -0.398 0 C-N-CA 125.214 1.406 . . . . 0.0 114.311 -174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -48.98 -59.75 5.83 Favored Pre-proline 0 N--CA 1.48 1.073 0 N-CA-C 115.404 1.631 . . . . 0.0 115.404 -172.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -68.2 -29.59 32.46 Favored 'Trans proline' 0 CA--C 1.538 0.679 0 CA-C-N 122.197 1.82 . . . . 0.0 113.38 177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -64.49 -45.18 88.42 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 119.877 1.217 . . . . 0.0 112.049 173.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -55.27 -59.33 4.94 Favored 'General case' 0 C--O 1.224 -0.278 0 C-N-CA 125.448 1.499 . . . . 0.0 109.878 170.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.0 mt -53.69 -42.58 68.13 Favored 'General case' 0 C--O 1.215 -0.742 0 CA-C-O 118.165 -0.921 . . . . 0.0 113.019 -178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.9 tm0? -58.92 -41.24 86.83 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 120.161 1.346 . . . . 0.0 112.182 -178.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 60.5 tp -69.07 -49.14 60.03 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.424 0.69 . . . . 0.0 111.701 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.4 -51.84 64.13 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 125.023 1.329 . . . . 0.0 111.848 -169.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -41.88 -48.52 4.43 Favored 'General case' 0 C--O 1.221 -0.428 0 C-N-CA 126.125 1.77 . . . . 0.0 112.248 168.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.55 -46.15 87.27 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.707 0.803 . . . . 0.0 112.658 -178.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.451 ' HB3' HD11 ' A' ' 36' ' ' ILE . 4.4 mp -62.22 -59.8 4.51 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 126.62 1.968 . . . . 0.0 111.448 178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -63.24 -26.85 68.98 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 175.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -62.49 -46.09 90.03 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 119.717 1.144 . . . . 0.0 111.475 164.042 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -71.77 -38.4 70.36 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.375 1.07 . . . . 0.0 112.716 -174.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.9 p90 -143.48 61.18 9.58 Favored Pre-proline 0 CA--C 1.546 0.82 0 C-N-CA 125.226 1.411 . . . . 0.0 113.856 -175.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -66.27 135.53 40.3 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 122.238 1.959 . . . . 0.0 110.749 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 67.3 -24.97 0.21 Allowed Glycine 0 N--CA 1.476 1.331 0 C-N-CA 125.765 1.65 . . . . 0.0 116.261 177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 36.5 m -60.5 -21.04 61.98 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.902 1.681 . . . . 0.0 111.977 161.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.435 ' HA ' ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -153.37 166.74 31.69 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 127.124 2.17 . . . . 0.0 112.623 -173.45 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -131.42 153.29 49.86 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.449 1.5 . . . . 0.0 110.566 167.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.451 HD11 ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -136.89 111.4 9.93 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 CA-C-O 123.837 1.779 . . . . 0.0 109.433 166.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 6' ' ' ARG . 1.3 m -98.94 -178.15 3.86 Favored 'General case' 0 C--N 1.317 -0.811 0 C-N-CA 126.846 2.058 . . . . 0.0 112.077 167.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.17 171.76 18.69 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 126.199 1.857 . . . . 0.0 112.14 167.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -138.82 96.25 3.1 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.551 2.34 . . . . 0.0 107.748 168.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.76 62.38 2.28 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 124.517 1.056 . . . . 0.0 113.504 -170.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.3 t -48.54 147.1 4.42 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 128.493 2.717 . . . . 0.0 113.541 173.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -82.39 -156.17 0.07 OUTLIER 'Trans proline' 0 CA--C 1.553 1.443 0 C-N-CA 124.474 3.449 . . . . 0.0 113.828 -176.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 29.8 pt20 -48.65 168.53 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 127.277 2.231 . . . . 0.0 114.909 174.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 t 67.5 -43.32 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 C-N-CA 127.627 2.371 . . . . 0.0 112.931 -169.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.1 p -73.74 151.64 40.6 Favored 'General case' 0 N--CA 1.474 0.74 0 O-C-N 121.06 -1.025 . . . . 0.0 111.876 166.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -170.25 54.76 0.19 Allowed Glycine 0 N--CA 1.471 0.987 0 C-N-CA 123.604 0.621 . . . . 0.0 112.682 -169.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 1.5 p90 -150.41 162.98 39.51 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.919 1.688 . . . . 0.0 110.578 -171.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -134.8 97.56 3.8 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 126.06 1.744 . . . . 0.0 109.304 -171.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -128.97 116.71 19.77 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 123.661 0.784 . . . . 0.0 110.564 -155.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.42 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 40.3 t -109.2 117.47 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.153 0 CA-C-N 118.706 0.684 . . . . 0.0 110.124 -169.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -128.39 133.99 48.72 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 123.951 0.9 . . . . 0.0 110.471 -175.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.7 p -119.13 122.07 68.28 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 127.1 2.16 . . . . 0.0 110.34 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.67 35.88 0.75 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.954 1.302 . . . . 0.0 114.242 -175.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.42 37.79 35.07 Favored Glycine 0 CA--C 1.536 1.398 0 O-C-N 120.767 -1.208 . . . . 0.0 114.75 -176.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 8.6 mmtt -135.62 110.71 8.9 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 128.254 2.621 . . . . 0.0 109.206 176.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.9 tt -74.19 136.31 42.8 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 121.316 -0.865 . . . . 0.0 111.039 178.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.5 t -123.44 -15.53 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 C-N-CA 125.028 1.331 . . . . 0.0 111.746 -178.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.42 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 78.6 t60 -149.58 153.47 37.17 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.515 1.926 . . . . 0.0 112.875 177.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 47.4 t -161.83 111.72 1.57 Allowed 'General case' 0 C--O 1.239 0.507 0 C-N-CA 126.121 1.768 . . . . 0.0 111.488 175.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.12 -29.6 70.72 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 119.909 -1.744 . . . . 0.0 113.245 164.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 7.1 ttpm? -57.65 -46.71 83.86 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 124.815 1.246 . . . . 0.0 112.574 175.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -19.95 55.15 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 114.117 1.154 . . . . 0.0 114.117 179.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.34 23.75 10.11 Favored Glycine 0 CA--C 1.527 0.788 0 CA-C-O 118.845 -0.975 . . . . 0.0 115.328 -174.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -59.29 -39.38 82.79 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 119.038 1.419 . . . . 0.0 111.613 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 66.62 151.26 0.16 Allowed Glycine 0 C--N 1.343 0.958 0 C-N-CA 126.397 1.951 . . . . 0.0 114.289 176.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 40.5 m-85 -61.49 -178.21 0.12 Allowed 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.981 0.913 . . . . 0.0 113.244 -178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.282 34.6 m -81.49 75.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 CA-C-O 124.271 1.986 . . . . 0.0 113.334 -166.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -65.68 -21.6 66.56 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 128.222 2.609 . . . . 0.0 111.402 176.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.76 156.32 45.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.365 1.066 . . . . 0.0 110.529 173.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -46.21 -52.37 12.53 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.306 1.442 . . . . 0.0 110.993 164.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.4 t -41.83 -45.9 3.77 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.108 1.763 . . . . 0.0 112.866 172.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.9 ttmt -76.61 -27.84 55.9 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 -176.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -68.16 -57.77 5.51 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-O 121.252 0.549 . . . . 0.0 110.779 163.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.3 mtp180 -64.66 -20.71 66.45 Favored 'General case' 0 C--O 1.223 -0.316 0 CA-C-O 116.9 -1.524 . . . . 0.0 113.708 -175.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.64 -23.69 65.37 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 122.024 2.193 . . . . 0.0 111.607 174.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.6 tt -90.49 -52.12 5.06 Favored 'General case' 0 CA--C 1.508 -0.664 0 CA-C-O 118.992 -0.528 . . . . 0.0 111.128 171.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 74.1 t -58.75 -44.1 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 119.214 -0.994 . . . . 0.0 111.471 -177.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 23.9 m -65.7 -35.98 82.3 Favored 'General case' 0 N--CA 1.466 0.339 0 O-C-N 121.782 -0.574 . . . . 0.0 111.738 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.36 -33.27 72.82 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 119.74 -0.784 . . . . 0.0 112.699 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 45.3 mm -73.67 -34.64 41.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.549 174.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -70.24 -36.36 74.44 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.963 1.305 . . . . 0.0 110.969 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.31 -50.99 61.74 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.556 1.142 . . . . 0.0 110.843 175.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -56.89 -40.48 76.32 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 123.33 0.652 . . . . 0.0 112.459 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 14.5 tp -62.75 -57.29 11.47 Favored 'General case' 0 C--O 1.222 -0.36 0 C-N-CA 124.391 1.077 . . . . 0.0 111.428 176.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.29 -20.02 16.82 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -85.3 -41.28 15.68 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 126.065 1.746 . . . . 0.0 112.299 172.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 95.7 m -69.94 -25.7 63.78 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.485 1.914 . . . . 0.0 114.16 172.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 . . . . . 0 N--CA 1.476 0.874 0 CA-C-N 119.518 1.054 . . . . 0.0 113.11 -174.845 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.0 ttt . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 118.5 -0.762 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -127.83 164.46 22.15 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 126.256 1.823 . . . . 0.0 109.898 158.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.3 tp -116.27 111.69 20.51 Favored 'General case' 0 N--CA 1.468 0.466 0 O-C-N 121.363 -0.835 . . . . 0.0 112.237 -167.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.23 117.89 17.54 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.212 1.405 . . . . 0.0 112.155 177.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG22 HG23 ' A' ' 52' ' ' VAL . 20.7 t -117.86 141.9 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.642 0 C-N-CA 125.024 1.33 . . . . 0.0 110.506 171.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 84.1 mmt-85 -127.97 154.97 44.98 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.021 1.729 . . . . 0.0 110.309 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 6.2 t -134.76 110.64 13.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 C-N-CA 125.15 1.38 . . . . 0.0 107.57 163.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.6 p -86.69 137.25 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 164.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -159.13 -168.85 2.46 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.739 1.216 . . . . 0.0 110.018 168.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 94.1 p -107.13 162.71 13.62 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 126.182 1.793 . . . . 0.0 111.526 171.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -78.78 1.51 72.98 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-O 118.372 -1.238 . . . . 0.0 115.188 179.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -41.98 -49.83 4.62 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 127.21 2.204 . . . . 0.0 115.694 -157.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.7 t -151.98 153.12 33.42 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.991 0.517 . . . . 0.0 110.492 162.185 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.89 4.61 1.03 Allowed Glycine 0 CA--C 1.539 1.589 0 N-CA-C 118.645 2.218 . . . . 0.0 118.645 167.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.7 p90 -55.21 -52.52 63.1 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 120.113 1.957 . . . . 0.0 114.799 -162.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 21.4 mtpp -50.83 -59.08 8.18 Favored Pre-proline 0 N--CA 1.481 1.092 0 N-CA-C 114.99 1.478 . . . . 0.0 114.99 -176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -67.49 -32.74 31.05 Favored 'Trans proline' 0 C--N 1.35 0.625 0 CA-C-N 122.025 1.759 . . . . 0.0 113.211 175.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 3.2 tmtp? -60.06 -46.8 88.34 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-N 120.209 1.368 . . . . 0.0 110.478 174.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -55.03 -56.06 23.95 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 126.019 1.728 . . . . 0.0 111.479 172.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 72.1 mt -53.99 -41.66 68.17 Favored 'General case' 0 C--O 1.213 -0.864 0 C-N-CA 123.859 0.864 . . . . 0.0 112.637 -179.125 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.42 -38.42 91.06 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 119.464 1.029 . . . . 0.0 111.574 -176.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 7.6 tt -71.26 -48.67 49.65 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.368 1.067 . . . . 0.0 111.637 170.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.465 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 3.1 mmmt -56.84 -60.03 4.16 Favored 'General case' 0 C--N 1.343 0.326 0 C-N-CA 126.789 2.036 . . . . 0.0 111.806 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.552 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 1.5 tm-20 -42.3 -48.42 5.0 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 126.085 1.754 . . . . 0.0 112.553 175.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.552 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -61.2 -49.9 75.29 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.913 0.885 . . . . 0.0 112.598 179.013 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.7 mp -56.64 -56.49 20.76 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.808 2.043 . . . . 0.0 112.009 176.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.465 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 2.3 mt-10 -57.4 -33.61 68.03 Favored 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 125.29 1.436 . . . . 0.0 114.573 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -64.18 -41.51 97.08 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 120.271 1.396 . . . . 0.0 111.99 166.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HG3' ' HE2' ' A' ' 81' ' ' LYS . 4.6 tp10 -68.88 -35.68 77.18 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.897 1.679 . . . . 0.0 113.379 -173.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -149.35 73.46 9.94 Favored Pre-proline 0 CA--C 1.554 1.107 0 C-N-CA 126.189 1.796 . . . . 0.0 112.481 178.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -69.15 142.72 51.42 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.528 2.818 . . . . 0.0 113.714 -172.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 66.13 -25.32 0.15 Allowed Glycine 0 N--CA 1.473 1.148 0 C-N-CA 128.498 2.952 . . . . 0.0 117.749 167.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.464 ' HB3' HD21 ' A' ' 84' ' ' LEU . 19.1 m -69.3 -17.09 63.69 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.86 1.264 . . . . 0.0 111.378 167.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -112.93 144.78 41.92 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 126.394 1.878 . . . . 0.0 110.028 177.142 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -100.16 137.6 38.38 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 126.973 2.109 . . . . 0.0 107.314 151.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 9.6 mt -140.82 111.52 3.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-O 123.619 1.676 . . . . 0.0 107.633 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 23.2 m -117.45 175.96 5.38 Favored 'General case' 0 C--N 1.311 -1.081 0 C-N-CA 127.56 2.344 . . . . 0.0 110.834 178.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -129.45 176.97 18.3 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 124.929 1.252 . . . . 0.0 111.189 168.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -151.71 173.83 14.24 Favored 'General case' 0 N--CA 1.442 -0.839 0 C-N-CA 127.253 2.221 . . . . 0.0 108.918 175.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -170.81 38.14 0.18 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 126.79 2.138 . . . . 0.0 114.803 -175.273 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -64.58 147.76 97.33 Favored Pre-proline 0 N--CA 1.476 0.834 0 CA-C-N 118.708 1.254 . . . . 0.0 114.082 -172.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -77.71 63.97 8.08 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.932 3.088 . . . . 0.0 112.882 -171.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.6 mm-40 -135.4 -83.91 0.4 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.904 1.682 . . . . 0.0 111.284 178.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.6 t -118.98 7.77 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 C-N-CA 124.642 1.177 . . . . 0.0 112.376 -168.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.7 0.55 0.13 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 119.063 2.986 . . . . 0.0 119.063 -154.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.56 -20.02 67.51 Favored Glycine 0 CA--C 1.54 1.62 0 O-C-N 119.272 -2.143 . . . . 0.0 114.001 172.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.9 m-30 -62.96 104.7 0.58 Allowed 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.443 1.497 . . . . 0.0 111.132 169.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.58 95.08 0.46 Allowed 'General case' 0 N--CA 1.473 0.708 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 162.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -123.57 120.88 34.14 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 118.366 0.53 . . . . 0.0 110.977 -172.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.1 t -108.9 123.32 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 CA-C-N 118.792 0.724 . . . . 0.0 109.844 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.07 139.05 52.75 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 124.247 1.019 . . . . 0.0 109.884 -171.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 5' ' ' VAL . 11.8 p -126.25 131.16 71.84 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.89 1.676 . . . . 0.0 109.642 174.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.93 30.81 0.44 Allowed 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -176.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.06 14.68 57.34 Favored Glycine 0 CA--C 1.539 1.563 0 N-CA-C 115.915 1.126 . . . . 0.0 115.915 -177.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 24.4 mtmt -127.08 124.11 38.49 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 119.417 1.608 . . . . 0.0 113.612 -176.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.4 tt -57.31 133.53 55.19 Favored 'General case' 0 N--CA 1.468 0.425 0 C-N-CA 125.303 1.441 . . . . 0.0 111.187 172.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.75 -20.02 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.591 1.157 . . . . 0.0 112.133 173.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 2.5 t60 -148.13 141.7 25.46 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 126.688 1.995 . . . . 0.0 109.18 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 16.3 t -164.09 105.54 0.9 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.317 0.488 . . . . 0.0 112.317 -168.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HE2' ' N ' ' A' ' 66' ' ' TYR . 55.0 mmtt -71.33 -21.05 62.1 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 120.478 -1.389 . . . . 0.0 112.922 159.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 -9.5 59.4 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 179.323 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ppt_? -104.53 -22.84 13.21 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.702 1.601 . . . . 0.0 113.628 168.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 88.85 45.74 4.75 Favored Glycine 0 CA--C 1.527 0.789 0 O-C-N 123.384 0.428 . . . . 0.0 113.005 -165.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -83.62 -38.25 21.82 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 121.972 -0.722 . . . . 0.0 112.226 164.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.33 178.93 20.77 Favored Glycine 0 CA--C 1.538 1.487 0 C-N-CA 125.679 1.609 . . . . 0.0 112.684 -171.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.564 ' N ' ' HE2' ' A' ' 60' ' ' LYS . 6.9 m-85 -84.83 -157.72 0.31 Allowed 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 127.666 2.386 . . . . 0.0 107.811 162.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.69 82.94 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.279 0 CA-C-O 123.605 1.669 . . . . 0.0 110.076 140.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -75.18 -23.32 57.7 Favored 'General case' 0 CA--C 1.55 0.947 0 CA-C-N 113.328 -1.76 . . . . 0.0 110.991 177.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 29.7 p -146.15 167.18 24.07 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 128.747 2.819 . . . . 0.0 112.282 175.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -55.01 -48.2 73.68 Favored 'General case' 0 N--CA 1.476 0.853 0 O-C-N 121.194 -0.941 . . . . 0.0 112.0 166.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -29.61 69.36 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 120.723 -1.236 . . . . 0.0 112.882 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.88 -42.87 66.32 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 127.332 2.253 . . . . 0.0 112.851 174.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 45.9 t80 -57.34 -57.85 10.84 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 125.748 1.619 . . . . 0.0 111.062 167.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -62.46 -23.56 66.97 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 114.27 1.211 . . . . 0.0 114.27 -175.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 9.1 tmtt? -63.95 -29.06 70.26 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-N 120.13 1.332 . . . . 0.0 113.02 171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.0 -46.98 7.84 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 123.229 0.612 . . . . 0.0 111.702 173.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 44.2 t -58.23 -39.31 73.01 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 121.136 0.493 . . . . 0.0 111.095 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 67.8 m -66.79 -40.06 88.0 Favored 'General case' 0 CA--C 1.513 -0.443 0 C-N-CA 122.872 0.469 . . . . 0.0 112.014 175.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.4 -29.41 59.8 Favored 'General case' 0 C--O 1.233 0.21 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -174.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 37.8 mm -74.56 -39.38 47.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 118.565 -0.731 . . . . 0.0 109.856 174.163 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.453 ' HE2' ' HG3' ' A' ' 29' ' ' GLU . 12.5 ttmm -66.64 -43.54 84.37 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 119.24 0.927 . . . . 0.0 109.845 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.59 -42.5 86.87 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.415 1.086 . . . . 0.0 111.761 -178.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.53 -41.58 90.31 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 170.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.464 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.3 tm? -67.1 -57.48 6.72 Favored 'General case' 0 C--N 1.332 -0.171 0 C-N-CA 123.292 0.637 . . . . 0.0 111.333 -176.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.0 -12.84 61.0 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 114.592 1.33 . . . . 0.0 114.592 -177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -95.31 -40.07 9.72 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 124.576 1.15 . . . . 0.0 111.806 175.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 32.3 t -59.69 -35.13 73.87 Favored 'General case' 0 C--O 1.22 -0.457 0 C-N-CA 124.711 1.204 . . . . 0.0 112.1 166.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 42.9 tt0 . . . . . 0 CA--C 1.543 0.702 0 N-CA-C 115.698 1.74 . . . . 0.0 115.698 -179.213 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.8 mtt . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -69.62 154.38 42.08 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 118.883 0.765 . . . . 0.0 110.354 156.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.1 tp -86.11 119.3 26.26 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.585 1.154 . . . . 0.0 109.687 179.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -84.1 107.75 16.62 Favored 'General case' 0 CA--C 1.548 0.902 0 C-N-CA 126.288 1.835 . . . . 0.0 112.718 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 t -114.31 145.61 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 CA-C-O 122.841 1.305 . . . . 0.0 110.852 -179.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.471 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.2 tpp180 -134.76 157.29 47.12 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 129.146 2.979 . . . . 0.0 110.666 178.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.47 120.71 8.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 C-N-CA 127.453 2.301 . . . . 0.0 106.344 176.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.2 t -98.22 130.32 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.875 1.216 . . . . 0.0 110.074 164.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -146.36 142.51 28.31 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 113.731 1.011 . . . . 0.0 113.731 172.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 66.3 p -67.44 74.1 0.15 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.87 2.068 . . . . 0.0 111.202 167.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.67 27.92 0.28 Allowed Glycine 0 CA--C 1.535 1.302 0 C-N-CA 127.554 2.502 . . . . 0.0 117.164 -172.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.13 -18.07 44.82 Favored 'General case' 0 CA--C 1.546 0.817 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -173.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 8.5 t -149.44 158.82 44.51 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.389 1.076 . . . . 0.0 110.873 165.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.03 -1.13 0.14 Allowed Glycine 0 CA--C 1.542 1.75 0 C-N-CA 127.513 2.482 . . . . 0.0 118.632 170.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.6 p90 -57.81 -44.2 86.22 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 115.232 1.567 . . . . 0.0 115.232 -157.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt -56.21 -58.25 17.69 Favored Pre-proline 0 N--CA 1.474 0.748 0 CA-C-O 117.342 -1.313 . . . . 0.0 113.733 -169.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.57 -33.73 35.37 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 CA-C-N 121.746 1.659 . . . . 0.0 112.402 171.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 1.5 tmtt? -62.41 -29.6 70.62 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-N 120.26 1.391 . . . . 0.0 112.812 178.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.8 m-30 -71.98 -63.27 1.17 Allowed 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 127.421 2.288 . . . . 0.0 111.642 164.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.3 mt -55.04 -41.84 71.89 Favored 'General case' 0 C--O 1.214 -0.8 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 -171.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 23.8 tm0? -60.43 -36.51 78.35 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.438 1.095 . . . . 0.0 112.542 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 39.4 tp -76.91 -37.78 54.75 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 123.371 0.668 . . . . 0.0 111.782 170.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 0.7 OUTLIER -66.53 -56.48 10.63 Favored 'General case' 0 C--N 1.345 0.383 0 C-N-CA 124.308 1.043 . . . . 0.0 112.333 -178.276 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -40.8 -45.25 2.42 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 127.33 2.252 . . . . 0.0 112.373 177.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.18 -44.21 92.18 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.645 1.578 . . . . 0.0 114.84 176.095 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 tp -73.28 -44.94 58.35 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.557 1.943 . . . . 0.0 112.778 179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -58.93 -40.71 85.44 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.351 1.86 . . . . 0.0 113.881 167.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -59.1 -46.15 89.03 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 119.272 0.942 . . . . 0.0 111.315 172.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.41 ' CD ' ' HZ1' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -69.29 -34.22 74.39 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.662 0.785 . . . . 0.0 112.49 -178.138 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -133.1 57.5 28.16 Favored Pre-proline 0 CA--C 1.55 0.968 0 C-N-CA 125.22 1.408 . . . . 0.0 112.344 -170.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -67.16 117.56 4.9 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.86 2.373 . . . . 0.0 112.867 -164.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 44.12 6.58 0.01 OUTLIER Glycine 0 CA--C 1.536 1.374 0 C-N-CA 127.813 2.625 . . . . 0.0 117.057 -162.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.0 m -72.22 -16.65 61.95 Favored 'General case' 0 CA--C 1.543 0.704 0 O-C-N 120.645 -1.503 . . . . 0.0 109.71 162.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 mp -120.15 155.16 33.64 Favored 'General case' 0 N--CA 1.444 -0.754 0 C-N-CA 127.203 2.201 . . . . 0.0 111.124 172.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -107.07 138.67 42.8 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 127.284 2.234 . . . . 0.0 107.437 150.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.9 mp -136.25 117.96 19.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-O 122.405 1.098 . . . . 0.0 108.057 158.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.471 ' HB2' HH11 ' A' ' 6' ' ' ARG . 92.3 m -106.39 172.13 6.98 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.695 162.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -146.0 161.74 28.3 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 124.258 0.933 . . . . 0.0 110.978 167.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -150.0 95.01 2.23 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.455 1.598 . . . . 0.0 110.347 -154.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -89.68 66.02 2.93 Favored Glycine 0 CA--C 1.527 0.824 0 CA-C-N 114.179 -1.373 . . . . 0.0 112.457 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 p -81.95 153.33 69.68 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 124.001 0.92 . . . . 0.0 112.038 177.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -69.8 1.36 4.53 Favored 'Trans proline' 0 CA--C 1.542 0.895 0 C-N-CA 123.424 2.75 . . . . 0.0 114.181 178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -68.78 -10.84 58.98 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 124.374 1.07 . . . . 0.0 112.753 169.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.5 m -126.79 133.2 69.05 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 C-N-CA 124.591 1.156 . . . . 0.0 112.006 175.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 13.4 t -123.98 -5.13 7.96 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -166.9 30.03 0.19 Allowed Glycine 0 CA--C 1.53 0.98 0 C-N-CA 124.761 1.172 . . . . 0.0 112.345 177.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -130.77 137.25 49.38 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 125.294 1.438 . . . . 0.0 108.869 -164.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -129.83 129.18 43.67 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 126.735 2.014 . . . . 0.0 107.363 175.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -133.81 157.23 46.44 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.607 1.163 . . . . 0.0 112.655 174.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 57.6 t -128.11 131.4 69.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 C-N-CA 123.117 0.567 . . . . 0.0 110.559 170.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.7 m -131.26 139.49 49.65 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.605 1.162 . . . . 0.0 110.958 175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.5 140.07 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 126.883 2.073 . . . . 0.0 109.352 172.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.92 29.81 0.14 Allowed 'General case' 0 CA--C 1.555 1.164 0 C-N-CA 125.484 1.513 . . . . 0.0 114.553 -172.86 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.43 51.62 47.08 Favored Glycine 0 CA--C 1.534 1.278 0 O-C-N 120.35 -1.468 . . . . 0.0 113.492 -171.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.0 mmtm -144.21 115.18 7.85 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 130.404 3.482 . . . . 0.0 108.599 178.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.4 tt -69.21 129.0 38.59 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 123.735 0.814 . . . . 0.0 110.736 178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.1 t -101.32 -37.13 5.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.747 1.619 . . . . 0.0 110.233 172.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -139.96 150.09 44.08 Favored 'General case' 0 N--CA 1.457 -0.107 0 C-N-CA 125.688 1.595 . . . . 0.0 111.588 -167.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.09 100.3 1.86 Allowed 'General case' 0 C--O 1.236 0.365 0 C-N-CA 123.52 0.728 . . . . 0.0 112.439 162.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.529 ' HA ' ' HE3' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -51.54 -32.83 29.5 Favored 'General case' 0 N--CA 1.466 0.347 0 O-C-N 118.356 -2.715 . . . . 0.0 113.142 172.029 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -58.67 -37.25 75.62 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.357 1.863 . . . . 0.0 114.001 171.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.85 -23.75 48.8 Favored 'General case' 0 N--CA 1.47 0.555 0 N-CA-C 113.923 1.082 . . . . 0.0 113.923 172.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 146.13 -15.66 1.71 Allowed Glycine 0 C--O 1.227 -0.341 0 C-N-CA 123.481 0.563 . . . . 0.0 112.629 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.09 -40.41 74.99 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 114.849 1.426 . . . . 0.0 114.849 -134.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 85.54 151.36 15.83 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 118.464 0.574 . . . . 0.0 113.943 -174.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.4 m-30 -67.92 -158.18 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.073 2.149 . . . . 0.0 113.13 -178.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 31.4 m -74.15 79.94 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 CA-C-O 124.019 1.866 . . . . 0.0 110.054 157.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -72.82 -23.56 60.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 112.883 -1.962 . . . . 0.0 111.899 -177.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.9 p -146.35 165.34 29.61 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.43 1.492 . . . . 0.0 111.916 -179.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -56.98 -43.32 81.56 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 169.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -58.47 -40.4 82.59 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.801 -0.562 . . . . 0.0 111.383 176.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 15.2 mttt -60.19 -51.61 68.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.058 1.343 . . . . 0.0 113.948 172.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -54.39 -47.22 72.97 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 118.641 0.655 . . . . 0.0 110.928 176.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 8.7 mpt_? -63.27 -26.43 68.78 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 115.12 1.526 . . . . 0.0 115.12 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mptt -67.23 -37.58 83.82 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 121.3 1.863 . . . . 0.0 111.317 171.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 36.9 tp -72.79 -49.17 32.29 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 118.423 0.556 . . . . 0.0 110.375 174.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 56.1 t -55.48 -41.55 63.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.637 -0.71 . . . . 0.0 111.407 177.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.4 m -63.28 -46.15 88.16 Favored 'General case' 0 CA--C 1.509 -0.597 0 CA-C-N 119.149 0.886 . . . . 0.0 112.009 175.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.31 -29.27 60.0 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 119.699 -0.8 . . . . 0.0 112.08 -171.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 31.6 mm -79.52 -34.77 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.607 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.569 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.41 ' HZ1' ' CD ' ' A' ' 29' ' ' GLU . 13.8 ttmm -68.88 -44.12 73.9 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-N 120.733 1.606 . . . . 0.0 111.215 178.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.08 -50.17 69.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.256 1.022 . . . . 0.0 111.71 177.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -66.1 -31.71 72.74 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.212 0.819 . . . . 0.0 113.212 176.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -63.61 -53.7 47.48 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 123.039 0.536 . . . . 0.0 110.445 172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.06 -21.79 47.24 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 114.78 1.4 . . . . 0.0 114.78 177.451 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -80.69 -45.97 16.3 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.904 1.281 . . . . 0.0 111.977 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.04 -26.43 66.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 125.295 1.438 . . . . 0.0 113.476 175.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 72.5 mt-30 . . . . . 0 N--CA 1.471 0.625 0 C-N-CA 123.599 0.76 . . . . 0.0 112.921 168.147 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 ttm . . . . . 0 N--CA 1.477 0.891 0 CA-C-O 119.08 -0.486 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.27 159.27 20.1 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 118.412 0.551 . . . . 0.0 110.862 157.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -88.33 113.75 24.26 Favored 'General case' 0 C--O 1.223 -0.302 0 C-N-CA 124.494 1.118 . . . . 0.0 111.716 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -75.74 105.72 6.92 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.219 1.808 . . . . 0.0 112.261 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.424 HG22 HG23 ' A' ' 52' ' ' VAL . 9.7 t -114.44 149.12 16.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 C-N-CA 125.397 1.479 . . . . 0.0 111.01 178.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.419 ' HD3' ' HB2' ' A' ' 37' ' ' CYS . 0.6 OUTLIER -136.25 154.76 50.81 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 130.934 3.694 . . . . 0.0 110.864 -175.294 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -149.02 97.88 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 C-N-CA 125.449 1.5 . . . . 0.0 111.15 -179.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.0 p -104.03 118.85 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.175 0 CA-C-N 120.246 1.385 . . . . 0.0 113.571 -175.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.67 162.53 36.45 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.534 1.134 . . . . 0.0 112.867 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.7 t -73.02 86.43 1.32 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.74 1.216 . . . . 0.0 112.287 170.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -65.85 39.11 0.14 Allowed Glycine 0 CA--C 1.536 1.389 0 C-N-CA 128.075 2.75 . . . . 0.0 115.11 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.34 -8.33 38.97 Favored 'General case' 0 CA--C 1.549 0.905 0 C-N-CA 125.823 1.649 . . . . 0.0 113.724 173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p -139.07 -172.01 3.23 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.409 1.484 . . . . 0.0 111.339 170.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -61.54 68.23 0.01 OUTLIER Glycine 0 CA--C 1.534 1.259 0 C-N-CA 127.43 2.443 . . . . 0.0 115.619 -176.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -54.46 -34.42 61.46 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 125.782 1.633 . . . . 0.0 113.507 179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.6 mmmm -45.42 -59.91 3.91 Favored Pre-proline 0 N--CA 1.474 0.746 0 CA-C-O 116.458 -1.734 . . . . 0.0 114.39 -167.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -64.89 -44.2 10.6 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 121.947 1.764 . . . . 0.0 112.636 174.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -57.91 -33.6 68.94 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 120.499 -1.376 . . . . 0.0 112.066 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -74.18 -60.47 2.25 Favored 'General case' 0 N--CA 1.457 -0.103 0 C-N-CA 126.875 2.07 . . . . 0.0 111.294 170.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 44.7 mt -50.82 -49.2 59.22 Favored 'General case' 0 C--O 1.207 -1.165 0 C-N-CA 123.964 0.906 . . . . 0.0 110.869 -177.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -68.96 -11.54 60.8 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-N 121.378 1.899 . . . . 0.0 113.881 -173.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 19.5 tp -85.52 -50.26 7.4 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.24 1.016 . . . . 0.0 111.371 158.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -58.64 5.04 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 127.511 2.325 . . . . 0.0 112.105 -170.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -38.55 -47.93 1.36 Allowed 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 129.199 3.0 . . . . 0.0 112.632 167.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.86 -49.64 76.64 Favored 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 119.195 0.907 . . . . 0.0 112.718 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.585 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.3 mp -62.72 -52.53 62.91 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.8 2.04 . . . . 0.0 112.511 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -59.64 -34.36 72.71 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.508 1.923 . . . . 0.0 114.407 171.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -67.78 -39.84 84.06 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 119.584 1.084 . . . . 0.0 111.913 171.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.89 -36.52 75.5 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 112.975 0.731 . . . . 0.0 112.975 177.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -131.17 51.41 7.51 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 125.891 1.676 . . . . 0.0 113.231 -169.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -62.28 128.6 24.29 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.657 2.238 . . . . 0.0 111.93 -170.057 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.73 -13.34 0.01 OUTLIER Glycine 0 CA--C 1.533 1.168 0 C-N-CA 127.513 2.482 . . . . 0.0 117.567 -172.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.651 ' CB ' HD21 ' A' ' 84' ' ' LEU . 15.9 m -72.63 -10.83 60.26 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-N 118.512 1.156 . . . . 0.0 111.619 165.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 mp -122.9 151.87 41.34 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 127.63 2.372 . . . . 0.0 111.258 171.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -107.46 144.68 34.06 Favored 'General case' 0 C--N 1.324 -0.518 0 C-N-CA 127.53 2.332 . . . . 0.0 107.81 147.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.585 HD11 ' HB3' ' A' ' 26' ' ' LEU . 3.1 mt -145.23 104.49 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 123.58 1.657 . . . . 0.0 108.255 165.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.419 ' HB2' ' HD3' ' A' ' 6' ' ' ARG . 93.5 m -88.59 169.57 11.6 Favored 'General case' 0 C--N 1.311 -1.065 0 CA-C-N 113.224 -1.807 . . . . 0.0 109.661 163.253 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -160.16 139.05 5.88 Favored Glycine 0 CA--C 1.525 0.666 0 C-N-CA 124.537 1.065 . . . . 0.0 110.814 176.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -119.37 48.27 1.54 Allowed 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 127.394 2.278 . . . . 0.0 109.386 -160.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.85 93.7 0.27 Allowed Glycine 0 CA--C 1.523 0.555 0 C-N-CA 126.914 2.197 . . . . 0.0 110.522 178.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 p -128.98 151.09 77.0 Favored Pre-proline 0 N--CA 1.471 0.599 0 C-N-CA 125.474 1.509 . . . . 0.0 112.085 -164.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -68.52 166.5 25.53 Favored 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.126 1.884 . . . . 0.0 112.159 178.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 58.51 -120.8 1.19 Allowed 'General case' 0 CA--C 1.55 0.955 0 C-N-CA 125.215 1.406 . . . . 0.0 111.384 -169.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . 0.285 25.8 m 50.86 -34.27 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.411 1 C-N-CA 132.474 4.309 . . . . 0.0 119.628 -176.102 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 16.3 m 101.49 153.8 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 1 C-N-CA 132.148 4.179 . . . . 0.0 109.922 -175.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -65.64 33.35 0.13 Allowed Glycine 0 CA--C 1.541 1.703 0 C-N-CA 127.655 2.55 . . . . 0.0 117.311 -174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.473 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 3.4 m-85 -67.94 164.08 20.69 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 126.199 1.8 . . . . 0.0 110.551 163.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -155.46 91.47 1.32 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.494 1.517 . . . . 0.0 108.253 172.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -119.79 111.79 18.44 Favored 'General case' 0 CA--C 1.539 0.545 0 O-C-N 120.844 -1.16 . . . . 0.0 110.208 -156.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 46.3 t -100.86 125.95 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.024 0 C-N-CA 123.443 0.697 . . . . 0.0 109.126 -170.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -126.37 142.55 51.49 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.062 1.345 . . . . 0.0 109.881 -173.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.424 HG23 HG22 ' A' ' 5' ' ' VAL . 8.6 p -135.05 132.17 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 126.64 1.976 . . . . 0.0 110.231 174.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 45.41 33.14 1.2 Allowed 'General case' 0 CA--C 1.556 1.204 0 C-N-CA 125.478 1.511 . . . . 0.0 114.472 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 80.97 20.92 64.2 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.936 1.255 . . . . 0.0 115.338 -175.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 mmtp -128.53 114.18 16.41 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 126.58 1.952 . . . . 0.0 109.764 -174.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.2 tt -63.43 139.44 58.77 Favored 'General case' 0 N--CA 1.47 0.531 0 O-C-N 121.635 -0.666 . . . . 0.0 110.886 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 5.3 t -125.29 -23.81 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 124.512 1.125 . . . . 0.0 111.577 176.033 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -135.22 152.15 51.28 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.649 1.18 . . . . 0.0 112.223 174.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.423 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 40.4 t -154.45 113.22 3.62 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 126.677 1.991 . . . . 0.0 111.061 174.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.93 -28.6 67.62 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 120.08 -1.637 . . . . 0.0 112.599 163.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.473 ' HE3' ' CD1' ' A' ' 47' ' ' PHE . 2.0 ttmp? -51.29 -55.09 20.15 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 125.898 1.679 . . . . 0.0 112.054 175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.47 ' HE ' ' N ' ' A' ' 64' ' ' ASP . 0.0 OUTLIER -77.11 -3.04 37.32 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 115.046 1.499 . . . . 0.0 115.046 178.233 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 75.2 34.2 52.15 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 110.756 -0.938 . . . . 0.0 110.756 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' N ' ' HE ' ' A' ' 62' ' ' ARG . 24.8 t0 -62.72 -29.99 71.09 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-N 118.806 1.303 . . . . 0.0 112.777 168.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 76.08 144.96 1.53 Allowed Glycine 0 N--CA 1.473 1.131 0 O-C-N 121.839 -0.538 . . . . 0.0 111.813 -170.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -59.84 -162.81 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 127.428 2.291 . . . . 0.0 112.362 -175.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.312 8.7 m -71.0 72.65 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.5 0 O-C-N 119.644 -1.91 . . . . 0.0 111.274 143.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -78.72 -19.07 53.25 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.768 2.427 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 49.5 p -147.68 169.08 20.46 Favored 'General case' 0 C--N 1.345 0.39 0 C-N-CA 125.612 1.565 . . . . 0.0 112.022 175.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -55.68 -44.88 77.72 Favored 'General case' 0 N--CA 1.47 0.556 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 168.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -61.97 -37.4 84.65 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.994 0.902 . . . . 0.0 112.098 178.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.71 -46.63 78.23 Favored 'General case' 0 N--CA 1.464 0.267 0 C-N-CA 126.102 1.761 . . . . 0.0 111.679 176.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -56.25 -52.42 64.53 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.003 1.321 . . . . 0.0 112.122 170.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -59.31 -27.42 65.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.853 1.261 . . . . 0.0 113.408 -176.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 17.7 tptp -61.53 -40.29 94.11 Favored 'General case' 0 N--CA 1.464 0.261 0 C-N-CA 125.623 1.569 . . . . 0.0 112.582 174.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 47.8 tp -77.18 -49.28 15.53 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 124.36 1.037 . . . . 0.0 110.702 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 55.1 t -50.84 -44.63 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 O-C-N 123.702 0.626 . . . . 0.0 110.688 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 87.3 m -62.96 -40.71 98.54 Favored 'General case' 0 CA--C 1.513 -0.446 0 O-C-N 121.63 -0.668 . . . . 0.0 112.513 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.62 -33.29 58.39 Favored 'General case' 0 C--N 1.332 -0.165 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 44.1 mm -75.0 -36.93 40.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.304 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -66.06 -46.69 76.88 Favored 'General case' 0 N--CA 1.475 0.808 0 O-C-N 121.363 -0.835 . . . . 0.0 110.645 179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.5 -48.5 77.34 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.063 -0.972 . . . . 0.0 111.22 177.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -61.92 -35.14 77.51 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 123.187 0.595 . . . . 0.0 112.588 177.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.651 HD21 ' CB ' ' A' ' 33' ' ' CYS . 1.2 tm? -61.25 -53.26 59.05 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 123.205 0.602 . . . . 0.0 110.883 176.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.45 -20.49 64.59 Favored 'General case' 0 CA--C 1.54 0.589 0 N-CA-C 114.162 1.171 . . . . 0.0 114.162 177.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -82.13 -44.66 16.19 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 125.116 1.366 . . . . 0.0 111.351 175.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.21 -27.19 64.29 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 125.145 1.378 . . . . 0.0 112.816 177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 12.0 tt0 . . . . . 0 CA--C 1.545 0.778 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 176.073 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ptp . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 118.654 -0.689 . . . . 0.0 109.763 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.49 159.26 34.79 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 118.151 0.432 . . . . 0.0 111.801 170.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -98.99 117.53 33.72 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.42 1.488 . . . . 0.0 110.902 -176.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.05 115.43 16.84 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.681 1.192 . . . . 0.0 111.801 174.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -120.72 144.73 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 124.568 1.147 . . . . 0.0 109.901 178.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.448 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.2 tpp180 -141.98 145.74 34.8 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 125.933 1.693 . . . . 0.0 112.378 -175.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.7 t -131.87 108.39 14.12 Favored 'Isoleucine or valine' 0 C--O 1.237 0.42 0 C-N-CA 124.536 1.135 . . . . 0.0 108.589 170.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 52.5 t -77.65 137.86 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.566 162.297 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 14.6 t80 -160.89 176.83 11.01 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 125.74 1.616 . . . . 0.0 110.975 171.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 24.6 p -79.64 150.09 31.08 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.572 1.549 . . . . 0.0 111.722 165.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -71.83 37.03 0.61 Allowed Glycine 0 CA--C 1.541 1.665 0 C-N-CA 125.225 1.393 . . . . 0.0 114.787 165.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.2 52.45 0.46 Allowed 'General case' 0 CA--C 1.552 1.052 0 C-N-CA 126.962 2.105 . . . . 0.0 114.249 -172.634 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 78.3 m 55.58 147.51 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 129.751 3.22 . . . . 0.0 115.801 -177.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 58.17 10.73 7.61 Favored Glycine 0 CA--C 1.541 1.676 0 O-C-N 119.994 -1.691 . . . . 0.0 115.981 -178.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -58.62 -40.06 82.27 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 119.616 1.708 . . . . 0.0 112.964 -174.148 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.25 -61.69 3.45 Favored Pre-proline 0 N--CA 1.477 0.883 0 CA-C-O 117.247 -1.358 . . . . 0.0 114.179 177.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -64.76 -36.25 41.68 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 CA-C-N 121.976 1.742 . . . . 0.0 113.178 177.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -55.79 -45.34 78.23 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 119.294 0.952 . . . . 0.0 111.637 173.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -60.61 -58.08 9.97 Favored 'General case' 0 N--CA 1.462 0.159 0 C-N-CA 126.126 1.77 . . . . 0.0 111.027 174.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -54.56 -34.9 62.64 Favored 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.064 0.945 . . . . 0.0 112.835 -178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.01 -25.78 68.0 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 120.014 -1.679 . . . . 0.0 111.963 -176.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 9.6 tt -80.92 -58.09 3.24 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.041 1.336 . . . . 0.0 111.278 158.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -56.22 -54.72 41.95 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 125.635 1.574 . . . . 0.0 112.454 -167.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.19 -20.84 65.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.829 2.052 . . . . 0.0 113.446 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.15 -54.07 9.41 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 123.805 0.842 . . . . 0.0 112.223 166.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' A' ' 36' ' ' ILE . 3.4 mm? -60.58 -43.84 96.89 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.427 1.891 . . . . 0.0 112.907 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -66.08 -36.34 82.94 Favored 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 114.817 1.414 . . . . 0.0 114.817 168.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.4 t60 -63.93 -38.83 92.54 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 120.217 1.371 . . . . 0.0 112.351 170.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -71.09 -41.66 70.33 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 127.329 2.252 . . . . 0.0 112.317 -179.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -130.13 54.8 15.58 Favored Pre-proline 0 CA--C 1.552 1.029 0 C-N-CA 125.598 1.559 . . . . 0.0 113.395 -174.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -63.86 127.81 20.48 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 123.046 2.497 . . . . 0.0 112.738 -167.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.1 -9.76 0.01 OUTLIER Glycine 0 CA--C 1.532 1.148 0 C-N-CA 127.278 2.371 . . . . 0.0 117.005 -172.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.635 ' HB3' HD21 ' A' ' 84' ' ' LEU . 13.3 m -75.52 -10.47 59.48 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.029 1.331 . . . . 0.0 111.051 164.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.28 153.15 45.19 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 127.289 2.235 . . . . 0.0 111.46 173.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.448 ' CG ' HH12 ' A' ' 6' ' ' ARG . 8.3 t0 -114.19 139.62 49.22 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 128.537 2.735 . . . . 0.0 106.685 156.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.558 HD11 ' HB3' ' A' ' 26' ' ' LEU . 4.1 mt -141.15 126.87 19.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 122.537 1.161 . . . . 0.0 108.494 168.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.7 t -135.02 -176.86 4.39 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.36 172.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -149.04 152.85 24.81 Favored Glycine 0 CA--C 1.522 0.488 0 C-N-CA 124.496 1.046 . . . . 0.0 113.511 -177.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -147.88 93.11 2.14 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 122.922 1.344 . . . . 0.0 110.367 -160.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -74.32 32.53 0.96 Allowed Glycine 0 CA--C 1.541 1.717 0 N-CA-C 117.16 1.624 . . . . 0.0 117.16 -158.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.8 t -130.07 73.19 81.59 Favored Pre-proline 0 N--CA 1.476 0.871 0 CA-C-N 119.422 1.611 . . . . 0.0 115.159 -167.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.61 7.73 2.58 Favored 'Trans proline' 0 CA--C 1.547 1.15 0 C-N-CA 124.974 3.783 . . . . 0.0 114.876 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 64.37 -39.72 0.24 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 129.133 2.973 . . . . 0.0 114.88 -172.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 14.7 t -139.2 147.5 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.276 1.43 . . . . 0.0 110.637 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.1 m 52.51 -79.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 128.356 2.663 . . . . 0.0 116.432 175.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.26 54.29 0.01 OUTLIER Glycine 0 N--CA 1.472 1.088 0 CA-C-N 119.498 1.045 . . . . 0.0 115.482 -168.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -77.05 108.83 10.4 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.189 0.996 . . . . 0.0 113.05 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -73.96 99.88 3.39 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 126.292 1.837 . . . . 0.0 109.742 168.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -123.51 115.38 21.45 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 125.025 1.33 . . . . 0.0 110.697 -170.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.9 t -104.17 121.19 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 119.082 0.855 . . . . 0.0 110.081 -174.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 m -123.72 146.49 48.23 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 125.168 1.387 . . . . 0.0 110.541 -179.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 7.3 p -134.7 131.35 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 C-N-CA 125.782 1.633 . . . . 0.0 110.317 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 47.06 31.03 1.44 Allowed 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 125.334 1.454 . . . . 0.0 114.815 -173.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 84.24 20.97 57.97 Favored Glycine 0 CA--C 1.537 1.449 0 O-C-N 120.995 -1.066 . . . . 0.0 114.99 -176.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 37.9 mtmt -130.28 109.31 10.67 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 126.138 1.775 . . . . 0.0 110.703 -174.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.7 tt -68.43 135.97 52.54 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 121.815 0.817 . . . . 0.0 111.291 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 t -115.46 -27.3 2.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.408 1.483 . . . . 0.0 110.615 179.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 16.4 t60 -144.5 149.97 36.81 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.552 0.741 . . . . 0.0 111.35 -168.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -164.17 98.23 0.83 Allowed 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.894 0.878 . . . . 0.0 112.197 -168.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.404 ' HE3' ' CE1' ' A' ' 66' ' ' TYR . 40.2 mmtt -58.32 -22.37 52.88 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.019 -1.676 . . . . 0.0 114.195 166.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.0 ptmt -66.96 -24.74 66.09 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 172.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.9 ptt180 -97.2 -26.48 14.93 Favored 'General case' 0 C--N 1.345 0.404 0 C-N-CA 125.171 1.389 . . . . 0.0 113.78 174.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.06 43.54 3.78 Favored Glycine 0 C--O 1.225 -0.442 0 N-CA-C 114.432 0.533 . . . . 0.0 114.432 -176.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.18 -47.45 45.92 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.103 1.361 . . . . 0.0 114.019 156.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 110.26 -174.48 17.51 Favored Glycine 0 C--N 1.338 0.662 0 N-CA-C 110.41 -1.076 . . . . 0.0 110.41 -148.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.404 ' CE1' ' HE3' ' A' ' 60' ' ' LYS . 62.8 m-85 -81.91 -162.61 0.56 Allowed 'General case' 0 CA--C 1.542 0.657 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 139.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.7 m -76.43 80.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-O 123.821 1.772 . . . . 0.0 110.886 155.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.421 ' H ' ' HD2' ' A' ' 72' ' ' LYS . 75.0 m-20 -73.97 -15.28 61.11 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 128.539 2.735 . . . . 0.0 113.841 -169.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -152.49 161.7 42.23 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 120.879 -1.138 . . . . 0.0 110.233 -172.461 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -51.35 -55.49 18.18 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.479 1.112 . . . . 0.0 110.071 175.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.58 -25.63 68.06 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.786 -1.097 . . . . 0.0 113.218 -176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.421 ' HD2' ' H ' ' A' ' 68' ' ' ASP . 31.0 ttmt -74.29 -50.23 19.79 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 123.944 0.898 . . . . 0.0 111.256 172.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.0 t80 -58.97 -52.34 66.18 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.753 1.221 . . . . 0.0 111.941 177.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 10.7 ttt85 -57.39 -22.85 45.61 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 127.125 2.17 . . . . 0.0 113.372 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.0 tptp -64.55 -39.49 93.85 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 125.177 1.391 . . . . 0.0 111.989 171.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 39.3 tp -73.65 -51.55 16.36 Favored 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 124.247 0.967 . . . . 0.0 111.166 173.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.2 t -53.62 -44.35 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 O-C-N 123.516 0.51 . . . . 0.0 110.912 178.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 68.6 m -64.9 -37.76 88.71 Favored 'General case' 0 CA--C 1.518 -0.281 0 O-C-N 121.317 -0.864 . . . . 0.0 112.445 178.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.97 -34.23 61.98 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.7 mm -74.1 -33.06 34.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 176.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -64.18 -44.88 90.68 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 119.0 0.818 . . . . 0.0 109.904 176.524 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.44 -49.23 76.28 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 125.765 1.626 . . . . 0.0 110.877 177.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.63 88.51 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.762 0.825 . . . . 0.0 112.911 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.635 HD21 ' HB3' ' A' ' 33' ' ' CYS . 1.0 OUTLIER -60.71 -52.41 65.25 Favored 'General case' 0 N--CA 1.464 0.242 0 C-N-CA 123.679 0.791 . . . . 0.0 109.95 177.24 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -63.63 -17.69 63.16 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 178.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -81.1 -53.82 6.06 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 126.019 1.728 . . . . 0.0 109.408 171.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.75 -22.68 63.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 126.082 1.753 . . . . 0.0 115.671 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 -175.407 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.777 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.57 175.06 3.68 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 120.023 1.283 . . . . 0.0 111.008 150.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 10.0 tp -122.86 167.43 13.54 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.242 1.817 . . . . 0.0 108.662 168.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -129.33 130.82 46.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.206 1.403 . . . . 0.0 111.743 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.5 t -111.9 146.85 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-O 122.62 1.2 . . . . 0.0 109.541 168.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -124.42 158.27 33.16 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 127.195 2.198 . . . . 0.0 110.174 172.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 23.0 t -144.83 100.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.602 0 C-N-CA 126.262 1.825 . . . . 0.0 108.587 178.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.5 p -73.82 135.79 26.77 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 O-C-N 121.015 -1.053 . . . . 0.0 109.61 167.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -161.37 160.7 29.89 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 118.974 0.806 . . . . 0.0 112.424 167.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 92.6 p -90.08 84.18 6.12 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.107 1.763 . . . . 0.0 111.316 164.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -70.85 38.42 0.51 Allowed Glycine 0 CA--C 1.538 1.518 0 N-CA-C 116.107 1.203 . . . . 0.0 116.107 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.45 -23.43 62.7 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -169.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.4 t -150.99 162.29 41.11 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 123.996 0.918 . . . . 0.0 109.99 164.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 56.23 -0.25 0.15 Allowed Glycine 0 CA--C 1.541 1.694 0 C-N-CA 127.223 2.344 . . . . 0.0 118.156 173.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -66.82 -42.2 86.24 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 119.135 1.468 . . . . 0.0 114.106 -158.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.4 mmtt -48.81 -61.19 3.52 Favored Pre-proline 0 N--CA 1.474 0.765 0 CA-C-O 116.567 -1.682 . . . . 0.0 113.886 -175.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -66.42 -36.37 27.2 Favored 'Trans proline' 0 CA--C 1.535 0.559 0 CA-C-N 121.716 1.648 . . . . 0.0 112.921 177.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -55.13 -47.43 75.06 Favored 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 120.173 1.351 . . . . 0.0 111.744 173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 92.9 t80 -63.03 -56.43 17.04 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 126.471 1.909 . . . . 0.0 111.196 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 mp -55.6 -36.56 67.05 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-O 117.369 -1.301 . . . . 0.0 112.626 178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -61.42 -38.78 88.35 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 121.317 1.871 . . . . 0.0 111.74 -176.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 66.0 tp -70.35 -47.85 59.12 Favored 'General case' 0 CA--C 1.539 0.549 0 O-C-N 121.963 -0.461 . . . . 0.0 111.625 167.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.74 -55.43 26.66 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -171.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -38.18 -52.16 1.45 Allowed 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 127.544 2.337 . . . . 0.0 112.577 170.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.74 -49.55 77.29 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 123.439 0.696 . . . . 0.0 112.02 -175.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.494 ' HB3' HD11 ' A' ' 36' ' ' ILE . 1.5 tp -71.87 -42.12 67.24 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 124.048 0.939 . . . . 0.0 112.533 -174.164 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -67.19 -28.54 68.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 169.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -70.67 -36.75 73.51 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 119.546 1.066 . . . . 0.0 113.018 168.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -70.84 -36.28 72.81 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.503 1.521 . . . . 0.0 113.397 177.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 20.7 m-85 -132.24 46.21 2.06 Favored Pre-proline 0 CA--C 1.551 0.999 0 C-N-CA 125.624 1.57 . . . . 0.0 113.655 -171.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -60.96 129.52 29.17 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 122.579 2.186 . . . . 0.0 111.808 -168.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.29 -11.57 0.02 OUTLIER Glycine 0 CA--C 1.531 1.076 0 C-N-CA 127.528 2.489 . . . . 0.0 117.202 -174.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.594 ' HB3' HD21 ' A' ' 84' ' ' LEU . 12.4 m -71.64 -16.14 62.26 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-N 118.631 1.216 . . . . 0.0 111.192 165.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.1 160.88 42.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 124.546 1.138 . . . . 0.0 111.713 -171.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -123.28 151.07 42.75 Favored 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 128.831 2.852 . . . . 0.0 110.321 167.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.494 HD11 ' HB3' ' A' ' 26' ' ' LEU . 17.7 mt -139.22 126.3 25.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 123.678 1.704 . . . . 0.0 108.649 154.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 4.3 m -114.6 175.88 5.29 Favored 'General case' 0 C--N 1.314 -0.946 0 C-N-CA 131.104 3.762 . . . . 0.0 110.52 173.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.73 139.04 6.12 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.381 -1.088 . . . . 0.0 110.381 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 52.5 mm-40 -128.84 82.77 2.1 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 122.912 1.339 . . . . 0.0 107.928 -155.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.24 70.22 2.99 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.228 0.918 . . . . 0.0 113.17 -166.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.4 m -123.17 61.78 19.16 Favored Pre-proline 0 CA--C 1.547 0.864 0 C-N-CA 125.524 1.53 . . . . 0.0 111.681 -179.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -79.8 173.66 12.61 Favored 'Trans proline' 0 CA--C 1.535 0.529 0 C-N-CA 124.245 3.297 . . . . 0.0 111.554 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 33.7 mm-40 -131.05 -108.3 0.26 Allowed 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 124.349 1.06 . . . . 0.0 109.53 165.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 33.8 m -81.82 -1.57 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 -170.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 10.2 t -159.4 165.07 34.01 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.427 1.091 . . . . 0.0 112.289 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -97.39 66.19 0.87 Allowed Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.77 2.128 . . . . 0.0 114.222 -177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -57.38 93.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.032 0.933 . . . . 0.0 110.174 163.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -84.03 93.32 8.06 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.448 1.499 . . . . 0.0 108.083 169.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 25.5 mt-10 -127.7 125.11 39.42 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-N 120.101 1.319 . . . . 0.0 112.966 -173.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.1 t -104.58 130.48 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 C-N-CA 124.458 1.103 . . . . 0.0 110.137 -173.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.55 122.43 24.8 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 124.92 1.288 . . . . 0.0 111.51 -174.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.8 p -106.81 121.71 59.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 125.46 1.504 . . . . 0.0 110.202 174.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 44.07 30.41 0.42 Allowed 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.323 1.849 . . . . 0.0 114.751 -176.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 91.83 22.53 30.5 Favored Glycine 0 CA--C 1.538 1.528 0 O-C-N 120.816 -1.178 . . . . 0.0 115.633 -176.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -123.86 116.5 23.04 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 126.721 2.008 . . . . 0.0 110.479 177.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 7.0 tt -64.18 127.56 31.99 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 123.174 0.589 . . . . 0.0 110.656 173.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 1.4 t -116.18 -23.15 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 125.186 1.394 . . . . 0.0 111.381 -179.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -146.19 153.89 41.13 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 124.556 1.142 . . . . 0.0 111.986 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 19.4 t -161.84 125.39 3.15 Favored 'General case' 0 C--O 1.241 0.651 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 172.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 60' ' ' LYS . 0.0 OUTLIER -68.94 -19.35 64.18 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 116.361 -1.78 . . . . 0.0 114.454 163.341 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . 0.264 0.0 OUTLIER -92.21 -21.72 20.21 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 121.185 1.811 . . . . 0.0 115.727 174.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -76.33 -17.92 59.18 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 120.091 1.314 . . . . 0.0 113.736 170.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.52 20.88 7.89 Favored Glycine 0 C--O 1.224 -0.484 0 C-N-CA 124.226 0.917 . . . . 0.0 113.546 176.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.54 -49.47 16.35 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 117.946 0.873 . . . . 0.0 112.571 -170.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 61.07 148.76 0.01 OUTLIER Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.927 1.251 . . . . 0.0 114.86 -170.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -57.07 176.77 0.1 Allowed 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -176.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.2 m -63.1 97.79 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 122.614 1.197 . . . . 0.0 111.996 179.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -70.57 -32.6 70.05 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 125.666 1.586 . . . . 0.0 111.532 160.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 41.2 p -138.57 151.85 47.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.271 1.028 . . . . 0.0 111.655 -170.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -52.12 -41.63 62.66 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-N 114.791 -1.095 . . . . 0.0 111.848 165.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.87 -35.64 77.13 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 177.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.0 ttpt -64.03 -50.51 68.17 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 118.149 0.432 . . . . 0.0 110.39 173.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.8 t80 -56.3 -52.57 64.03 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-O 122.092 0.948 . . . . 0.0 112.03 177.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.63 -28.88 67.6 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 128.024 2.529 . . . . 0.0 113.913 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 37.2 tptt -54.61 -47.44 73.39 Favored 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 125.808 1.643 . . . . 0.0 110.934 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 1.4 tt -76.63 -43.2 39.25 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 124.82 1.248 . . . . 0.0 110.794 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 89.6 t -54.44 -49.0 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.002 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 42.1 m -63.87 -37.29 86.83 Favored 'General case' 0 CA--C 1.52 -0.198 0 O-C-N 122.017 -0.427 . . . . 0.0 111.803 -178.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.42 -31.94 58.2 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -177.534 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.5 mm -78.26 -30.49 15.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 118.415 -0.803 . . . . 0.0 109.119 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.3 ttmm -64.63 -44.27 91.05 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 119.571 1.078 . . . . 0.0 110.988 174.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.49 -51.35 67.8 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 114.764 -1.107 . . . . 0.0 111.115 173.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -58.84 -35.65 73.26 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.594 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.5 tm? -64.73 -56.22 15.03 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 124.486 1.115 . . . . 0.0 110.935 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.49 -23.15 62.53 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 176.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -84.78 -32.1 23.56 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.463 1.905 . . . . 0.0 111.579 177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 6.4 t -76.32 -31.31 58.09 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 125.825 1.65 . . . . 0.0 113.128 172.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 69.0 mt-30 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 179.98 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.1 ttt . . . . . 0 N--CA 1.474 0.763 0 CA-C-O 118.191 -0.909 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.31 -179.81 7.22 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.13 2.172 . . . . 0.0 108.091 171.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -107.06 168.98 8.83 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.456 1.102 . . . . 0.0 109.818 163.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -131.9 139.63 48.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 125.557 1.543 . . . . 0.0 111.272 170.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.4 HG22 HG23 ' A' ' 52' ' ' VAL . 24.6 t -128.87 150.61 34.67 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.819 0 CA-C-O 122.332 1.063 . . . . 0.0 109.853 -176.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.11 152.91 46.69 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 125.438 1.495 . . . . 0.0 111.822 -173.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.445 HG22 HG23 ' A' ' 50' ' ' VAL . 3.3 t -133.97 99.43 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 C-N-CA 127.948 2.499 . . . . 0.0 107.606 167.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -65.97 137.82 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 162.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -150.2 -176.39 5.44 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.22 1.008 . . . . 0.0 108.681 163.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 87.6 p -97.72 161.79 13.59 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.913 -1.117 . . . . 0.0 111.309 166.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -72.33 40.02 0.73 Allowed Glycine 0 CA--C 1.539 1.591 0 C-N-CA 126.79 2.138 . . . . 0.0 115.106 176.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.84 23.37 0.01 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 C-N-CA 128.715 2.806 . . . . 0.0 116.88 -171.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.8 t 56.44 176.95 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 126.128 1.771 . . . . 0.0 112.229 -163.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 57.16 -9.68 0.01 OUTLIER Glycine 0 CA--C 1.545 1.92 0 N-CA-C 119.707 2.643 . . . . 0.0 119.707 172.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 32.6 p90 -60.17 -44.71 94.82 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 120.443 2.122 . . . . 0.0 114.446 -164.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -45.17 -55.97 10.24 Favored Pre-proline 0 N--CA 1.476 0.828 0 CA-C-O 116.523 -1.703 . . . . 0.0 114.426 -170.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -64.34 -38.97 31.7 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 CA-C-N 122.148 1.803 . . . . 0.0 114.236 176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.24 -33.9 73.99 Favored 'General case' 0 N--CA 1.488 1.464 0 CA-C-N 122.744 2.52 . . . . 0.0 111.564 175.75 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -55.44 -62.27 1.79 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.158 1.383 . . . . 0.0 110.061 168.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 79.9 mt -53.89 -41.03 67.14 Favored 'General case' 0 C--O 1.216 -0.695 0 C-N-CA 125.594 1.557 . . . . 0.0 112.717 178.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -65.0 -27.16 68.64 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.687 1.195 . . . . 0.0 113.016 -177.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.51 -44.22 17.67 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-N 118.455 0.57 . . . . 0.0 112.06 161.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.06 -56.53 20.45 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.766 1.226 . . . . 0.0 111.739 -172.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -41.03 -47.34 3.07 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 127.431 2.293 . . . . 0.0 112.757 172.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -49.91 74.92 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.657 1.183 . . . . 0.0 113.174 177.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mp -62.92 -49.47 74.67 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 125.994 1.718 . . . . 0.0 112.056 -178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -64.71 -34.64 78.8 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 125.593 1.557 . . . . 0.0 114.463 171.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -63.44 -36.58 84.22 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 120.078 1.308 . . . . 0.0 112.381 171.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.403 ' CD ' ' HZ3' ' A' ' 81' ' ' LYS . 0.9 OUTLIER -70.83 -38.81 73.24 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.79 0.836 . . . . 0.0 112.973 172.528 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -130.66 53.8 12.85 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 124.604 1.162 . . . . 0.0 113.937 -171.7 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.12 126.72 14.09 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 121.504 1.469 . . . . 0.0 111.278 -169.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.95 -14.61 0.05 OUTLIER Glycine 0 CA--C 1.534 1.271 0 C-N-CA 126.611 2.053 . . . . 0.0 116.856 -175.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.456 ' HB3' HD23 ' A' ' 84' ' ' LEU . 78.0 m -62.72 -19.18 63.66 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.926 1.29 . . . . 0.0 112.097 160.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.83 158.95 44.29 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 125.274 1.429 . . . . 0.0 112.222 -178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.1 152.92 22.8 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.884 2.474 . . . . 0.0 109.82 150.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -136.12 138.96 46.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 C-N-CA 125.664 1.586 . . . . 0.0 108.323 153.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 1.3 m -142.88 -177.57 5.39 Favored 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 130.415 3.486 . . . . 0.0 108.854 -175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -179.43 164.26 32.21 Favored Glycine 0 CA--C 1.52 0.391 0 O-C-N 121.614 -0.679 . . . . 0.0 112.617 167.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.7 mp0 -129.05 91.6 3.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 123.376 1.56 . . . . 0.0 108.661 -167.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.51 73.73 1.81 Allowed Glycine 0 CA--C 1.532 1.114 0 C-N-CA 126.849 2.166 . . . . 0.0 111.68 178.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.5 t -59.49 149.86 68.13 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.849 1.66 . . . . 0.0 112.667 -176.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -67.93 -7.38 19.51 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 122.466 2.111 . . . . 0.0 113.571 172.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -58.25 117.09 4.04 Favored 'General case' 0 CA--C 1.539 0.539 0 O-C-N 120.919 -1.113 . . . . 0.0 110.475 170.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.0 m -58.17 -6.24 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.137 0 N-CA-C 115.826 1.787 . . . . 0.0 115.826 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.6 p -62.01 84.38 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.193 1.797 . . . . 0.0 111.565 166.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.8 50.26 0.86 Allowed Glycine 0 N--CA 1.476 1.355 0 C-N-CA 126.748 2.118 . . . . 0.0 114.88 -178.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -92.62 89.61 6.77 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.069 2.147 . . . . 0.0 109.518 -174.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -66.94 93.23 0.26 Allowed 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.908 1.683 . . . . 0.0 109.87 172.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -123.73 112.51 17.44 Favored 'General case' 0 CA--C 1.535 0.376 0 O-C-N 121.026 -1.046 . . . . 0.0 112.112 -169.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.445 HG23 HG22 ' A' ' 7' ' ' VAL . 0.5 OUTLIER -99.65 127.62 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 CA-C-O 121.28 0.562 . . . . 0.0 109.927 -168.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -136.35 125.17 24.02 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.337 0.655 . . . . 0.0 110.961 -172.154 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.4 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -106.46 111.44 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 C-N-CA 127.004 2.121 . . . . 0.0 108.979 -177.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 48.54 19.98 0.28 Allowed 'General case' 0 CA--C 1.551 0.993 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 102.58 22.05 9.96 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 120.536 -1.352 . . . . 0.0 114.934 -174.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -120.12 109.76 15.83 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.012 1.725 . . . . 0.0 109.135 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 12.1 tp -65.59 130.73 44.33 Favored 'General case' 0 N--CA 1.465 0.286 0 N-CA-C 109.266 -0.642 . . . . 0.0 109.266 173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.4 t -118.77 -19.64 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.425 -175.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 31.9 t60 -156.55 150.66 25.16 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 127.143 2.177 . . . . 0.0 111.683 -169.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.522 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 22.3 t -160.49 113.19 2.02 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 115.659 1.726 . . . . 0.0 115.659 -179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 3.7 mmmt -53.81 -42.83 68.81 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 119.682 -1.886 . . . . 0.0 113.875 164.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.39 -24.94 57.25 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 115.499 1.666 . . . . 0.0 115.499 -176.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -75.78 -13.96 60.3 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 119.788 1.176 . . . . 0.0 113.462 168.496 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.12 25.92 10.76 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 124.968 1.271 . . . . 0.0 114.011 -177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -82.18 -13.92 56.41 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 77.8 -165.36 52.41 Favored Glycine 0 C--N 1.34 0.763 0 N-CA-C 110.477 -1.049 . . . . 0.0 110.477 -172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 36.3 m-85 -92.92 -168.86 2.03 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 125.58 1.552 . . . . 0.0 110.055 159.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.5 m -64.84 106.46 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.695 0 O-C-N 120.369 -1.457 . . . . 0.0 110.079 149.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -122.55 -9.31 8.48 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 129.0 2.92 . . . . 0.0 111.529 -176.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.08 164.8 38.36 Favored 'General case' 0 N--CA 1.473 0.702 0 O-C-N 120.181 -1.574 . . . . 0.0 110.382 179.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -53.61 -54.75 33.09 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 125.156 1.382 . . . . 0.0 110.065 172.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.5 t -53.85 -38.48 64.71 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 114.022 -1.444 . . . . 0.0 111.912 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.51 -41.89 79.31 Favored 'General case' 0 C--N 1.342 0.278 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 179.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -63.41 -51.82 64.17 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.361 1.064 . . . . 0.0 111.007 171.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 37.7 ttt180 -57.45 -34.54 69.09 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 127.563 2.345 . . . . 0.0 115.148 -178.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 13.2 tptp -61.46 -33.05 73.09 Favored 'General case' 0 C--O 1.238 0.454 0 C-N-CA 128.656 2.783 . . . . 0.0 113.218 170.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 28.8 tp -83.42 -47.9 10.92 Favored 'General case' 0 CA--C 1.511 -0.539 0 C-N-CA 124.199 0.999 . . . . 0.0 111.953 171.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 71.9 t -51.5 -48.45 35.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 O-C-N 123.523 0.515 . . . . 0.0 110.044 178.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.2 m -65.13 -31.09 72.11 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 123.258 0.623 . . . . 0.0 112.543 -179.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.26 -28.13 38.5 Favored 'General case' 0 CA--C 1.53 0.202 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 49.4 mm -78.3 -30.4 15.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 172.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.403 ' HZ3' ' CD ' ' A' ' 29' ' ' GLU . 5.6 tppt? -64.23 -42.47 96.53 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.559 1.144 . . . . 0.0 110.738 174.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.77 -51.02 62.5 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.475 1.11 . . . . 0.0 111.314 173.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.68 -31.54 70.78 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.456 HD23 ' HB3' ' A' ' 33' ' ' CYS . 0.5 OUTLIER -62.82 -61.58 2.31 Favored 'General case' 0 CA--C 1.514 -0.431 0 C-N-CA 124.843 1.257 . . . . 0.0 110.085 173.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.16 -19.18 52.64 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 114.185 1.18 . . . . 0.0 114.185 -178.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 10.8 tt0 -80.93 -51.47 8.52 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.005 1.322 . . . . 0.0 111.188 173.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.6 t -62.89 -27.82 69.62 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.829 1.652 . . . . 0.0 113.424 175.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 20.6 tt0 . . . . . 0 CA--C 1.541 0.62 0 C-N-CA 124.237 1.015 . . . . 0.0 113.067 178.951 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.5 mtt . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 119.291 -0.385 . . . . 0.0 111.457 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.47 142.39 46.82 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.072 0.549 . . . . 0.0 109.699 158.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 7.2 tp -89.28 112.43 23.49 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-O 121.56 0.695 . . . . 0.0 111.237 -163.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -77.46 102.63 6.97 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 127.144 2.177 . . . . 0.0 113.243 -173.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.41 HG22 HG23 ' A' ' 52' ' ' VAL . 4.8 t -110.39 144.12 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.235 1.414 . . . . 0.0 110.625 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 37' ' ' CYS . 1.0 OUTLIER -132.28 160.3 36.63 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 128.802 2.841 . . . . 0.0 111.366 174.574 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 7.0 t -141.65 118.63 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.425 0 C-N-CA 125.682 1.593 . . . . 0.0 107.381 167.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 22.4 t -85.64 137.77 20.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.098 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 166.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -148.78 158.58 44.26 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 120.993 -1.067 . . . . 0.0 111.048 170.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 58.5 p -82.62 88.21 6.69 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.161 0.984 . . . . 0.0 110.626 171.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.34 55.03 0.29 Allowed Glycine 0 CA--C 1.534 1.266 0 C-N-CA 129.054 3.216 . . . . 0.0 116.624 -167.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.43 53.5 0.41 Allowed 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 127.175 2.19 . . . . 0.0 113.308 176.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.9 t 55.83 -177.26 0.04 OUTLIER 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 126.505 1.922 . . . . 0.0 113.472 -166.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 63.99 -20.29 0.09 OUTLIER Glycine 0 CA--C 1.542 1.751 0 C-N-CA 127.821 2.629 . . . . 0.0 117.078 -178.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -64.37 -33.78 76.65 Favored 'General case' 0 C--O 1.225 -0.214 0 C-N-CA 125.193 1.397 . . . . 0.0 114.208 -169.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.4 mmmt -50.95 -66.04 0.77 Allowed Pre-proline 0 N--CA 1.477 0.891 0 CA-C-O 116.717 -1.611 . . . . 0.0 113.549 -179.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -64.94 -30.15 57.44 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 CA-C-N 122.541 1.943 . . . . 0.0 113.02 178.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -60.99 -40.49 93.7 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 119.659 1.118 . . . . 0.0 112.389 173.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -64.72 -56.93 10.58 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 126.075 1.75 . . . . 0.0 110.3 171.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mt -50.73 -45.4 58.65 Favored 'General case' 0 C--O 1.214 -0.785 0 C-N-CA 123.61 0.764 . . . . 0.0 111.702 -177.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.27 -18.66 65.49 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 119.859 -1.775 . . . . 0.0 114.237 -175.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 8.4 tt -86.5 -43.2 12.93 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 119.214 0.916 . . . . 0.0 111.261 161.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -61.72 -56.31 21.01 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.877 1.271 . . . . 0.0 112.771 -175.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -68.15 13.67 0.08 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 130.278 3.431 . . . . 0.0 113.622 171.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.42 -61.6 1.36 Allowed 'General case' 0 C--O 1.219 -0.538 0 C-N-CA 126.165 1.786 . . . . 0.0 111.325 148.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 tp -56.71 -41.69 77.86 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.216 1.406 . . . . 0.0 114.292 -170.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.05 -36.62 77.89 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 125.313 1.445 . . . . 0.0 114.747 169.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 1.8 t60 -65.58 -40.18 92.46 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 123.631 0.773 . . . . 0.0 112.536 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -62.63 -41.22 98.9 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.62 1.568 . . . . 0.0 111.206 176.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -133.6 52.1 7.78 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 125.132 1.373 . . . . 0.0 113.43 -164.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -66.6 126.22 15.1 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.589 2.192 . . . . 0.0 112.222 -165.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.72 -12.66 0.04 OUTLIER Glycine 0 CA--C 1.534 1.225 0 C-N-CA 126.371 1.938 . . . . 0.0 116.609 -170.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 61.3 m -70.35 -10.4 58.92 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.347 1.574 . . . . 0.0 112.445 163.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.14 163.23 32.19 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 127.176 2.19 . . . . 0.0 112.546 -174.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -134.1 137.86 44.88 Favored 'General case' 0 C--N 1.322 -0.621 0 C-N-CA 131.137 3.775 . . . . 0.0 107.694 165.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.3 mp -137.05 111.95 10.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 122.894 1.33 . . . . 0.0 109.002 163.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . 0.651 ' HB2' HH11 ' A' ' 6' ' ' ARG . 68.2 m -106.72 -171.89 1.98 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.136 163.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -162.17 165.71 36.08 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.453 1.025 . . . . 0.0 114.748 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -139.37 59.26 1.61 Allowed 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 128.826 2.85 . . . . 0.0 109.4 -167.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -72.35 60.42 1.51 Allowed Glycine 0 CA--C 1.536 1.372 0 C-N-CA 126.341 1.924 . . . . 0.0 113.738 178.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 11.7 t -53.83 128.03 53.78 Favored Pre-proline 0 N--CA 1.475 0.8 0 C-N-CA 125.572 1.549 . . . . 0.0 112.302 -176.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -76.74 65.68 7.54 Favored 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 124.834 3.689 . . . . 0.0 112.651 -170.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -138.49 -171.89 3.16 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 128.105 2.562 . . . . 0.0 108.991 175.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.27 111.8 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.939 0 C-N-CA 124.436 1.094 . . . . 0.0 110.64 -174.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 39.8 p -141.45 -25.19 0.71 Allowed 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 124.557 1.143 . . . . 0.0 113.957 174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 77.93 -5.08 55.32 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 124.649 1.119 . . . . 0.0 114.844 -176.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -64.72 141.04 58.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.107 1.763 . . . . 0.0 109.424 170.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.8 t80 -149.27 93.31 2.06 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 128.68 2.792 . . . . 0.0 107.646 -173.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -123.34 104.73 9.3 Favored 'General case' 0 CA--C 1.547 0.828 0 O-C-N 121.13 -0.981 . . . . 0.0 111.317 -151.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 42.3 t -101.44 122.61 53.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 O-C-N 121.461 -0.775 . . . . 0.0 110.222 -166.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.92 140.88 51.22 Favored 'General case' 0 N--CA 1.448 -0.544 0 C-N-CA 126.03 1.732 . . . . 0.0 110.922 178.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.41 HG23 HG22 ' A' ' 5' ' ' VAL . 7.7 p -132.67 128.36 57.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.616 0 C-N-CA 125.835 1.654 . . . . 0.0 110.378 171.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 42.0 32.89 0.32 Allowed 'General case' 0 CA--C 1.557 1.219 0 C-N-CA 126.376 1.87 . . . . 0.0 114.665 -170.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 87.8 5.32 77.98 Favored Glycine 0 CA--C 1.54 1.596 0 C-N-CA 125.475 1.512 . . . . 0.0 115.581 -176.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -98.96 106.15 18.38 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 126.984 2.113 . . . . 0.0 110.647 177.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -62.06 118.81 7.81 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 124.8 1.24 . . . . 0.0 110.621 167.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.3 t -106.54 -30.03 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 124.863 1.265 . . . . 0.0 110.68 -178.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 34.3 t60 -148.48 149.74 32.2 Favored 'General case' 0 CA--C 1.521 -0.139 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.384 -165.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 43.8 t -166.85 111.51 0.76 Allowed 'General case' 0 C--O 1.242 0.66 0 C-N-CA 123.466 0.706 . . . . 0.0 112.291 -169.112 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.657 ' HE3' ' H ' ' A' ' 65' ' ' GLY . 0.2 OUTLIER -67.84 -23.5 65.17 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 117.23 -1.366 . . . . 0.0 113.334 161.134 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.2 tmtm? -62.12 -35.21 78.03 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 120.134 1.334 . . . . 0.0 112.473 172.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.4 ' HE ' ' HB2' ' A' ' 64' ' ' ASP . 7.9 ptt180 -82.37 -32.84 29.02 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 119.237 0.926 . . . . 0.0 112.089 170.283 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.6 9.75 10.99 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 124.878 1.228 . . . . 0.0 114.789 167.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.4 ' HB2' ' HE ' ' A' ' 62' ' ' ARG . 24.7 t0 -37.56 -52.01 1.18 Allowed 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 128.39 2.676 . . . . 0.0 113.441 -174.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.657 ' H ' ' HE3' ' A' ' 60' ' ' LYS . . . 131.59 -156.46 21.88 Favored Glycine 0 C--O 1.226 -0.373 0 CA-C-N 114.753 -1.112 . . . . 0.0 111.333 -159.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -117.28 -153.74 0.54 Allowed 'General case' 0 C--N 1.317 -0.845 0 C-N-CA 129.81 3.244 . . . . 0.0 108.449 163.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.3 m -78.65 82.65 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-O 123.222 1.487 . . . . 0.0 111.222 147.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -78.61 -14.51 59.28 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 126.198 1.799 . . . . 0.0 114.015 -173.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.72 169.0 25.36 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 125.46 1.504 . . . . 0.0 110.659 -167.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.81 -53.31 59.62 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.666 0.746 . . . . 0.0 110.781 167.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.6 t -56.56 -38.48 71.99 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 115.437 -0.801 . . . . 0.0 112.011 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt -60.41 -55.5 32.81 Favored 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 126.233 1.813 . . . . 0.0 111.793 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 35.4 t80 -56.03 -52.34 64.57 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 122.751 0.42 . . . . 0.0 111.281 174.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.0 ttt85 -62.56 -26.6 68.66 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 125.764 1.625 . . . . 0.0 114.403 -177.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -61.71 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 124.864 1.266 . . . . 0.0 110.548 168.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.51 -45.56 62.09 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 123.584 0.553 . . . . 0.0 110.704 179.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.06 -47.11 80.82 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.685 0 C-N-CA 122.422 0.289 . . . . 0.0 110.752 173.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 96.5 m -60.11 -43.41 95.61 Favored 'General case' 0 CA--C 1.51 -0.57 0 O-C-N 121.851 -0.531 . . . . 0.0 111.133 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.46 -34.54 72.55 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 21.6 mm -76.62 -33.88 22.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 122.916 0.487 . . . . 0.0 109.937 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.32 -42.4 75.4 Favored 'General case' 0 N--CA 1.476 0.829 0 O-C-N 121.271 -0.893 . . . . 0.0 109.272 178.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.83 -53.73 51.91 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.029 1.332 . . . . 0.0 110.701 175.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -60.21 -38.88 84.69 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.806 0.842 . . . . 0.0 112.487 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.3 -59.35 5.25 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.518 0.675 . . . . 0.0 110.532 170.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -62.28 -7.51 4.39 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 115.821 1.786 . . . . 0.0 115.821 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 69.2 mt-30 -91.23 -49.95 6.09 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 125.825 1.65 . . . . 0.0 111.052 166.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -19.3 65.9 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.017 1.727 . . . . 0.0 114.587 178.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 17.2 tt0 . . . . . 0 N--CA 1.476 0.859 0 CA-C-N 119.2 0.909 . . . . 0.0 112.926 175.56 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.3 mpp? . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 118.07 -0.967 . . . . 0.0 109.179 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.75 -178.17 0.04 OUTLIER 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 125.73 1.612 . . . . 0.0 114.465 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 9.9 tp -127.23 123.74 37.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.257 1.423 . . . . 0.0 110.941 -176.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -93.09 100.79 13.13 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 125.852 1.661 . . . . 0.0 114.496 -165.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 8.6 t -108.24 148.59 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 O-C-N 120.654 -1.279 . . . . 0.0 111.922 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.61 157.41 46.84 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 128.933 2.893 . . . . 0.0 112.078 -175.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.474 ' H ' ' HA2' ' A' ' 38' ' ' GLY . 6.0 t -142.54 104.84 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 C-N-CA 127.693 2.397 . . . . 0.0 109.503 177.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.59 115.7 32.06 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.03 0.832 . . . . 0.0 110.477 177.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -135.0 155.4 50.84 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.917 1.287 . . . . 0.0 111.881 -174.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 73.5 p -69.21 81.56 0.35 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.001 1.72 . . . . 0.0 111.254 159.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.98 43.29 1.2 Allowed Glycine 0 CA--C 1.538 1.502 0 C-N-CA 126.165 1.84 . . . . 0.0 116.439 -171.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 62.78 0.08 Allowed 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 128.665 2.786 . . . . 0.0 113.168 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.6 t 57.14 -173.82 0.07 Allowed 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 126.453 1.901 . . . . 0.0 112.305 -165.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 62.9 -18.36 0.07 OUTLIER Glycine 0 CA--C 1.541 1.677 0 C-N-CA 127.015 2.245 . . . . 0.0 117.006 179.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -67.32 -30.88 70.83 Favored 'General case' 0 C--O 1.22 -0.479 0 CA-C-N 118.99 1.395 . . . . 0.0 114.405 -171.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.2 mmtt -53.96 -63.62 2.49 Favored Pre-proline 0 N--CA 1.476 0.854 0 CA-C-O 116.783 -1.58 . . . . 0.0 113.929 -177.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -66.34 -32.45 41.17 Favored 'Trans proline' 0 C--N 1.351 0.659 0 CA-C-N 122.419 1.899 . . . . 0.0 112.372 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -58.33 -48.77 79.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.088 0.955 . . . . 0.0 111.975 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 4.2 m-30 -58.88 -54.82 42.84 Favored 'General case' 0 C--O 1.223 -0.299 0 C-N-CA 125.917 1.687 . . . . 0.0 110.913 169.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 80.7 mt -59.2 -39.35 82.35 Favored 'General case' 0 C--O 1.212 -0.889 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -176.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -67.57 -44.39 78.32 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 120.935 1.698 . . . . 0.0 111.044 -178.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -61.75 -47.32 85.75 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 123.78 0.832 . . . . 0.0 110.512 172.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.418 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 5.1 mmmt -59.33 -58.5 8.35 Favored 'General case' 0 CA--C 1.515 -0.387 0 C-N-CA 126.716 2.006 . . . . 0.0 112.072 179.031 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -43.49 -42.5 4.92 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.751 1.621 . . . . 0.0 112.444 179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -71.91 -21.54 61.62 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 116.53 2.048 . . . . 0.0 116.53 179.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.3 tp -92.91 -46.76 7.35 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.48 2.312 . . . . 0.0 111.096 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.418 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 10.9 mt-10 -63.23 -29.68 70.97 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.953 1.701 . . . . 0.0 114.972 168.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 14.6 t-80 -54.91 -50.49 68.68 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.973 1.309 . . . . 0.0 111.224 161.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -71.84 -35.66 69.94 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.669 -171.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -130.53 43.01 0.99 Allowed Pre-proline 0 CA--C 1.547 0.855 0 C-N-CA 126.716 2.006 . . . . 0.0 114.296 -166.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -63.22 120.54 8.04 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.149 1.899 . . . . 0.0 111.546 -166.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 56.67 -6.55 0.02 OUTLIER Glycine 0 CA--C 1.535 1.313 0 C-N-CA 126.249 1.881 . . . . 0.0 117.357 -169.039 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.7 m -69.75 -12.44 61.63 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 120.089 1.944 . . . . 0.0 112.164 164.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.16 157.78 45.91 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 127.331 2.252 . . . . 0.0 112.413 -178.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -109.95 140.37 44.01 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 127.337 2.255 . . . . 0.0 108.674 153.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.4 mp -136.4 124.86 36.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-O 123.271 1.51 . . . . 0.0 108.274 158.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.0 m -120.91 -179.79 4.12 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 127.357 2.263 . . . . 0.0 110.155 167.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.474 ' HA2' ' H ' ' A' ' 7' ' ' VAL . . . -159.07 155.53 26.61 Favored Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.637 1.113 . . . . 0.0 111.636 170.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -134.05 82.55 1.98 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 127.091 2.156 . . . . 0.0 107.489 -163.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -76.42 35.69 1.35 Allowed Glycine 0 CA--C 1.534 1.248 0 C-N-CA 126.712 2.101 . . . . 0.0 115.667 -168.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 m -53.79 103.96 0.4 Allowed Pre-proline 0 N--CA 1.478 0.948 0 C-N-CA 126.639 1.976 . . . . 0.0 112.579 -175.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 68.0 Cg_endo -87.17 75.18 2.5 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.723 2.949 . . . . 0.0 111.859 -161.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.58 -22.19 3.66 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 -172.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 22.4 t -138.62 100.89 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 CA-C-N 121.13 1.787 . . . . 0.0 112.062 -177.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 20.2 m 57.39 -70.34 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 118.203 2.668 . . . . 0.0 118.203 157.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 173.04 24.14 0.02 OUTLIER Glycine 0 CA--C 1.536 1.384 0 N-CA-C 116.287 1.275 . . . . 0.0 116.287 -159.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 13.8 m-30 -67.75 157.34 34.91 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 118.376 1.088 . . . . 0.0 111.288 168.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -163.22 87.21 0.55 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 127.294 2.238 . . . . 0.0 107.263 -175.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -117.43 115.33 24.98 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 120.809 -1.182 . . . . 0.0 109.108 -157.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -106.43 132.68 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 121.195 0.521 . . . . 0.0 110.11 -169.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 2.9 m -137.07 136.15 38.12 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.009 0.924 . . . . 0.0 110.606 -177.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.32 121.32 64.44 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 127.882 2.473 . . . . 0.0 109.639 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 41.89 35.94 0.59 Allowed 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 125.994 1.718 . . . . 0.0 114.811 -174.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 82.13 32.75 28.1 Favored Glycine 0 CA--C 1.536 1.385 0 O-C-N 121.105 -0.997 . . . . 0.0 114.708 -177.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -133.35 106.27 7.42 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.996 2.118 . . . . 0.0 109.817 178.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 8.7 tt -66.91 132.8 48.73 Favored 'General case' 0 C--N 1.333 -0.118 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 175.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -119.23 -21.51 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 CA-C-N 114.339 -1.3 . . . . 0.0 111.41 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -145.6 155.97 43.38 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 124.142 0.977 . . . . 0.0 112.943 -172.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.499 ' HB3' ' CG ' ' A' ' 62' ' ' ARG . 14.0 t -163.36 110.64 1.18 Allowed 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.513 1.125 . . . . 0.0 112.44 -175.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 2.2 mmmt -61.51 -31.45 71.46 Favored 'General case' 0 N--CA 1.469 0.497 0 O-C-N 119.841 -1.787 . . . . 0.0 113.171 160.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.3 ttmp? -57.38 -49.29 76.63 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.419 1.488 . . . . 0.0 112.015 175.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.499 ' CG ' ' HB3' ' A' ' 59' ' ' SER . 0.0 OUTLIER -74.43 -12.43 60.5 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.785 1.234 . . . . 0.0 113.794 -178.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 93.14 28.82 11.11 Favored Glycine 0 C--N 1.332 0.308 0 C-N-CA 124.037 0.827 . . . . 0.0 112.684 177.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -69.35 -35.5 75.94 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 179.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 69.91 151.52 0.61 Allowed Glycine 0 CA--C 1.536 1.385 0 C-N-CA 123.553 0.597 . . . . 0.0 113.336 -176.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 23.7 m-85 -62.72 -169.54 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.428 1.491 . . . . 0.0 113.555 -175.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 18.6 m -77.12 67.18 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.68 0 CA-C-O 124.89 2.281 . . . . 0.0 112.771 176.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 64.7 m-20 -67.23 -14.48 62.96 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 131.119 3.768 . . . . 0.0 111.943 -179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.77 163.89 39.27 Favored 'General case' 0 C--O 1.233 0.222 0 O-C-N 120.846 -1.159 . . . . 0.0 111.019 172.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -53.49 -43.83 68.52 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.804 1.241 . . . . 0.0 112.295 171.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -64.03 -29.98 71.09 Favored 'General case' 0 N--CA 1.47 0.542 0 O-C-N 120.781 -1.199 . . . . 0.0 112.952 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.95 -52.67 40.14 Favored 'General case' 0 N--CA 1.465 0.323 0 C-N-CA 123.45 0.7 . . . . 0.0 110.742 171.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -58.92 -45.82 89.42 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.202 0.525 . . . . 0.0 112.362 178.249 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 -57.13 -29.5 63.62 Favored 'General case' 0 N--CA 1.465 0.286 0 C-N-CA 125.871 1.668 . . . . 0.0 112.983 178.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.5 tptt -53.44 -47.09 69.98 Favored 'General case' 0 N--CA 1.464 0.275 0 C-N-CA 124.882 1.273 . . . . 0.0 110.915 172.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 14.1 tp -73.26 -49.13 29.42 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.732 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 76.2 t -57.67 -42.51 81.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.036 -178.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 39.7 m -64.45 -43.88 92.89 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-O 118.844 -0.598 . . . . 0.0 111.856 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.5 -31.42 60.17 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 119.772 -0.771 . . . . 0.0 112.748 -173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 35.8 mm -83.4 -27.23 7.67 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.8 ttpt -73.84 -36.59 64.92 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 123.483 0.713 . . . . 0.0 111.328 175.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.35 -52.62 64.84 Favored 'General case' 0 CA--C 1.538 0.5 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.096 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.16 -23.21 67.05 Favored 'General case' 0 CA--C 1.542 0.635 0 N-CA-C 114.051 1.13 . . . . 0.0 114.051 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -61.09 -59.41 5.39 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.359 1.064 . . . . 0.0 109.856 169.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.97 -20.52 58.07 Favored 'General case' 0 CA--C 1.543 0.711 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -179.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 24.5 tt0 -84.2 -42.08 16.32 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.774 1.23 . . . . 0.0 111.762 175.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 8.7 t -62.31 -29.04 70.15 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.429 1.492 . . . . 0.0 112.713 170.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 59.5 tt0 . . . . . 0 CA--C 1.546 0.815 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 174.553 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ptm . . . . . 0 N--CA 1.478 0.932 0 CA-C-O 120.201 0.048 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -148.83 154.1 39.03 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 120.848 -1.158 . . . . 0.0 111.601 175.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 6.3 tp -108.37 116.7 32.45 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.75 1.22 . . . . 0.0 112.357 -166.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -82.86 107.47 15.49 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 128.741 2.816 . . . . 0.0 114.406 -175.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 52' ' ' VAL . 17.5 t -111.59 143.66 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.825 0 C-N-CA 124.774 1.23 . . . . 0.0 110.709 -178.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.435 HH12 ' CG ' ' A' ' 35' ' ' ASP . 1.7 mpp_? -140.78 153.23 45.76 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 128.313 2.645 . . . . 0.0 111.031 -177.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 21.2 t -142.71 119.33 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 125.047 1.339 . . . . 0.0 108.244 177.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.1 p -82.55 121.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.706 0 O-C-N 123.201 0.313 . . . . 0.0 110.617 166.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 26.7 t80 -133.88 149.4 51.33 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 113.308 0.855 . . . . 0.0 113.308 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 97.3 p -86.19 94.15 9.22 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.861 1.665 . . . . 0.0 110.459 163.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -68.13 30.15 0.25 Allowed Glycine 0 CA--C 1.538 1.488 0 C-N-CA 128.106 2.765 . . . . 0.0 117.177 -171.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -52.85 -36.45 58.86 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.683 1.993 . . . . 0.0 115.815 -161.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 9.0 t -153.56 163.99 39.02 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.525 1.13 . . . . 0.0 109.623 163.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 55.25 9.5 2.17 Favored Glycine 0 CA--C 1.54 1.644 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 167.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -63.37 -38.71 92.19 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 115.561 1.689 . . . . 0.0 115.561 -156.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 63.3 mtpt -54.02 -59.05 10.86 Favored Pre-proline 0 N--CA 1.477 0.885 0 CA-C-O 117.188 -1.387 . . . . 0.0 114.148 -175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -64.57 -35.85 45.81 Favored 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 121.965 1.777 . . . . 0.0 113.37 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 12.2 tptp -54.13 -46.01 72.09 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 119.822 1.192 . . . . 0.0 112.19 172.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -60.47 -57.9 10.79 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 125.998 1.719 . . . . 0.0 110.549 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.2 mp -55.53 -35.53 65.76 Favored 'General case' 0 C--O 1.215 -0.75 0 CA-C-O 117.681 -1.152 . . . . 0.0 112.931 179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -29.59 70.25 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 120.961 1.709 . . . . 0.0 111.702 -176.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 59.1 tp -79.41 -48.67 13.58 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.69 -0.631 . . . . 0.0 112.036 164.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 1.4 ttpt -63.56 -51.37 65.7 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.979 0.911 . . . . 0.0 113.191 -170.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.502 ' CD ' ' HZ3' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -40.92 -48.49 3.15 Favored 'General case' 0 C--O 1.221 -0.405 0 C-N-CA 127.51 2.324 . . . . 0.0 111.847 171.961 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.502 ' HZ3' ' CD ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER -63.41 -45.54 90.52 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 124.977 1.311 . . . . 0.0 112.392 -178.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mp -64.16 -51.07 65.6 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 126.323 1.849 . . . . 0.0 112.345 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -66.57 -31.89 72.88 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 125.933 1.693 . . . . 0.0 114.395 172.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -63.21 -44.87 94.1 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 119.358 0.981 . . . . 0.0 111.646 168.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -67.67 -40.04 84.48 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.083 0.953 . . . . 0.0 112.166 -176.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -137.67 51.19 3.97 Favored Pre-proline 0 CA--C 1.547 0.863 0 C-N-CA 124.716 1.207 . . . . 0.0 113.854 -168.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -61.73 133.79 47.04 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 121.709 1.606 . . . . 0.0 111.449 -173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 70.38 -26.23 0.46 Allowed Glycine 0 N--CA 1.473 1.149 0 C-N-CA 126.437 1.97 . . . . 0.0 116.399 -178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.627 ' HB3' HD21 ' A' ' 84' ' ' LEU . 5.7 m -71.47 -13.1 61.72 Favored 'General case' 0 CA--C 1.533 0.295 0 O-C-N 121.233 -1.157 . . . . 0.0 111.611 164.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.83 153.7 50.72 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 123.263 1.506 . . . . 0.0 114.001 -176.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.435 ' CG ' HH12 ' A' ' 6' ' ' ARG . 4.6 t0 -124.32 133.24 53.51 Favored 'General case' 0 C--N 1.319 -0.72 0 C-N-CA 128.707 2.803 . . . . 0.0 106.615 174.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mp -134.34 121.31 36.6 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.842 0 C-N-CA 124.259 1.024 . . . . 0.0 108.46 160.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' CYS . . . . . . . . . . . . . 74.4 m -120.39 -176.59 3.25 Favored 'General case' 0 C--N 1.321 -0.672 0 C-N-CA 127.137 2.175 . . . . 0.0 109.04 167.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -157.19 162.22 31.68 Favored Glycine 0 N--CA 1.475 1.251 0 N-CA-C 116.786 1.474 . . . . 0.0 116.786 -175.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -125.77 79.02 1.79 Allowed 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 128.761 2.824 . . . . 0.0 109.614 -176.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -100.36 82.94 0.53 Allowed Glycine 0 CA--C 1.531 1.085 0 O-C-N 120.646 -1.284 . . . . 0.0 113.85 -169.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.2 t -74.76 145.73 82.06 Favored Pre-proline 0 N--CA 1.473 0.692 0 C-N-CA 124.663 1.185 . . . . 0.0 112.738 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.53 -0.35 8.66 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 123.394 2.729 . . . . 0.0 113.95 171.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -68.09 84.19 0.23 Allowed 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.699 1.2 . . . . 0.0 111.863 177.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 6.0 p -49.7 95.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.401 2.281 . . . . 0.0 112.461 171.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 19.1 p -142.81 -15.86 0.71 Allowed 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.472 1.509 . . . . 0.0 114.12 -171.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.09 1.96 66.71 Favored Glycine 0 CA--C 1.534 1.27 0 N-CA-C 115.919 1.128 . . . . 0.0 115.919 172.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 -68.48 141.74 55.51 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 118.765 1.282 . . . . 0.0 110.806 171.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -151.93 79.26 1.26 Allowed 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 128.899 2.879 . . . . 0.0 107.214 167.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -111.09 124.44 52.18 Favored 'General case' 0 CA--C 1.538 0.482 0 O-C-N 120.657 -1.277 . . . . 0.0 110.195 -166.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.418 ' HB ' ' HB3' ' A' ' 58' ' ' HIS . 55.4 t -112.53 128.29 69.27 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.172 0 C-N-CA 123.535 0.734 . . . . 0.0 109.915 -165.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 16.8 p -127.13 145.81 50.61 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 126.772 2.029 . . . . 0.0 111.386 -176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.475 HG23 HG22 ' A' ' 5' ' ' VAL . 11.4 p -137.72 126.46 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 C-N-CA 125.362 1.465 . . . . 0.0 110.378 176.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 43.83 28.56 0.24 Allowed 'General case' 0 CA--C 1.558 1.262 0 C-N-CA 124.825 1.25 . . . . 0.0 113.643 -158.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 88.5 -20.7 29.48 Favored Glycine 0 CA--C 1.54 1.626 0 C-N-CA 126.034 1.778 . . . . 0.0 115.426 -171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.74 111.0 2.58 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.727 1.763 . . . . 0.0 111.491 174.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.6 tt -49.05 131.83 19.07 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.654 0.782 . . . . 0.0 111.31 162.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 2.1 t -121.3 -26.66 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.129 0 C-N-CA 126.524 1.93 . . . . 0.0 111.807 171.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' HIS . . . . . 0.418 ' HB3' ' HB ' ' A' ' 50' ' ' VAL . 44.8 t60 -135.33 153.76 51.74 Favored 'General case' 0 CA--C 1.522 -0.106 0 C-N-CA 125.173 1.389 . . . . 0.0 110.583 -178.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.56 101.44 2.33 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.014 174.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.19 -33.86 67.91 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 120.266 -1.521 . . . . 0.0 112.401 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 3.5 ttpt -75.2 -12.03 60.2 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 125.999 1.719 . . . . 0.0 113.973 175.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.74 -13.73 33.47 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 120.378 1.444 . . . . 0.0 113.885 162.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 83.75 32.3 24.62 Favored Glycine 0 CA--C 1.526 0.755 0 C-N-CA 123.783 0.706 . . . . 0.0 111.786 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -68.26 -31.68 71.33 Favored 'General case' 0 CA--C 1.552 1.03 0 O-C-N 121.031 -1.276 . . . . 0.0 112.415 170.182 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 70.32 153.12 0.92 Allowed Glycine 0 CA--C 1.536 1.369 0 C-N-CA 125.302 1.43 . . . . 0.0 114.153 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -60.84 -174.47 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.256 1.422 . . . . 0.0 114.346 -174.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.253 26.7 m -77.41 69.95 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.595 0 CA-C-O 124.886 2.279 . . . . 0.0 112.147 174.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -70.94 -16.14 62.64 Favored 'General case' 0 C--N 1.316 -0.872 0 C-N-CA 129.944 3.297 . . . . 0.0 111.534 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -159.91 163.58 34.17 Favored 'General case' 0 C--O 1.234 0.289 0 O-C-N 120.934 -1.104 . . . . 0.0 110.117 172.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -58.51 -36.97 74.63 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.566 0.746 . . . . 0.0 112.483 178.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.07 -31.76 72.82 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 120.946 -1.096 . . . . 0.0 112.594 176.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.97 -46.71 70.62 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 123.388 0.675 . . . . 0.0 111.69 172.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -56.8 -46.77 81.38 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 120.816 0.341 . . . . 0.0 111.555 172.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -56.31 -29.73 61.64 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.268 1.827 . . . . 0.0 114.542 178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.15 -34.0 77.07 Favored 'General case' 0 N--CA 1.472 0.627 0 CA-C-N 120.117 1.326 . . . . 0.0 111.826 171.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.63 -42.76 24.17 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 123.588 0.755 . . . . 0.0 111.587 173.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 81.0 t -52.4 -51.24 34.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 O-C-N 122.388 -0.195 . . . . 0.0 110.815 172.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 50.1 m -60.27 -38.43 83.52 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 119.196 -0.43 . . . . 0.0 111.399 -174.153 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.13 -28.41 38.94 Favored 'General case' 0 C--O 1.23 0.075 0 C-N-CA 119.557 -0.857 . . . . 0.0 113.127 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 33.5 mm -76.0 -39.1 36.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.284 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 174.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.7 ttmm -68.2 -43.99 76.82 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.318 1.047 . . . . 0.0 110.782 -176.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -61.34 -54.06 48.68 Favored 'General case' 0 CA--C 1.533 0.307 0 O-C-N 124.268 0.98 . . . . 0.0 110.577 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -63.48 -28.99 70.34 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.272 0.841 . . . . 0.0 113.272 -179.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.627 HD21 ' HB3' ' A' ' 33' ' ' CYS . 2.1 tm? -65.21 -54.79 24.12 Favored 'General case' 0 N--CA 1.464 0.253 0 O-C-N 121.828 -0.545 . . . . 0.0 111.094 172.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -59.45 -20.61 56.45 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 177.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -77.86 -56.12 4.76 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 125.518 1.527 . . . . 0.0 111.308 171.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' CYS . . . . . . . . . . . . . 1.5 m -60.1 -17.78 42.38 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.908 1.283 . . . . 0.0 114.291 174.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 . . . . . 0 CA--C 1.544 0.715 0 CA-C-N 119.692 1.133 . . . . 0.0 113.622 172.695 . . . . . . . . 0 0 . 1 stop_ save_